<SEC-DOCUMENT>0001999371-25-015465.txt : 20251015
<SEC-HEADER>0001999371-25-015465.hdr.sgml : 20251015
<ACCEPTANCE-DATETIME>20251015135705
ACCESSION NUMBER:		0001999371-25-015465
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20251015
DATE AS OF CHANGE:		20251015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nuveen Global High Income Fund
		CENTRAL INDEX KEY:			0001615905
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287584
		FILM NUMBER:		251394335

	BUSINESS ADDRESS:	
		STREET 1:		333 WEST WACKER DRIVE
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		312-917-8146

	MAIL ADDRESS:	
		STREET 1:		333 WEST WACKER DRIVE
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>jgh-424b2_101525.htm
<DESCRIPTION>PROSPECTUS FILED UNDER RULE 424(B)(2)
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:jgh="http://nuveen.com/20251015">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_CEF%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_jgh_nuveen.com_20251015 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20251015_20251015 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DEntityCentralIndexKey_0001615905 -->
<!-- Field: Set; Name: xdx; ID: xdx_07B_XDX_P%2D%2D\Clients\Nuveen\2025\q25%2D30468__424B2__Global High Income Fund\jgh%2D424b2.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-10-15" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-10-15" id="Fact000004" name="dei:EntityCentralIndexKey">0001615905</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-10-15" id="xdx2ixbrl0010" name="dei:DocumentType">424B2</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="jgh-20251015.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-10-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-15</xbrli:startDate>
        <xbrli:endDate>2025-10-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-10-08_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-10-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-07-012025-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-07-01</xbrli:startDate>
        <xbrli:endDate>2025-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-012025-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-10-082025-10-08_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-08</xbrli:startDate>
        <xbrli:endDate>2025-10-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-10-082025-10-08_custom_CommonStockAdjustedForOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jgh:CommonStockAdjustedForOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-08</xbrli:startDate>
        <xbrli:endDate>2025-10-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-10-08_custom_CommonStockAdjustedForOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001615905</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jgh:CommonStockAdjustedForOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-10-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000020" toRefs="Footnote000023"/>
  <ix:relationship fromRefs="Fact000021" toRefs="Footnote000023"/>
  <ix:relationship fromRefs="Fact000022" toRefs="Footnote000024"/>
  <ix:relationship fromRefs="Fact000028" toRefs="Footnote000033"/>
  <ix:relationship fromRefs="Fact000029" toRefs="Footnote000033 Footnote000034"/>
  <ix:relationship fromRefs="Fact000030" toRefs="Footnote000033 Footnote000035"/>
  <ix:relationship fromRefs="Fact000031" toRefs="Footnote000033"/>
  <ix:relationship fromRefs="Fact000039" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000040" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000041" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000042" toRefs="Footnote000043"/>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Filed Pursuant to Rule <span id="xdx_904_edei--DocumentType_dxL_c20251015__20251015_zvtFIkbi0Jn6" title="::XDX::424B2"><span style="-sec-ix-hidden: xdx2ixbrl0010">424(b)(2)</span></span><br/>
Registration Statement No. 333-287584</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; color: Red"><img src="jqc424b2001.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>PROSPECTUS SUPPLEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(To Prospectus dated August 19, 2025)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>23,317,392 Rights for 5,829,348
Common Shares</b> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="background-color: white"><b>Issuable Upon the Exercise of </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="background-color: white"><b>Transferable Subscription Rights to Purchase Common Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_900_edei--EntityRegistrantName_c20251015__20251015_zqDcxdBRUGt6"><b><ix:nonNumeric contextRef="AsOf2025-10-15" id="Fact000011" name="dei:EntityRegistrantName">Nuveen
Global High Income Fund</ix:nonNumeric></b></span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 38%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 24%">&#160;</td>
  <td style="width: 38%">&#160;</td></tr>
</table>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>



<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Nuveen Global High Income Fund (the &#8220;Fund&#8221;), a diversified, closed-end management investment company, is issuing transferable subscription rights (the &#8220;Rights&#8221;) to its common shareholders (the &#8220;Common Shareholders&#8221;) to subscribe for an aggregate of 5,829,348 common shares, $0.01 par value per share (each, a &#8220;Common Share,&#8221; and collectively, the &#8220;Common Shares&#8221;), pursuant to this prospectus supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Common Shares are listed on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;JGH.&#8221; Common Shareholders of record on October 21, 2025 (the &#8220;Record Date&#8221;) will receive one Right for each Common Share held. These Rights are transferable and will allow the holders thereof to purchase additional Common Shares. The Rights will be listed for trading on the NYSE under the symbol &#8220;JGH RT&#8221; during the course of the Rights offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Rights entitle the holders to purchase one new Common Share for every four Rights held (1 for 4) (the &#8220;Primary Subscription&#8221;). Record Date Common Shareholders (&#8220;Record Date Shareholders&#8221;) who fully exercise their Rights will be entitled to over-subscribe for additional Common Shares covered by any unexercised Rights in the Primary Subscription, subject to certain limitations and subject to allotment. In addition, the Fund, subject to approval by the Board of Trustees of the Fund (the &#8220;Board&#8221;), may increase the number of Common Shares available for subscription by up to 25%, or up to an additional 1,457,337 Common Shares, for an aggregate total of 7,286,685 Common Shares. See &#8220;Description of the Rights Offering&#8212;Primary and Secondary Over-Subscription Privileges.&#8221; Fractional shares will not be issued upon exercise of Rights. Accordingly, Common Shares may be purchased only pursuant to the exercise of Rights in integral multiples of four. The number of Rights issued to a Record Date Shareholder will be rounded up to the nearest number of Rights evenly divisible by four.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The subscription price per Common Share (the &#8220;Subscription Price&#8221;) will be determined based upon a formula equal to 95% of the average of the last reported sales price of the Common Shares on the NYSE on the Expiration Date (as defined below) and each of the four (4) preceding trading days (the &#8220;Formula Price&#8221;). If, however, the Formula Price is less than 90% of the net asset value (&#8220;NAV&#8221;) per Common Share at the close of trading on the NYSE on the Expiration Date, then the Subscription Price will be 90% of the Fund's NAV per Common Share at the close of trading on the NYSE on the Expiration Date. The Rights offering will expire at 5:00 p.m., Eastern time, on November 20, 2025 (the &#8220;Expiration Date&#8221;).&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Per&#160;Common</b></span><br/> <span style="font-size: 10pt"><b>Share</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Total<sup>(1)</sup></b></span></td>
    <td>&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt">Estimated subscription price of Common Shares to shareholders exercising Rights<sup>(2)</sup></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; width: 8%; text-align: right"><span style="font-size: 10pt">12.84</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right">74,848,828</td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt">Estimated sales load</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-size: 10pt">&#8211;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt">Estimated proceeds, before expenses, to the Fund<sup>(3)</sup></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-size: 10pt">12.84</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-size: 10pt">74,848,828</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0"/>
    <td style="width: 0.5in"><sup>(1)</sup></td>
    <td><span style="background-color: white">Assumes that all Rights are exercised at the estimated Subscription Price (as described below). All of the Rights may not be exercised, and the estimated Subscription Price may be higher or lower than the actual Subscription Price.&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td/>
    <td><sup>(2)</sup></td>
    <td><span style="background-color: white">The estimated Subscription Price to the public is based upon 95% of the average of the last reported sales price of the Fund&#8217;s Common Shares on the NYSE on October 8, 2025 and each of the four (4) preceding trading days. See &#8220;Terms of the Rights Offering&#8212;Subscription Price.&#8221;</span></td></tr>
  <tr style="vertical-align: top">
    <td/>
    <td><sup>(3)</sup></td>
    <td><span style="background-color: white">Nuveen Fund Advisors, LLC ("Nuveen Fund Advisors"), and not the Fund or its Common Shareholders,
will bear all expenses incurred in connection with the Rights offering. Offering expenses borne by Nuveen Fund Advisors are estimated
to be approximately $375,000 in the aggregate. </span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Common Shares are expected to be ready for delivery in book-entry form through the Depository Trust Company on or about November 28, 2025, unless extended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The closing price for the Common Shares on the NYSE on October 8, 2025 was&#160;<span id="xdx_90F_eus-gaap--SharePrice_iI_c20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zlXDhKtNtueg">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-10-08_us-gaap_CommonStockMember" id="Fact000012" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.62</ix:nonFraction></span>. The NAV of the Common Shares at the close of business on October 8, 2025 was&#160;<span id="xdx_902_eus-gaap--NetAssetValuePerShare_iI_c20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zp3tRn3W0Dgk">$<ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2025-10-08_us-gaap_CommonStockMember" id="Fact000013" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.05</ix:nonFraction></span>&#160;per Common Share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Investing in the Common Shares through Rights involves risks. See &#8220;Risk Factors&#8221; beginning on page 14 of the accompanying prospectus and &#8220;Special Characteristics and Risks of the Rights Offering&#8221; beginning on page 21 in this prospectus supplement. You should consider carefully these risks together with all of the other information in this prospectus supplement and the accompanying prospectus before making a decision to invest in Common Shares through Rights.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white"><b>SHAREHOLDERS
WHO DO NOT FULLY EXERCISE THEIR RIGHTS MAY, AT THE COMPLETION OF THE RIGHTS OFFERING, OWN A SMALLER PROPORTIONAL INTEREST IN THE
FUND THAN IF THEY EXERCISED THEIR RIGHTS. AS A RESULT OF THE RIGHTS OFFERING YOU MAY EXPERIENCE SUBSTANTIAL DILUTION OF THE
AGGREGATE NET ASSET VALUE OF YOUR COMMON SHARES. ALL COSTS OF THE OFFERING WILL BE BORNE BY NUVEEN FUND ADVISORS, AND NOT THE FUND
OR COMMON SHAREHOLDERS. RIGHTS EXERCISED BY A RIGHTS HOLDER ARE IRREVOCABLE.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>THE FUND HAS DECLARED MONTHLY OR EXPECTS
TO DECLARE DISTRIBUTIONS PAYABLE ON NOVEMBER 3, 2025 AND DECEMBER 1, 2025, WITH RECORD DATES OF OCTOBER 15, 2025 AND NOVEMBER 14, 2025,
RESPECTIVELY. ANY COMMON SHARES ISSUED AFTER SUCH RECORD DATES AS A RESULT OF THE RIGHTS OFFERING WILL NOT BE RECORD DATE COMMON
SHARES FOR THE FUND&#8217;S MONTHLY DISTRIBUTIONS TO BE PAID ON NOVEMBER 3, 2025 AND DECEMBER 1, 2025 AND WILL NOT BE ENTITLED TO RECEIVE
SUCH DISTRIBUTIONS.</b></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>The date of this prospectus supplement is October 15, 2025.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><i>(continued on next page)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><i>(continued from previous page)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should read this prospectus supplement, together with the accompanying prospectus, which contains important information about the Fund, before deciding whether to invest in Common Shares through Rights and retain it for future reference. A&#160;<a href="http://www.sec.gov/Archives/edgar/data/1615905/000199937125011457/jgh-n2a_052725.htm">statement of additional information</a>, dated August 19, 2025, and as it may be supplemented (the &#8220;SAI&#8221;), containing additional information about the Fund, has been filed with the SEC and is incorporated by reference in its entirety into this prospectus supplement and the accompanying prospectus. This prospectus supplement, the accompanying prospectus and the SAI are part of a &#8220;shelf&#8221; registration statement filed with the SEC. This prospectus supplement describes the specific details regarding this offering. If information in this prospectus supplement is inconsistent with the accompanying prospectus or the SAI, you should rely on this prospectus supplement. You may request a free copy of the SAI, annual and semi-annual reports to shareholders, and other information about the Fund, and make shareholder inquiries by calling (800) 257-8787 or by writing to the Fund at 333 West Wacker Drive, Chicago, Illinois 60606, or from the Fund&#8217;s website (www.nuveen.com). The information contained in, or that can be accessed through, the Fund&#8217;s website is not part of this prospectus supplement, the accompanying prospectus or the SAI, except to the extent specifically incorporated by reference herein. You also may obtain a copy of the SAI (and other information regarding the Fund) from the SEC&#8217;s website (www.sec.gov).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should not construe the contents of this prospectus supplement and the accompanying prospectus as legal, tax or financial advice. You should consult with your own professional advisors as to the legal, tax, financial or other matters relevant to the suitability of an investment in the Common Shares through Rights.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 38%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 24%">&#160;</td>
  <td style="width: 38%">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Common Shares do not represent a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Prospectus Supplement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 91%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#jdc424b2a001">Forward-Looking Statements</a></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; text-align: right; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#jdc424b2a002">Prospectus Supplement Summary</a></span></td>
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</span></td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#jdc424b2a005">Description of the Rights Offering</a></td>
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: right">S-7</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#jdc424b2a003">Summary of Fund Expenses</a></span></td>
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-17</span></td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#jdc424b2a004">Trading and Net Asset Value Information</a></span></td>
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-19</span></td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#jdc424b2a006">Use of Proceeds</a></span></td>
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-19</span></td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#jdc424b2a007">Capitalization</a></span></td>
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-20</span></td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#jdc424b2a008">Special Characteristics and Risks of the Rights Offering</a></td>
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: right">S-21</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#jdc424b2a009">Taxation</a></td>
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: right">S-22</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#jdc424b2a010">Legal Matters</a></span></td>
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-24</span></td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#jdc424b2a011">Available Information</a></span></td>
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-24</span></td>
    <td style="white-space: nowrap">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Prospectus</b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-left: auto; border-collapse: collapse; margin-right: auto">


<tr>

<td style="width: 97%"/>

<td style="vertical-align: bottom; width: 1%"/>
<td/>
<td/>
<td/></tr>


<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_1">Prospectus
                                 Summary</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">1</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_2">Summary
                                 of Fund Expenses</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">7</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_3">Financial
                                 Highlights</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">8</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_4">Trading
                                 and Net Asset Value Information</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">9</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_5">The
                                 Fund</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">9</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_6">Use
                                 of Proceeds</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">10</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_7">The
                                 Fund&#8217;s Investments</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">10</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_8">Use
                                 of Leverage</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">11</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_9">Risk
                                 Factors</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">14</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_10">Management
                                 of the Fund</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">14</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_11">Net
                                 Asset Value</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">17</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_12">Distributions</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">17</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_13">Dividend
                                 Reinvestment Plan</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">18</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_14">Plan
                                 of Distribution</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">18</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_15">Description
                                 of Shares</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">21</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_16">Rights
                                 Offerings</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">24</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_17">Certain
                                 Provisions in the Declaration of Trust and By-Laws</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">25</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_18">Repurchase
                                 of Fund Shares; Conversion to Open-End  Fund</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">27</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_19">Tax
                                 Matters</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">28</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_20">Custodian
                                 and Transfer Agent</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">29</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_21">Independent
                                 Registered Public Accounting Firm</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_22">Legal
                                 Matters</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_23">Available
                                 Information</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_24">Incorporation
                                 By Reference</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>You should rely only on the information contained or incorporated by reference into this prospectus supplement and the accompanying prospectus. The Fund has not authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. The Fund is not making an offer of Common Shares in any state where the offer is not permitted. You should not assume that the information contained in this prospectus supplement and the accompanying prospectus is accurate as of any date other than the respective dates on the front covers. The Fund&#8217;s business, financial condition and prospects may have changed since that date.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="jdc424b2a001"></span>FORWARD-LOOKING STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any projections, forecasts and estimates contained or incorporated by reference herein are forward looking statements and are based upon certain assumptions. Projections, forecasts and estimates are necessarily speculative in nature, and it can be expected that some or all of the assumptions underlying any projections, forecasts or estimates will not materialize or will vary significantly from actual results. Actual results may vary from any projections, forecasts and estimates and the variations may be material. Some important factors that could cause actual results to differ materially from those in any forward-looking statements include changes in interest rates, market, financial or legal uncertainties, including changes in tax law, and the timing and frequency of defaults on underlying investments. Consequently, the inclusion of any projections, forecasts and estimates herein should not be regarded as a representation by the Fund or any of its affiliates or any other person or entity of the results that will actually be achieved by the Fund. Neither the Fund nor its affiliates has any obligation to update or otherwise revise any projections, forecasts and estimates including any revisions to reflect changes in economic conditions or other circumstances arising after the date hereof or to reflect the occurrence of unanticipated events, even if the underlying assumptions do not come to fruition. The Fund acknowledges that, notwithstanding the foregoing, the safe harbor for forward-looking statements under the Private Securities Litigation Reform Act of 1995 does not apply to investment companies such as the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="jdc424b2a002"></span>PROSPECTUS SUPPLEMENT SUMMARY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>This is only a summary. You should review the more detailed information contained elsewhere in this prospectus supplement (&#8220;Prospectus Supplement&#8221;), in the accompanying prospectus and in the statement of additional information (&#8220;SAI&#8221;).</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 25%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Fund</b></span></td>
    <td style="width: 75%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nuveen Global High Income Fund (the &#8220;Fund&#8221;) is a diversified,&#160; closed-end &#160;management investment company. The Fund&#8217;s common shares, $0.01 par value per share (the &#8220;Common Shares&#8221;), are traded on the NYSE under the symbol &#8220;JGH.&#8221; See &#8220;Description of Shares&#8212;Common Shares&#8221; in the accompanying prospectus.</p></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; padding-bottom: 1pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 25%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Adviser</b></span></td>
    <td style="width: 75%">
        <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Fund Advisors, LLC (&#8220;Nuveen Fund Advisors&#8221;) is the Fund&#8217;s investment adviser, responsible for overseeing the Fund&#8217;s overall investment strategy and its implementation.</span></p></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; padding-bottom: 1pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; width: 25%">&#160;</td>
    <td style="vertical-align: top; width: 75%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Fund Advisors, a registered investment adviser, offers advisory and investment management services to a broad range of investment company clients. Nuveen Fund Advisors has overall responsibility for management of the Fund, oversees the management of the Fund&#8217;s portfolio, manages the Fund&#8217;s business affairs and provides certain clerical, bookkeeping and other administrative services. Nuveen Fund Advisors is located at 333 West Wacker Drive, Chicago, Illinois 60606. Nuveen Fund Advisors is an indirect subsidiary of Nuveen, LLC (&#8220;Nuveen&#8221;), the investment management arm of Teachers Insurance and Annuity Association of America (&#8220;TIAA&#8221;). TIAA is a life insurance company founded in 1918 by the Carnegie Foundation for the Advancement of Teaching and is the companion organization of College Retirement Equities Fund. As of September 30, 2025, Nuveen managed approximately $1.4 trillion in assets, of which approximately $154.6 billion was managed by Nuveen Fund Advisors.</span></td></tr>
  <tr>
    <td style="white-space: nowrap">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 25%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sub-Adviser</b></span></td>
    <td style="width: 75%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nuveen Asset Management, LLC (&#8220;Nuveen Asset Management&#8221;), located at 333 West Wacker Drive, Chicago, Illinois 60606, serves as the Fund&#8217;s investment&#160;sub-adviser &#160;and is an affiliate of Nuveen Fund Advisors. Nuveen Asset Management is a registered investment adviser. Nuveen Asset Management oversees the&#160;day-to-day&#160;investment operations of the Fund.</p></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; padding-bottom: 1pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 25%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purpose of the Rights Offering</b></span></td>
    <td style="width: 75%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board of Trustees of the Fund (the &#8220;Board&#8221;), based on the recommendations and presentations of Nuveen Fund Advisors, has determined that it is in the best interests of the Fund and holders of its Common Shares (the &#8220;Common Shareholders&#8221;) to conduct this offering of transferable subscription rights (&#8220;Rights,&#8221; and each, a &#8220;Right&#8221;), thereby increasing the assets of the Fund available for investment.</p></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 25%; font-size: 10pt">&#160;</td>
    <td style="width: 75%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nuveen Fund Advisors believes that a variety of factors indicate
that there may be opportunities to make new, attractive investments. Nuveen Fund Advisors expects that the Rights offering will provide
an opportunity to increase the assets of the Fund available for investment, thereby better enabling the Fund to take advantage more fully
of existing and future investment opportunities that may be or may become available, consistent with the Fund&#8217;s investment objective
to achieve a high level of current income. Nuveen Fund Advisors believes that the Fund may benefit from increased yields, enhanced earnings,
tax efficiency and lower expenses. &#160;&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt"><b>Terms of the Rights Offering</b></span></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">One Right will be issued for each Common Share held on the Record
        Date (as defined below). Rights are expected to trade on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol
        &#8220;JGH RT.&#8221; The Rights will allow Common Shareholders to subscribe for new Common Shares of the Fund. Four Rights will be
        required to purchase one Common Share (1 for 4). Upon exercise of the Rights offering, Common Shares may be issued at a price below
        net asset value (&#8220;NAV&#8221;) per Common Share. 23,177,393 Common Shares of the Fund are outstanding as of October 8, 2025.
        If all Rights in the Primary Subscription are exercised, 5,829,348 Common Shares of the Fund will be issued. See &#8220;Description
        of the Rights Offering&#8212;Terms of the Rights Offering.&#8221; Fractional shares will not be issued upon exercise of Rights.
        Accordingly, Common Shares may be purchased only pursuant to the exercise of Rights in integral multiples of four. The number of
        Rights issued to a Record Date Shareholder will be rounded up to the nearest number of Rights evenly divisible by four.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">An over-subscription privilege will be offered to Record Date
        Shareholders who fully exercise all Rights initially issued to them to buy those Common Shares that were not purchased by other
        Rights holders at the same Subscription Price (as defined below), subject to the right of the Board to eliminate the
        over-subscription privilege (the &#8220;Primary Over-Subscription Privilege&#8221;). Common Shares issued pursuant to the Primary
        Over-Subscription Privilege are referred to as &#8220;Primary Over-Subscription Shares.&#8221; Further, if the number of Common
        Shares requested by Record Date Shareholders exceeds the amount of Common Shares available in the Primary Subscription, the Fund
        may, subject to the approval of the Board, determine to issue additional Common Shares in an amount of up to 25% of the number of
        Common Shares issued pursuant to the Primary Subscription (the &#8220;Secondary Over-Subscription Privilege&#8221;). This amounts to
        up to an additional 1,457,337 Common Shares, for an aggregate total of 7,286,685 Common Shares. Common Shares issued pursuant to
        the Secondary Over-Subscription Privilege are referred to as the &#8220;Secondary Over-Subscription Shares,&#8221; and together with
        the Primary Over-Subscription Shares are referred to as the &#8220;Over-Subscription Shares.&#8221; Should the Fund determine to
        issue any Secondary Over-Subscription Shares, such Secondary Over-Subscription Shares will be allocated only among Record Date
        Shareholders who submitted requests for Over-Subscription Shares on their Subscription Certificate (as defined below).
        Over-Subscription Shares will be allocated pro rata among those fully exercising Record Date Shareholders who over-subscribe based
        on the number of Rights originally issued to them by the Fund.&#160;</p> </td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>








<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt; width: 25%">&#160;</td>
    <td style="width: 75%"><p style="font: 10pt Times New Roman, Times, Serif">The Fund has declared monthly distributions payable on November 3, 2025 and December 1, 2025, with record dates of October 15, 2025 and November 14, 2025, respectively. <b><i>Any Common Shares issued after
such record dates as a result of the Rights offering will not be record date Common Shares for the Fund&#8217;s monthly distributions
to be paid on November 3, 2025 and December 1, 2025 and will not be entitled to receive such distributions.</i></b></p></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt">&#160;</td>
    <td>Rights may be evidenced by subscription certificates or may be uncertificated and evidenced by other appropriate documentation (i.e., a rights card distributed to registered shareholders in lieu of a subscription certificate) (each, a &#8220;Subscription Certificate&#8221;).</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt">&#160;</td>
    <td><b>The exercise of Rights by a Rights holder is irrevocable.</b></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt"><b>Subscription Price</b></span></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The subscription price per Common Share (the &#8220;Subscription Price&#8221;) will be determined based upon a formula equal to 95% of the average of the last reported sales price of the Common Shares on the NYSE on the Expiration Date (as defined below) and each of the four (4) preceding trading days (the &#8220;Formula Price&#8221;). If, however, the Formula Price is less than 90% of the NAV per Common Share at the close of trading on the NYSE on the Expiration Date, then the Subscription Price will be 90% of the Fund's NAV per Common Share at the close of trading on the NYSE on the Expiration Date. The Rights offering will expire at 5:00 p.m., Eastern time, on November 20, 2025 (the &#8220;Expiration Date&#8221;).</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt"><b>Record Date</b></span></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rights will be issued to Common Shareholders of record as of the close of business on October 21, 2025 (the &#8220;Record Date&#8221;). See &#8220;Description of the Rights Offering&#8212;Terms of the Rights Offering.&#8221;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt"><b>Primary and Secondary<br/> Over-Subscription Privilege</b></span></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Shareholders as of the close of business on the Record
        Date who fully exercise all Rights initially issued to them are entitled to buy Primary Over-Subscription Shares. If enough Primary
        Over-Subscription Shares are available, all such requests will be honored in full. If the requests for Primary Over-Subscription
        Shares exceed the Primary Over-Subscription Shares available, the available Primary Over-Subscription Shares will be allocated
        pro rata among those fully exercising Record Date Shareholders who over-subscribe based on the number of Rights originally issued
        to them by the Fund. Common Shares acquired pursuant to the Primary Over-Subscription Privilege are subject to allotment. <b><i>Rights
        acquired in the secondary market may not participate in the Primary Over-Subscription Privilege</i></b><i>.</i></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Further, if the number of Common Shares requested by Record
        Date Shareholders exceeds the amount of Common Shares available in the Primary Subscription, the Fund may, subject to the approval
        of the Board, elect to issue up to an additional 25% of the amount of Common Shares offered in the Primary Subscription through
        a Secondary Over-Subscription Privilege. The Secondary Over-Subscription Shares will be allocated only among Record Date Shareholders
        who requested Over-Subscription Shares as part of the Primary Subscription. To the extent a sufficient amount of Common Shares
        are not available to fulfill all over-subscription requests, Common Shares will be allocated pro rata among those Record Date
        Shareholders who over-subscribe based on the number of Rights originally issued to them by the Fund. Like Primary Over-Subscription
        Shares, Secondary Over-Subscription Shares are subject to allotment. <b><i>Rights acquired in the secondary market may not participate
        in the Secondary Over-Subscription Privilege.</i></b><i> </i></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notwithstanding the above, the Board has the right in its absolute discretion to eliminate the Primary Over-Subscription Privilege if it considers it to be in the best interest of the Fund to do so. The Board may make that determination at any time, without prior notice to Rights holders or others, up to and including the fifth day following the Expiration Date. See &#8220;Description of the Rights Offering&#8212;Primary and Secondary Over-Subscription Privilege.&#8221;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Shareholders who choose not to exercise their full Rights to purchase additional Common Shares will permit Common Shareholders who exercise an over-subscription privilege to purchase additional Common Shares at a discount to NAV without furnishing additional Rights or providing any compensation to the non-participating Common Shareholders for the dilution of their ownership percentage or voting rights.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any Common Shares issued pursuant to an over-subscription privilege will be shares registered under the Prospectus.&#160;</p> </td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt; width: 25%"><span style="font-size: 10pt"><b>Transfer of Rights</b></span></td>
    <td style="width: 75%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Rights will be transferable. See &#8220;Description of the Rights Offering&#8212;Terms of the Rights Offering,&#8221; &#8220;Sale of Rights&#8221; and &#8220;Method of Transferring Rights.&#8221;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt"><b>Title</b></span></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscription Rights to Acquire Common Shares.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt"><b>Subscription Period</b></span></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Rights may be exercised at any time after issuance and prior to expiration of the Rights (the &#8220;Subscription Period&#8221;), which will be 5:00 p.m., Eastern time on November 20, 2025 (the &#8220;Expiration Date&#8221;), unless otherwise extended. See &#8220;Description of the Rights Offering&#8212;Terms of the Rights Offering&#8221; and &#8220;&#8212;Method of Exercise of Rights.&#8221; The Rights offering may be terminated or extended by the Fund at any time for any reason before the Expiration Date. If the Fund terminates the Rights offering, the Fund will issue a press release announcing such termination and will direct the Subscription Agent (defined below) to return, without interest, all subscription proceeds received to such shareholders who had elected to purchase Common Shares.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt"><b>Offering Expenses</b></span></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The expenses of the Rights offering are expected to be approximately $375,000 and will be borne by Nuveen Fund Advisors, and not the Fund or Common Shareholders. See &#8220;Use of Proceeds.&#8221;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt"><b>Sale of Rights</b></span></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Rights are transferable until the completion of the
        Subscription Period and will be admitted for trading on the NYSE under the symbol &#8220;JGH RT.&#8221; Although no assurance can be
        given that a market for the Rights will develop or be maintained, trading in the Rights on the NYSE is expected to begin October 20, 2025, one Business
        Day prior to the Record Date, and may be conducted until the close of trading on the last NYSE trading day prior to the Expiration
        Date. For purposes of this Prospectus Supplement, a &#8220;Business Day&#8221; shall mean any day on which trading is conducted on
        the NYSE. </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The value of the Rights, if any, will be reflected by their
        market price on the NYSE. Rights may be sold by individual holders through their broker or financial advisor or may be submitted to
        the Subscription Agent (defined below) for sale. Any Rights submitted to the Subscription Agent for sale must be received by the
        Subscription Agent prior to 5:00 p.m., Eastern time, on or before November 13, 2025, five Business Days prior to the Expiration Date
        (or, if the Subscription Period is extended, prior to 5:00 p.m., Eastern time, on the fifth Business Day prior to the extended
        Expiration Date). </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rights that are sold will not confer any right to acquire any Common Shares in any over-subscription, and any Record Date Shareholder who sells any Rights will not be eligible to participate in the over-subscription privilege, if any. </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Trading of the Rights on the NYSE will be conducted on a when-issued basis until and including the date on which the Subscription Certificates (as defined below) are mailed to Record Date Shareholders of record and thereafter will be conducted on a regular-way basis until and including the last NYSE trading day prior to the completion of the Subscription Period. The Common Shares are expected to begin trading ex-Rights on the Record Date. </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the Subscription Agent receives Rights for sale in a timely manner, the Subscription Agent will use its best efforts to sell the Rights on the NYSE. The Subscription Agent will also attempt to sell any Rights attributable to shareholders of record whose addresses are outside the United States, or who have an APO or FPO address. See &#8220;Description of the Rights Offering&#8212;Foreign Restrictions.&#8221; The Subscription Agent will attempt to sell such Rights on the NYSE.&#160;</p></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt; width: 25%">&#160;</td>
    <td style="width: 75%">Any commissions will be paid by the selling Rights holders. Neither the Fund nor the Subscription Agent will be responsible if Rights cannot be sold and neither has guaranteed any minimum sales price for the Rights. If the Rights can be sold, sales of these Rights will be deemed to have been effected at the weighted average price received by the Subscription Agent on the day such Rights are sold, less any applicable brokerage commissions, taxes and other expenses (i.e., costs incidental to the sale of Rights).</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt">&#160;</td>
    <td>Common Shareholders are urged to obtain a recent trading price for the Rights on the NYSE from their broker, bank, financial advisor or the financial press.</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt">&#160;</td>
    <td>Banks, broker-dealers and trust companies that hold shares for the accounts of others are advised to notify those persons that purchase Rights in the secondary market that such Rights will not participate in any over-subscription privilege. See &#8220;Description of the Rights Offering&#8212;Terms of the Rights Offering.&#8221;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt"><b>Use of Proceeds</b></span></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund estimates the net proceeds of the Rights offering to be approximately $74,848,828. This figure is based on the estimated Subscription Price per Common Share of $12.84 (95% of the average of the last reported sales price of the Fund&#8217;s Common Shares on the NYSE on October 8, 2025 and each of the four (4) preceding trading days) and assumes all new Common Shares offered are sold and that the expenses related to the Rights offering estimated at approximately $375,000 are paid by Nuveen Fund Advisors.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund intends to invest the net proceeds from the issuance of
        Rights hereunder in accordance with the Fund&#8217;s investment objective and policies as set forth in the accompanying prospectus. The Fund
        currently anticipates that it will be able to invest substantially all of the net proceeds in investments that meet the Fund&#8217;s
        investment objective and policies within approximately three months of the receipt of such proceeds; however, the identification of
        appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions may cause the
        investment period to extend as long as six months (the &#8220;invest-up period&#8221;). Pending investment, it is anticipated that
        the proceeds will be invested in short-term or long-term securities issued by the U.S. Government and its agencies or
        instrumentalities or in high-quality, short-term money market instruments. Current market conditions may change and the Fund may not
        be able to invest the proceeds as planned. Immediately after the initial invest-up period, the Fund&#8217;s portfolio allocations may vary
        over time consistent with the Fund&#8217;s investment policies as described in the accompanying prospectus.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Depending on market conditions and operations, a portion of the cash held by the Fund, including any proceeds raised from the offering, may be used to pay distributions in accordance with the Fund&#8217;s distribution policy and may be a return of capital. A return of capital is a return to investors of a portion of their original investment in the Fund. In general terms, a return of capital would involve a situation in which a Fund distribution (or a portion thereof) represents a return of a portion of a shareholder&#8217;s investment in the Fund, rather than making a distribution that is funded from the Fund&#8217;s earned income or other profits. Although return of capital distributions may not be currently taxable, such distributions would decrease the basis of a shareholder&#8217;s shares, and therefore, may increase a shareholder&#8217;s tax liability for capital gains upon a sale of shares, even if sold at a loss to the shareholder&#8217;s original investments. See &#8220;Use of Proceeds.&#8221;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt"><b>Taxation/ERISA</b></span></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See &#8220;Taxation&#8221; and &#8220;Description of the Rights Offering&#8212;Employee Benefit Plan and IRA Considerations.&#8221;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt"><b>Subscription Agent</b></span></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Computershare Trust Company, N.A. and Computershare Inc. See &#8220;Description of the Rights Offering&#8212;Subscription Agent.&#8221;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt"><b>Information Agent</b></span></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Georgeson LLC. See &#8220;Description of the Rights Offering&#8212;Information Agent.&#8221;&#160;</p></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 25%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk Factors</b></span></td>
    <td style="width: 75%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See &#8220;Risk Factors&#8221; in the accompanying prospectus and &#8220;Special Characteristics and Risks of the Rights Offering&#8221; in this Prospectus Supplement for a discussion of the principal risks you should carefully consider before deciding to invest in Common Shares through Rights.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="background-color: white"><b><span id="jdc424b2a005"></span>DESCRIPTION OF THE RIGHTS OFFERING </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Purpose of the Rights Offering </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The
Board, based on the recommendations and presentations of Nuveen Fund Advisors, has determined that it is in best interests of the
Fund and its Common Shareholders to conduct the Rights offering, thereby increasing the assets of the Fund available for investment.
In making this determination, the Board considered a number of factors, including potential benefits and costs. In particular, the
Board considered Nuveen Fund Advisors&#8217; opinion that the Rights offering would better enable the Fund to take advantage more
fully of existing and future investment opportunities that may be or may become available, consistent with the Fund&#8217;s
investment objective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">In
making its determination that the Rights offering would result in a net benefit to existing Common Shareholders of the Fund, the
Board considered various factors at its meeting held on October 8, 2025, including the advice and recommendations of Nuveen Fund
Advisors. The factors considered by the Board included: (i)&#160;the size of the Rights offering (including the number of Rights
needed to purchase one Common Share and size of the Rights offering in relation to the number of Common Shares outstanding),
Subscription Price, pricing (including the pricing formula, as compared to a fixed price, and reasons for selecting the formula) and
structure of the Rights offering (including the possible negative effect of the Rights offering on the market price of Common Shares), which will not discriminate among
shareholders; (ii)&#160;the expected lowering of the Fund&#8217;s ongoing operating expenses as a proportion of
net assets due to the increase in Fund assets as a result of the Rights offering because the Fund&#8217;s fixed costs would be
spread over a larger asset base; (iii)&#160;the Rights offering, if it is well-subscribed, which would result in a larger number of
outstanding Common Shares and a potentially larger number of beneficial owners of Common Shares, could increase the level of market
interest in and visibility of the Fund and improve the trading liquidity of the Common Shares on the NYSE; (iv)&#160;the opportunity
the Rights offering represents for current Common Shareholders to purchase additional Common Shares at a discount to market price
and NAV; (v)&#160;Nuveen Fund Advisors&#8217; opinion that raising additional capital through a Rights offering would allow the Fund
to better capitalize on attractive investment opportunities without having to sell existing positions and that the new investments
should be able to help sustain the Fund&#8217;s current distribution over the longer term; (vi)&#160;the size of the current
discount&#160;to NAV at which the Common Shares are trading and the potential impact of the Rights offering on the market price and
discount&#160;to NAV of the Common Shares; (vii)&#160;the extent of dilution for: (a)&#160;participating Common Shareholders, and
(b)&#160;non-participating Common Shareholders; (viii)&#160;the benefits and drawbacks of conducting
a&#160;non-transferable&#160;versus a transferable rights offering and Nuveen Fund Advisors&#8217; commitment to use its best
efforts to ensure an adequate trading  market will exist for the Rights; (ix)&#160;the expenses of the Rights offering and Nuveen Fund Advisors' commitment to bear all costs of the Rights offering, which would reduce the effects of any dilution as a result
of the Rights offering; and (x)&#160;the effect on the Fund and its existing Common Shareholders if the Rights offering is not fully
subscribed and, conversely, if the Rights offering is oversubscribed. The Board also considered that increasing the Fund&#8217;s
assets results in a benefit to Nuveen Fund Advisors because the management fee paid by the Fund to Nuveen Fund Advisors increases as
the Fund&#8217;s Managed Assets increase (including from the expected commensurate increase in the Fund&#8217;s use of leverage). </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Nuveen Fund
Advisors believes that a variety of factors indicate that there may be opportunities to make new, attractive investments for the Fund.
Nuveen Fund Advisors expects that the Rights offering will provide an opportunity to increase the assets of the Fund available for investment.
Nuveen Fund Advisors believes that the Fund may benefit from increased yields, enhanced earnings, tax efficiency and lower expenses.
Nuveen Fund Advisors has an inherent conflict of interest in recommending the Rights offering because the Fund pays fees to Nuveen Fund
Advisors based on a percentage of the Fund&#8217;s Managed Assets (the greater the Managed Assets of the Fund, the greater the compensation
paid to Nuveen Fund Advisors). &#8220;Managed Assets&#8221; means the total value of the assets of the Fund, minus the sum of its accrued
liabilities (other than Fund liabilities incurred for the express purpose of creating leverage). Total assets for this purpose shall
include assets attributable to the Fund&#8217;s use of leverage (whether or not those assets are reflected in the Fund&#8217;s financial
statements for purposes of generally accepted accounting principles).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The
Rights offering seeks to provide an opportunity to existing Common Shareholders to purchase Common Shares at a discount to market
price and NAV. The issuance to Common Shareholders of transferable Rights, which may themselves have intrinsic value, also will
afford non-participating Common Shareholders of record on the Record Date, the potential of receiving cash payment upon the sale of
the Rights, receipt of which may be viewed as partial compensation for dilution of their interests that will occur as a result of
the Rights offering. There can be no assurance that a market for the Rights will develop or, if such a market does develop, that such market will be maintained
or what the price of the Rights will be</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 11; Options: NewSection; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Terms of the Rights Offering </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The Fund is issuing to Record Date Shareholders Rights to subscribe for Common Shares of the Fund. Each Record Date Shareholder is being issued one transferable Right for each Common Share owned on the Record Date. The Rights entitle the holder to acquire one new Common Share for every four Rights held (1 for 4) (provided that any Record Date Shareholder who owns fewer than four Common Shares as of the close of business on the Record Date may subscribe for one full Common Share), at a Subscription Price per Common Share determined based upon a formula equal to 95% of the average of the last reported sales price of the Common Shares on the NYSE on the Expiration Date, as such date may be extended from time to time, and each of the four (4)&#160;preceding trading days (the &#8220;Formula Price&#8221;). If, however, the Formula Price is less than 90% of the NAV per Common Share at the close of trading on the NYSE on the Expiration Date, then the Subscription Price will be 90% of the Fund&#8217;s NAV per Common Share at the close of trading on the NYSE on the Expiration Date. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The estimated
Subscription Price to the public of $12.84 is based upon 95% of the average of the last reported sales price of the Common Shares on
the NYSE on October 8, 2025 and each of the four (4)&#160;preceding trading days. Fractional shares will not be issued upon exercise
of Rights. Accordingly, Common Shares may be purchased only pursuant to the exercise of Rights in integral multiples of four. The number
of Rights issued to a Record Date Shareholder will be rounded up to the nearest number of Rights evenly divisible by four. Rights may
be exercised at any time during the period (the &#8220;Subscription Period&#8221;) which commences on October 21, 2025, and ends at 5:00
p.m., Eastern time on November 20, 2025 (the &#8220;Expiration Date&#8221;), unless otherwise extended. Upon exercise of the Rights offering,
Common Shares may be issued at a price below NAV per Common Share. The right to acquire one Common Share for each four Rights held during
the Subscription Period (or any extension of the Subscription Period) at the Subscription Price will be referred to in the remainder
of this Prospectus Supplement as the &#8220;Rights offering.&#8221; <b><i>Rights will expire on the Expiration Date and all unexercised
rights at that time will become void and may not be exercised unless the Expiration Date is extended as described herein.</i></b><i>
</i>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Fund has declared monthly distributions payable on November 3,
2025 and December 1, 2025, with record dates of October 15, 2025 and November 14, 2025, respectively. <b><i>Any Common Shares issued after
such record dates as a result of the Rights offering will not be record date Common Shares for the Fund&#8217;s monthly distributions
to be paid on November 3, 2025 and December 1, 2025 and will not be entitled to receive such distributions.</i></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Rights may be evidenced by subscription certificates or may be uncertificated and evidenced by other appropriate documentation (<i>i.e.</i>, a rights card distributed to registered shareholders in lieu of a subscription certificate) (&#8220;Subscription Certificates&#8221;). The number of Rights issued to each holder will be stated on the Subscription Certificate delivered to the holder. The method by which Rights may be exercised and Common Shares paid for is set forth below in &#8220;Method of Exercise of Rights&#8221; and &#8220;Payment for Shares.&#8221; A holder of Rights will have no right to rescind a purchase after Computershare Trust Company, N.A. and Computershare Inc. (together, the &#8220;Subscription Agent&#8221;) has received payment. See &#8220;Payment for Shares&#8221; below. It is anticipated that the Common Shares issued pursuant to an exercise of Rights will be listed on the NYSE. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 12; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Holders of Rights who are Record Date Shareholders are entitled to over-subscribe for additional Common Shares at the same Subscription Price pursuant to the Primary Over-Subscription Privilege, subject to certain limitations, allotment and the right of the Board to eliminate the Primary Over-Subscription Privilege.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, if the number of Common Shares requested by Record Date Shareholders exceeds the amount of Common Shares available in the Primary Subscription, the Fund may, subject to the approval of the Board, elect to issue additional Common Shares in an amount of up to 25% of the number of Common Shares issued as part of the Primary Subscription. Should the Fund determine to issue some or all of the Secondary Over-Subscription Shares, they will be allocated only among Record Date Shareholders who requested Over-Subscription Shares on their Subscription Certificate. Secondary Over-Subscription Shares will be allocated pro rata among those fully exercising Record Date Shareholders who over-subscribe based on the number of Rights originally issued to them by the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The entitlement to subscribe for any Over-Subscription Shares is available only to those Record Date Shareholders who fully exercise all Rights initially issued to them and only on the basis of their Record Date holdings. See below under &#8220;Description of the Rights Offering&#8212;Primary and Secondary Over-Subscription Privileges&#8221; below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">For purposes of determining the maximum number of Common Shares that may be acquired pursuant to the Rights offering, broker-dealers, trust companies, banks or others whose shares are held of record by Cede&#160;&amp; Co. (&#8220;Cede&#8221;), as nominee for the Depository Trust Company (&#8220;DTC&#8221;), or by any other depository or nominee will be deemed to be the holders of the Rights that are held by Cede or such other depository or nominee on their behalf. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The
Rights are transferable until the completion of the Subscription Period and will be admitted for trading on the NYSE under the
symbol &#8220;JGH RT.&#8221; Assuming a market exists for the Rights, the Rights may be purchased and sold through usual brokerage
channels and also sold through the Subscription Agent. Although no assurance can be given that a market for the Rights will develop
or be maintained, trading in the Rights on the NYSE is expected to begin October 20, 2025, one Business Day prior to the Record Date, and may be
conducted until the close of trading on the last NYSE trading day prior to the Expiration Date. Trading of the Rights on the NYSE is
expected to be conducted on a when-issued basis on October 20, 2025 until and including the date on which the Subscription
Certificates are mailed to Record Date Shareholders of record and thereafter is expected to be conducted on a regular way basis
until and including the last NYSE trading day prior to the Expiration Date. The method by which Rights may be transferred is set
forth below under &#8220;Method of Transferring Rights.&#8221; The Common Shares are expected to begin trading ex-Rights on the
Record Date as determined and announced by the NYSE. The Rights offering may be terminated or extended by the Fund at any time for
any reason before the Expiration Date. If the Fund terminates the Rights offering, the Fund will issue a press release announcing
such termination and will direct the Subscription Agent to return, without interest, all subscription proceeds received to such
shareholders who had elected to purchase Common Shares. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Nominees who hold Common Shares for the account of others, such as banks, broker-dealers, trustees or depositories for securities, should notify the respective beneficial owners of such shares as soon as possible to ascertain such beneficial owners&#8217; intentions and to obtain instructions with respect to the Rights. If the beneficial owner so instructs, the nominee should complete the Subscription Certificate and submit it to the Subscription Agent with proper payment. In addition, beneficial owners of the Common Shares or Rights held through such a nominee should contact the nominee and request the nominee to effect transactions in accordance with such beneficial owner&#8217;s instructions. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Participants in the Fund&#8217;s Dividend Reinvestment Plan (the &#8220;Plan&#8221;) will be issued Rights in respect of the Common Shares held in their accounts in the Plan. Participants wishing to exercise these Rights must exercise the Rights in accordance with the procedures set forth in &#8220;Method of Exercise of Rights&#8221; and &#8220;Payment for Shares.&#8221; </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Conditions of the Rights Offering </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The Rights offering is being made in accordance with the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;), without shareholder approval. The staff of the SEC has interpreted the 1940 Act as not requiring shareholder approval of a transferable rights offering to purchase common shares at a price below the then current NAV so long as certain conditions are met, including: (i) the Board make a good faith determination that such offering would result in a net benefit to existing shareholders; (ii) the offering fully protects shareholders&#8217; preemptive rights and does not discriminate among shareholders (except for the possible effect of not offering fractional rights); (iii) management uses its best efforts to ensure an adequate trading market in the Rights for use by shareholders who do not exercise such Rights; and (iv) the ratio of such transferable Rights offering does not exceed one new share for each three rights held. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 13; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Important Dates to Remember </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Please note that the dates in the table below may change if the Rights offering is extended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding: 3pt 0; white-space: nowrap; width: 52%; text-indent: 0"><span style="font-size: 10pt"><b>Event</b></span></td>
    <td style="padding: 3pt 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding: 3pt 0; text-align: center; width: 47%; text-indent: 0"><span style="font-size: 10pt"><b>Date</b></span></td></tr>
  <tr>
    <td style="padding: 3pt 0; vertical-align: top; text-indent: 0"><span style="font-size: 10pt">Record Date</span></td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0"><span style="font-size: 10pt">October 21, 2025</span></td></tr>
  <tr>
    <td style="padding: 3pt 0; vertical-align: top; text-indent: 0"><span style="font-size: 10pt">Subscription Period</span></td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0"><span style="font-size: 10pt">October 21, 2025 through November 20, 2025&#8224;</span></td></tr>
  <tr>
    <td style="padding: 3pt 0; vertical-align: top; text-indent: 0"><span style="font-size: 10pt">Final Day Rights Will Trade</span></td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0"><span style="font-size: 10pt">November 19, 2025&#8224;</span></td></tr>
  <tr>
    <td style="padding: 3pt 0; vertical-align: top; text-indent: 0"><span style="font-size: 10pt">Expiration Date*</span></td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0">November 20, 2025&#8224;</td></tr>
  <tr>
    <td style="padding: 3pt 0; vertical-align: top; text-indent: 0"><span style="font-size: 10pt">Notice of Guaranteed Delivery Due*</span></td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0"><span style="font-size: 10pt">November 20, 2025&#8224;</span></td></tr>
  <tr>
    <td style="padding: 3pt 0; vertical-align: top; text-indent: 0">Guarantee Expiration Date</td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0">November 21, 2025</td></tr>
  <tr>
    <td style="padding: 3pt 0; vertical-align: top; text-indent: 0"><span style="font-size: 10pt">Issuance Date</span></td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0"><span style="font-size: 10pt">November 28, 2025&#8224;</span></td></tr>
  <tr>
    <td style="padding: 3pt 0; vertical-align: top; text-indent: 0"><span style="font-size: 10pt">Confirmation Date</span></td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 3pt 0; vertical-align: bottom; text-indent: 0"><span style="font-size: 10pt">December 2, 2025&#8224;</span></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0"/>
    <td style="width: 0.25in">*</td>
    <td>A shareholder exercising Rights must deliver to the Subscription Agent by 5:00 p.m., Eastern time on November 20, 2025 (unless the Rights offering is extended) either (a) a Subscription Certificate and payment for Common Shares or (b) a notice of guaranteed delivery and payment for Common Shares.</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0"/>
    <td style="width: 0.25in">&#8224;</td>
    <td>Unless the Rights offering is extended.</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Primary and Secondary Over-Subscription Privilege</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Record Date Shareholders who fully exercise their Rights are entitled to subscribe for additional Common Shares at the same Subscription Price pursuant to the Primary and Secondary Over-Subscription Privilege, subject to certain limitations and subject to allotment. The Board has the right in its absolute discretion to eliminate the Primary Over-Subscription Privilege if it considers it to be in the best interest of the Fund to do so. The Board may make that determination at any time, without prior notice to Rights holders or others, up to and including the fifth day following the Expiration Date. If the Primary Over-Subscription Privilege is exercised, it will operate as set forth below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Record Date Shareholders who fully exercise all Rights initially issued to them are entitled to buy those Common Shares, referred to as Primary Over-Subscription Shares, that were not purchased by other holders of Rights at the same Subscription Price. If enough Primary Over-Subscription Shares are available, all such requests will be honored in full. Common Shares acquired pursuant to the Primary Over-Subscription Privilege are subject to allotment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the number of Common Shares requested by Record Date Shareholders exceeds the amount of Common Shares available in the Primary Subscription, the Fund may, subject to the approval of the Board, elect to issue Secondary Over-Subscription Shares in an amount of up to 25% of the number of Common Shares issued pursuant to the Primary Subscription. Should the Fund determine to issue some or all of the Secondary Over-Subscription Shares, they will be allocated only among Record Date Shareholders who requested Over-Subscription Shares on their Subscription Certificate. Common Shares acquired pursuant to the Secondary Over-Subscription Privilege are subject to allotment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 14; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Record Date Shareholders who are fully exercising
their Rights during the Subscription Period should indicate on the Subscription Certificate that they submit with respect to the exercise
of the Rights issued to them, how many Common Shares they are willing to acquire pursuant to any Primary Over-Subscription Privilege
and Secondary Over-Subscription Privilege. <b><i>Rights acquired in the secondary market may not participate in any Primary Over-Subscription
Privilege or Secondary Over-Subscription Privilege.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To the extent sufficient Common Shares are not available to fulfill all over-subscription requests, the Over-Subscription Shares will be allocated pro rata among those Record Date Shareholders who over-subscribe based on the number of Rights issued to them by the Fund. The allocation process may involve a series of allocations in order to assure that the total number of Common Shares available for over-subscriptions is distributed on a pro rata basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The formula to be used in allocating the Over-Subscription Shares is as follows:<span style="background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center; width: 52%"><span style="font-size: 10pt">Shareholder&#8217;s Record Date Position</span></td>
    <td style="width: 1%">&#160;</td>
    <td rowspan="2" style="vertical-align: middle; width: 1%; text-align: center">
        <p style="margin-top: 0; margin-bottom: 0"></p>
        <p style="margin-top: 0; margin-bottom: 0">&#160;<span style="font-size: 10pt">X</span></p></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 45%"><span style="font-size: 10pt">Over-Subscription<br/> </span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-align: center; text-indent: -10pt"><span style="font-size: 10pt">Total Record Date Position of All Over-Subscribers&#160;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">Shares Remaining</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Banks, broker-dealers, trustees and other nominee holders of Rights will be required to certify to the Subscription Agent, before any over-subscription privilege may be exercised with respect to any particular beneficial owner, as to the aggregate number of Rights exercised during the Subscription Period and the number of Common Shares subscribed for pursuant to the over-subscription privilege by such beneficial owner and that such beneficial owner&#8217;s subscription was exercised in full. Nominee holder over-subscription forms and beneficial owner certification forms will be distributed to banks, broker-dealers, trustees and other nominee holders of Rights with the Subscription Certificates. Nominees should also notify holders purchasing Rights in the secondary market that such Rights may not participate in any over-subscription privilege.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Common Shareholders who choose not to exercise their full rights to purchase additional Common Shares will permit Common Shareholders who exercise an over-subscription privilege to purchase additional Common Shares at a discount to NAV without furnishing additional Rights or providing any compensation to the non-participating Common Shareholders for the dilution of their ownership percentage or voting rights.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Fund will not otherwise offer or sell any Common Shares that are not subscribed for pursuant to the Primary Subscription or over-subscription privileges pursuant to the Rights offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Sale of Rights </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The
Rights are transferable and will be admitted for trading on the NYSE under the symbol &#8220;JGH RT.&#8221; Although no assurance
can be given that a market for the Rights will develop or be maintained, trading in the Rights on the NYSE is expected to begin October 20, 2025, one
Business Day prior to the Record Date, and may be conducted until the close of trading on the last NYSE trading day prior to the
Expiration Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The value of the Rights, if any, will be reflected by the market price. Rights may be sold by individual holders through their broker or other financial intermediary. Holders of Rights attempting to sell any unexercised Rights in the open market through their broker or financial advisor may be charged a commission or incur other transaction expenses and should consider the commissions and fees charged prior to selling their Rights on the open market. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Rights that are sold will not confer any right to acquire any Common Shares in any Primary or Secondary Over-Subscription Privilege, if any, and any Record Date Shareholder who sells any Rights will not be eligible to participate in any Primary or Secondary Over-Subscription Privilege.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Trading of the Rights on the NYSE will be conducted on a when-issued basis until and including the date on which the Subscription Certificates are mailed to Record Date Shareholders of record and thereafter will be conducted on a regular-way basis until and including the last NYSE trading day prior to the Expiration Date. The Common Shares are expected to begin trading ex-Rights on the Record Date. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Shareholders are urged to obtain a recent trading price for the Rights on the NYSE from their broker, bank, financial advisor or the financial press. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 15; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Holders of Rights who are unable or do not wish to exercise any or all of their Rights may contact the Information Agent if they have
questions about the sale of any unexercised Rights. Rights holders who hold their shares through a broker-dealer or other applicable financial
intermediary should contact their broker-dealer or other applicable financial intermediary if they wish to sell their Rights. Shareholders
of record whose addresses are outside the United States, or who have an APO or FPO address, are encouraged to contact the Information
Agent if they want to exercise their Rights. If an instruction to exercise their Rights is not received within five business days of the
Expiration Date, their Rights will be sold. The selling Rights holder will pay all applicable brokerage commissions incurred. There can
be no assurance that the Subscription Agent will be able to facilitate the sale of any of Rights and neither the Fund nor the Subscription
Agent has guaranteed any minimum sales price for the Rights.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Method of Transferring Rights </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The Rights evidenced by a single Subscription Certificate may be transferred in whole by endorsing the Subscription Certificate for transfer in accordance with the accompanying instructions. A portion of the Rights evidenced by a single Subscription Certificate (but not fractional Rights) may be transferred by delivering to the Subscription Agent a Subscription Certificate properly endorsed for transfer, with instructions to register the portion of the Rights evidenced thereby in the name of the transferee (and to issue a new Subscription Certificate to the transferee evidencing the transferred Rights). In this event, a new Subscription Certificate evidencing the balance of the Rights will be issued to the Rights holder or, if the Rights holder so instructs, to an additional transferee. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Holders wishing to transfer all or a portion of their Rights (but not fractional Rights) should promptly transfer such Rights to ensure that: (i)&#160;the transfer instructions will be received and processed by the Subscription Agent, (ii)&#160;a new Subscription Certificate will be issued and transmitted to the transferee or transferees with respect to transferred Rights, and to the holder with respect to retained Rights, if any, and (iii)&#160;the Rights evidenced by the new Subscription Certificates may be exercised or sold by the recipients thereof prior to the Expiration Date. Neither the Fund nor the Subscription Agent shall have any liability to a transferee or holder of Rights if Subscription Certificates are not received in time for exercise or sale prior to the Expiration Date. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Except for the fees charged by the Subscription Agent (which will be paid by Nuveen Fund Advisors as described below), all commissions, fees and other expenses (including brokerage commissions and transfer taxes) incurred in connection with the purchase, sale, transfer or exercise of Rights will be for the account of the holder of the Rights, and none of these commissions, fees or expenses will be borne by the Fund or the Subscription Agent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The Fund anticipates that the Rights will be eligible for transfer through, and that the exercise of the Rights may be effected through, the facilities of DTC (Rights exercised through DTC are referred to as &#8220;DTC Exercised Rights&#8221;). </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Subscription Agent</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The Subscription Agent is Computershare Trust Company, N.A. and Computershare Inc. The Subscription Agent will receive an amount estimated to be $70,000, comprised of the fee for its services and the reimbursement for certain expenses related to the Rights offering. Nuveen Fund Advisors, not the Fund or Common Shareholders, will pay such amount. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 16; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Information Agent</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">INQUIRIES BY ALL HOLDERS OF RIGHTS SHOULD BE DIRECTED TO: THE INFORMATION AGENT, GEORGESON LLC. BANKS, BROKERS AND SHAREHOLDERS PLEASE CALL TOLL-FREE AT 866-989-7750.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Method of Exercise of Rights </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Rights may be exercised by completing and signing the Subscription Certificate and delivering the completed and signed Subscription Certificate to the Subscription Agent, together with payment for the Common Shares as described below under &#8220;Payment for Shares.&#8221; Rights may also be exercised through the broker of a holder of Rights, who may charge the holder of Rights a servicing fee in connection with such exercise. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Completed Subscription Certificates and payment must be received by the Subscription Agent prior to 5:00 p.m., Eastern time, on the Expiration Date (unless payment is effected by means of a notice of guaranteed delivery as described below under &#8220;Payment for Shares&#8221;). Your broker, bank, trust company or other intermediary may impose a deadline for exercising Rights earlier than 5:00 p.m., Eastern time, on the Expiration Date. The Subscription Certificate and payment should be delivered to the Subscription Agent at the following address: </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white">If By Mail: </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white">Computershare</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white">C/O Voluntary Corporate Actions </span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white">P.O. Box 43011 </span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white">Providence, RI 02940-3011 </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white">If By Overnight Courier: </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white">Computershare </span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white">C/O Voluntary Corporate Actions </span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white">150 Royall Street, Suite V </span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white">Canton, MA 02021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white">If By Notice of Guaranteed Delivery:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white">email to <span style="color: Blue"><span style="text-decoration: underline">canoticeofguarantee@computershare.com</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Contact your broker-dealer, trust company, bank or other nominee to notify the Fund of your intent to exercise, sell or transfer the Rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Payment for Shares </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Holders of Rights who acquire Common Shares in the Rights offering may choose between the following methods of payment: &#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"/>
    <td style="width: 0.25in">(1)</td>
    <td><span style="background-color: white">A holder of Rights can send the Subscription Certificate, together with payment in the form of a check (which must include the name of the shareholder on the check) for the Common Shares subscribed for in the Rights offering and, if eligible, for any additional Common Shares subscribed for pursuant to the over-subscription privilege, to the Subscription Agent based on the estimated Subscription Price. To be accepted, the payment, together with the executed Subscription Certificate, must be received by the Subscription Agent at one of the addresses noted above prior to 5:00 p.m., Eastern time on the Expiration Date. The Subscription Agent will deposit all share purchase checks received by it prior to the final due date into a segregated account pending proration and distribution of Common Shares. The Subscription Agent will not accept cash as a means of payment for Common Shares.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 17; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"/>
    <td style="width: 0.25in">(2)</td>
    <td><span style="background-color: white">Alternatively, a subscription will be accepted by the Subscription Agent if, prior to 5:00 p.m., Eastern time on the Expiration Date, the Subscription Agent has received a written notice of guaranteed delivery by mail or email from a bank, trust company, or a NYSE member, guaranteeing delivery of a properly completed and executed Subscription Certificate. In order for the notice of guarantee to be valid, full payment for the Common Shares at the estimated Subscription Price must be received with the notice. The Subscription Agent will not honor a notice of guaranteed delivery unless a properly completed and executed Subscription Certificate is received by the Subscription Agent by the close of business on the first Business Day after the Expiration Date. The notice of guaranteed delivery must be emailed to the Subscription Agent at canoticeofguarantee@computershare.com or delivered to the Subscription Agent at one of the addresses noted above.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white"><b>A PAYMENT
PURSUANT TO THIS METHOD MUST BE IN UNITED STATES DOLLARS BY CHECK (WHICH MUST INCLUDE THE NAME OF THE SHAREHOLDER ON THE CHECK) DRAWN
ON A BANK LOCATED IN THE UNITED STATES, MUST BE PAYABLE TO NUVEEN GLOBAL HIGH INCOME FUND AND MUST ACCOMPANY AN EXECUTED SUBSCRIPTION
CERTIFICATE TO BE ACCEPTED.</b> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">If a holder of Rights who acquires Common Shares pursuant to the subscription makes payment of an insufficient amount, the Fund reserves the right to take any or all of the following actions: (i)&#160;reallocate such subscribed and unpaid-for Common Shares to Record Date Shareholders exercising the over-subscription privilege who did not receive the full over-subscription requested; (ii)&#160;apply any payment actually received by it toward the purchase of the greatest whole number of Common Shares which could be acquired by such holder upon exercise of the Rights or any over-subscription privilege; and (iii)&#160;exercise any and all other rights or remedies to which it may be entitled, including, without limitation, the right to set off against payments actually received by it with respect to such subscribed Common Shares (in other words, retain such payments) and to enforce the exercising Rights holder&#8217;s relevant payment obligation. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Any payment required from a holder of Rights must be received by the Subscription Agent prior to 5:00 p.m., Eastern time on the Expiration Date. Issuance and delivery of the Common Shares purchased are subject to collection of checks. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Within
eight Business Days following the Expiration Date (the &#8220;Confirmation Date&#8221;), a confirmation will be sent by the
Subscription Agent to each holder of Rights (or, if the Common Shares are held by Cede or any other depository or nominee, to Cede
or such other depository or nominee), showing (i) the number of Common Shares acquired pursuant to the Primary Subscription, (ii)
the number of Over-Subscription Shares, if any, acquired pursuant to any over-subscription privilege, and (iii) the per share and
total purchase price for the Common Shares. Any additional payment required from a Record Date Shareholder for the difference
between the estimated Subscription Price and the actual Subscription Price will be reflected in an invoice to such shareholder. Any
excess payment to be refunded by the Fund to a holder of Rights, or to be paid to a holder of Rights as a result of sales of Rights
on its behalf by the Subscription Agent, will be mailed by the Subscription Agent to the holder within eight Business Days after
the Expiration Date. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">A holder of Rights will have no right to rescind a purchase after the Subscription Agent has received payment either by means of a notice of guaranteed delivery or a check, which must include the name of the shareholder on the check. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Upon acceptance of a subscription, all funds received by the Subscription Agent shall be held by the Subscription Agent as agent for the Fund and deposited in one or more bank accounts. Such funds may be invested by the Subscription Agent in bank accounts, short-term certificates of deposit, bank repurchase agreements, and disbursement accounts with commercial banks meeting certain standards. The Subscription Agent may receive interest, dividends or other earnings in connection with such deposits or investments. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 18; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Holders, such as broker-dealers, trustees or depositories for securities, who hold Common Shares for the account of others, should notify the respective beneficial owners of the Common Shares as soon as possible to ascertain such beneficial owners&#8217; intentions and to obtain instructions with respect to the Rights. If the beneficial owner so instructs, the record holder of the Rights should complete Subscription Certificates and submit them to the Subscription Agent with the proper payment. In addition, beneficial owners of Common Shares or Rights held through such a holder should contact the holder and request that the holder effect transactions in accordance with the beneficial owner&#8217;s instructions. <b>Banks, broker-dealers, trustees and other nominee holders that hold Common Shares of the Fund for the accounts of others are advised to notify those persons that purchase Rights in the secondary market that such Rights may not participate in any over-subscription privilege offered.</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white"><b>THE INSTRUCTIONS
ACCOMPANYING THE SUBSCRIPTION CERTIFICATES SHOULD BE READ CAREFULLY AND FOLLOWED IN DETAIL. DO NOT SEND SUBSCRIPTION CERTIFICATES TO
THE FUND. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white"><b>THE METHOD
OF DELIVERY OF SUBSCRIPTION CERTIFICATES AND PAYMENT OF THE ESTIMATED SUBSCRIPTION PRICE TO THE SUBSCRIPTION AGENT WILL BE AT THE ELECTION
AND RISK OF THE RIGHTS HOLDERS, BUT IF SENT BY MAIL IT IS RECOMMENDED THAT THE CERTIFICATES AND PAYMENTS BE SENT BY REGISTERED MAIL,
PROPERLY INSURED, WITH RETURN RECEIPT REQUESTED, AND THAT A SUFFICIENT NUMBER OF DAYS BE ALLOWED TO ENSURE DELIVERY TO THE SUBSCRIPTION
AGENT AND CLEARANCE OF PAYMENT PRIOR TO 5:00 P.M., EASTERN TIME, ON THE EXPIRATION DATE BECAUSE UNCERTIFIED PERSONAL CHECKS MAY TAKE
AT LEAST FIVE BUSINESS DAYS TO CLEAR. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">All questions concerning the timeliness, validity, form and eligibility of any exercise of Rights will be determined by the Fund, whose determinations will be final and binding. The Fund in its sole discretion may waive any defect or irregularity, or permit a defect or irregularity to be corrected within such time as it may determine, or reject the purported exercise of any Right. Subscriptions will not be deemed to have been received or accepted until all irregularities have been waived or cured within such time as the Fund determines in its sole discretion. Neither the Fund nor the Subscription Agent will be under any duty to give notification of any defect or irregularity in connection with the submission of Subscription Certificates or incur any liability for failure to give such notification. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Foreign Restrictions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Subscription Certificates will only be mailed to Record Date Shareholders whose addresses are within the United States (other than an
APO or FPO address). Because the Rights offering will not be registered in any jurisdiction other than the United States, shareholders
of record in any jurisdiction outside of the United States should contact the Information Agent for assistance in facilitating the sale
of the Rights issued to Record Date Shareholders outside of the United States. The Subscription Agent will attempt to sell all of the
Rights issued to shareholders outside these jurisdictions and remit the net proceeds, if any, to such shareholders of record. If the Rights
can be sold, sales of these Rights will be deemed to have been effected at the weighted average price received by the Subscription Agent
on the day the Rights are sold, less any applicable brokerage commissions, taxes and other expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">For beneficial owners of the Fund&#8217;s Common Shares who hold their Common Shares through a custodian bank, broker, dealer, or other nominee,
it is the responsibility of the nominee holder to determine whether the beneficial owner is eligible to participate in the jurisdiction
in which they reside, as the nominee holder will submit instructions on behalf of the beneficial owner through DTC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 19; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Employee Benefit Plan and IRA Considerations </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Holders of Rights that are employee benefit plans subject to limitations imposed by the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), such as employee plans subject to the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;), Keogh Plans and Individual Retirement Accounts (&#8220;IRA&#8221;) (each a &#8220;Benefit Plan&#8221; and collectively, &#8220;Benefit Plans&#8221;), should be aware that the use of additional contributions of cash outside of the Benefit Plan to exercise Rights may be treated as additional contributions to the Benefit Plan. When taken together with contributions previously made, such deemed additional contributions may be in excess of tax limitations and subject the Rights holder to excise taxes for excess or nondeductible contributions. In the case of Benefit Plans qualified under Section&#160;401(a) of the Code, additional contributions could cause the maximum contribution limitations of Section&#160;415 of the Code or other qualification rules to be violated. Benefit Plans contemplating making additional contributions to exercise Rights should consult with their legal and tax counsel prior to making such contributions. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Benefit Plans and other tax-exempt entities, including governmental plans, should also be aware that if they borrow to finance their exercise of Rights, they may become subject to the tax on unrelated business taxable income (&#8220;UBTI&#8221;) under Section&#160;511 of the Code. If any portion of an IRA is used as security for a loan, the portion so used may also be treated as distributed to the IRA depositor. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">A Benefit Plan may also be subject to laws, such as ERISA, that impose certain requirements on the Benefit Plan and on those persons who are fiduciaries with respect to the Benefit Plans. Such requirements may include prudence and diversification requirements and require that investments be made in accordance with the documents governing the Benefit Plan. The exercise of Rights by a fiduciary for a Benefit Plan should be considered in light of such fiduciary requirements. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">In addition, ERISA and the Code prohibit certain transactions involving the assets of a Benefit Plan and certain persons (referred to as &#8220;parties in interest&#8221; for purposes of ERISA and &#8220;disqualified persons&#8221; for purposes of the Code) having certain relationships to such Benefit Plans, unless a statutory or administrative exemption is applicable to the transaction. A party in interest or disqualified person who engages in a nonexempt prohibited transaction may be subject to excise taxes and other penalties and liabilities under ERISA and the Code (or with respect to certain Benefit Plans, such as IRAs, a prohibited transaction may cause the Benefit Plan to lose its tax-exempt status). In this regard, the U.S. Department of Labor has issued prohibited transaction class exemptions (&#8220;PTCEs&#8221;) that may apply to the exercise of the Rights and holding of the Common Shares. These class exemptions include, without limitation, PTCE 84-14 respecting transactions determined by independent qualified professional asset managers, PTCE 90-1 respecting insurance company pooled separate accounts, PTCE 91-38 respecting bank collective investment funds, PTCE 95-60 respecting life insurance company general accounts and PTCE 96-23 respecting transactions determined by in-house asset managers, PTCE 84-24 governing purchases of shares in investment companies) and PTCE 75-1 respecting sales of securities. In addition, Section&#160;408(b)(17) of ERISA and Section&#160;4975(d)(20) of the Code each provides a limited exemption, commonly referred to as the &#8220;service provider exemption,&#8221; from the prohibited transaction provisions of ERISA and Section&#160;4975 of the Code for certain transactions between a Benefit Plan and a person that is a party in interest and/or a disqualified person (other than a fiduciary or an affiliate that, directly or indirectly, has or exercises any discretionary authority or control or renders any investment advice with respect to the assets of any Benefit Plan involved in the transaction) solely by reason of providing services to the Benefit Plan or by relationship to a service provider, provided that the Benefit Plan receives no less, nor pays no more, than adequate consideration. There can be no assurance that all of the conditions of any such exemptions or any other exemption will be satisfied at the time that the Rights are exercised, or thereafter while the Common Shares are held, if the facts relied upon for utilizing a prohibited transaction exemption change. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Due to the complexity of these rules and the penalties for noncompliance, fiduciaries of Benefit Plans should consult with their legal and tax counsel regarding the consequences of their exercise of Rights under ERISA, the Code and other similar laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 20; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="jdc424b2a003"></span>SUMMARY OF FUND EXPENSES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="AsOf2025-10-15" escape="true" id="Fact000015" name="cef:PurposeOfFeeTableNoteTextBlock"><p id="xdx_804_ecef--PurposeOfFeeTableNoteTextBlock_dU_z1hWVATSQ52l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The purpose of the table and the example below is to help you understand all fees and expenses that you, as a shareholder of Common Shares (&#8220;Common Shareholder&#8221;), would bear directly or indirectly. The table shows the expenses of the Fund as a percentage of the average net assets applicable to Common Shares, and not as a percentage of total assets or Managed Assets.</p>

</ix:nonNumeric><ix:nonNumeric contextRef="AsOf2025-10-15" continuedAt="ConU000018-01" escape="true" id="Fact000018" name="cef:ShareholderTransactionExpensesTableTextBlock"><p id="xdx_809_ecef--ShareholderTransactionExpensesTableTextBlock_dU_gL1STETTB-XWWQ_z4tJYeLsjUfg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder Transaction Expenses</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt">Offering Costs Borne by the Common Shareholders of the Fund <span id="xdx_907_ecef--BasisOfTransactionFeesNoteTextBlock_c20251015__20251015_z5gwanZMGJml"><ix:nonNumeric contextRef="AsOf2025-10-15" escape="true" id="Fact000019" name="cef:BasisOfTransactionFeesNoteTextBlock">(as a percentage of common net assets
    including proceeds of the offering)</ix:nonNumeric></span><sup>(1)</sup></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_983_ecef--OtherTransactionExpense1Percent_dpn_c20251015__20251015_fKDEp_zPLE8A7eBUP7" style="text-align: right"><ix:nonFraction name="cef:OtherTransactionExpense1Percent" contextRef="AsOf2025-10-15" id="Fact000020" format="ixt-sec:numwordsen" decimals="INF" scale="-2" unitRef="Ratio">None</ix:nonFraction></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 20pt; width: 92%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering Costs
    (as a percentage of the proceeds of the offering)<sup>(1)</sup></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecef--OtherTransactionExpense2Percent_dpn_c20251015__20251015_fKDEp_z71S6e6ZhwRh" style="text-align: right; width: 5%"><ix:nonFraction name="cef:OtherTransactionExpense2Percent" contextRef="AsOf2025-10-15" id="Fact000021" format="ixt-sec:numwordsen" decimals="INF" scale="-2" unitRef="Ratio">None</ix:nonFraction></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend Reinvestment Plan Fees<sup>(2)</sup> </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecef--DividendReinvestmentAndCashPurchaseFees_pp2p0_c20251015__20251015_fKDIp_z1Oltq02qti6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="cef:DividendReinvestmentAndCashPurchaseFees" contextRef="AsOf2025-10-15" id="Fact000022" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">2.50</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F02_zle62FK0Fgf2">(1)</sup></span></td>
    <td id="xdx_F11_zQDtGIZiXKBb"><ix:footnote id="Footnote000023" xml:lang="en-US">Total offering costs, which will be borne by Nuveen Fund Advisors and not the Fund or Common Shareholders, are estimated to be $375,000, which assumes that the Rights offering is fully subscribed.</ix:footnote></td></tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F03_zkWa65rVR6G3">(2)</sup></span></td>
    <td><span id="xdx_F1D_zX7ob0gNJsm8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000024" xml:lang="en-US">You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment account.</ix:footnote></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify">&#160;</p>
</ix:nonNumeric><ix:nonNumeric contextRef="AsOf2025-10-15" continuedAt="ConU000027-01" escape="true" id="Fact000027" name="cef:AnnualExpensesTableTextBlock"><div id="xdx_801_ecef--AnnualExpensesTableTextBlock_dU_gL1AETTB-WBQWO_zOYuGDr7ExJ6"></div>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="background-color: white">
    <td style="vertical-align: top; width: 87%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As a Percentage <br/> of Net Assets<br/> Attributable to<br/> Common <br/> Shares<sup>(3)</sup></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Annual Expenses</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management Fees</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_988_ecef--ManagementFeesPercent_dp_c20251015__20251015_fKDMp_zzGGfjMRB9Ug" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="cef:ManagementFeesPercent" contextRef="AsOf2025-10-15" id="Fact000028" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.20</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%&#160;&#160;</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest and Other Related Expenses<sup>(4)</sup></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_986_ecef--InterestExpensesOnBorrowingsPercent_dp_c20251015__20251015_fKDMpKDQp_zUO7xuhwzGQk" style="vertical-align: bottom; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="cef:InterestExpensesOnBorrowingsPercent" contextRef="AsOf2025-10-15" id="Fact000029" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">2.16</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Expenses<sup>(5)</sup></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_986_ecef--OtherAnnualExpensesPercent_dp_c20251015__20251015_fKDMpKDUp_z2q7KxYaC2Wk" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="cef:OtherAnnualExpensesPercent" contextRef="AsOf2025-10-15" id="Fact000030" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.11</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%&#160;</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Annual Expenses</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_989_ecef--TotalAnnualExpensesPercent_dp_c20251015__20251015_fKDMp_z00ZuLpY61Rd" style="vertical-align: bottom; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="cef:TotalAnnualExpensesPercent" contextRef="AsOf2025-10-15" id="Fact000031" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">3.47</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>
</ix:nonNumeric><div id="xdx_818_z9d9nPwuHQSe"></div>
<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<div id="xdx_C0D_gL1STETTB-XWWQ_zl17bG9SrRWa"><ix:continuation id="ConU000018-01"><p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td>
    <td><span id="xdx_90D_ecef--OtherTransactionFeesNoteTextBlock_c20251015__20251015_zV6ecFEyaxHg"><ix:nonNumeric contextRef="AsOf2025-10-15" escape="true" id="Fact000032" name="cef:OtherTransactionFeesNoteTextBlock">Total offering costs, which will be borne by Nuveen Fund Advisors and not the Fund or Common Shareholders, are estimated to be $375,000, which assumes that the Rights offering is fully subscribed.</ix:nonNumeric></span></td></tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment account.</span></td></tr>
</table></ix:continuation></div>
<div id="xdx_C0C_gL1AETTB-WBQWO_zeXTbTDSnuUf"><ix:continuation id="ConU000027-01">
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0D_zeZYgDU7X0V8">(3)</sup></span></td>
    <td><span id="xdx_F17_zqFUJIyW4KH8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000033" xml:lang="en-US">Stated as percentages of average net assets
    attributable to Common Shares for the six-month period ended June 30, 2025 (unaudited).</ix:footnote></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0D_z7gP7arp7nK2">(4)</sup></span></td>
    <td><span id="xdx_F11_zKjaEorI4tU2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000034" xml:lang="en-US">Interest and Other Related
    Expenses reflect actual expenses and fees for leverage incurred by the Fund for the six-month period ended June 30, 2025
    (annualized). The types of leverage used by the Fund for the six-month period ended June 30, 2025 (annualized) are described in the
    Fund Performance, Leverage and Holdings Summaries &#8212; Leverage and Holdings section of the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1539337/000119312525196804/d64165dncsrs.htm">semi-annual report</a>, Actual Interest and Other Related Expenses incurred in the future may be higher or lower. If short-term market interest
    rates rise in the future, and if the Fund continues to maintain leverage, the cost of which is tied to short-term interest rates,
    the Fund's interest expenses on its short-term borrowings can be expected to rise in tandem. The Fund's use of leverage will
    increase the amount of management fees paid to the Fund's adviser and sub-advisor(s).</ix:footnote></span></td></tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0E_zH6joYWD4Qsh">(5)</sup></span></td>
    <td><span id="xdx_F12_z9U7zJAY38hb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecef--OtherExpensesNoteTextBlock_c20251015__20251015_zheN3r5ojcp9"><ix:footnote id="Footnote000035" xml:lang="en-US"><ix:nonNumeric contextRef="AsOf2025-10-15" escape="true" id="Fact000036" name="cef:OtherExpensesNoteTextBlock">Other Expenses is based on estimated amounts for the current fiscal year. Expenses attributable to the Fund&#8217;s investments, if any, in other investment companies are currently estimated not to exceed 0.01%. See &#8220;The Fund&#8217;s Investments&#8212;Other Investment Companies&#8221; in the SAI.</ix:nonNumeric></ix:footnote></span></span></td></tr>
  </table></ix:continuation></div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 21; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="AsOf2025-10-15" escape="true" id="Fact000038" name="cef:ExpenseExampleTableTextBlock"><p id="xdx_809_ecef--ExpenseExampleTableTextBlock_dU_z3JZg0zh3Pvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Example</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following example illustrates the
expenses that a Common Shareholder would pay on a $1,000 investment held for the time periods provided in the table, assuming a 5%
annual total return. The example assumes that all dividends and other distributions are reinvested in the Fund and that the
Fund&#8217;s Annual Total Expenses, as provided above, remain the same.<sup>1</sup></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1&#160;Year</b></span></td>
    <td style="width: 15%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3&#160;Years</b></span></td>
    <td style="width: 15%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5&#160;Years</b></span></td>
    <td style="width: 15%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10&#160;Years</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td id="xdx_983_ecef--ExpenseExampleYear01_c20251015__20251015_fKDEp_zntPFca9yiTj" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<ix:nonFraction name="cef:ExpenseExampleYear01" contextRef="AsOf2025-10-15" id="Fact000039" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td id="xdx_98C_ecef--ExpenseExampleYears1to3_c20251015__20251015_fKDEp_zCKBbwQAyJ8e" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">$<ix:nonFraction name="cef:ExpenseExampleYears1to3" contextRef="AsOf2025-10-15" id="Fact000040" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td id="xdx_98F_ecef--ExpenseExampleYears1to5_c20251015__20251015_fKDEp_z145oz8kH8P7" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">$<ix:nonFraction name="cef:ExpenseExampleYears1to5" contextRef="AsOf2025-10-15" id="Fact000041" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td id="xdx_98A_ecef--ExpenseExampleYears1to10_c20251015__20251015_fKDEp_zJOorvNNXNib" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">$<ix:nonFraction name="cef:ExpenseExampleYears1to10" contextRef="AsOf2025-10-15" id="Fact000042" format="ixt:numdotdecimal" decimals="0" unitRef="USD">375</ix:nonFraction></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>The example should not be considered a representation of future expenses. Actual expenses may be greater or less than those shown above.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 37px">
        <p id="xdx_F0E_zogCGKyrdQll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1)</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td>
    <td><span id="xdx_F16_zkBZTMB5ZdX8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000043" xml:lang="en-US">The example assumes that all dividends and distributions are reinvested at Common Shares NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</ix:footnote></span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_81D_zrAg5vrWyoNl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 22; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="AsOf2025-10-15" escape="true" id="Fact000045" name="cef:SharePriceTableTextBlock"><p id="xdx_808_ecef--SharePriceTableTextBlock_dU_znTbprxup8Ma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="jdc424b2a004"></span>TRADING AND NET ASSET VALUE INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table shows for the periods
indicated: (i)&#160;the high and low sales prices for the Common Shares reported as of the end of the day on the NYSE, (ii)&#160;the
corresponding NAV per share, and (iii)&#160;the premium/(discount) to NAV per share at which the Common Shares were trading as of such date. The Fund&#8217;s Common Shares have historically traded both at premiums and discounts in relation to the Fund&#8217;s NAV
per share. The Fund cannot predict whether its Common Shares will trade at a premium or discount to NAV in the future. The Board of Trustees has currently determined that, at least annually, it will consider action that might be taken to
reduce or eliminate any material discount from NAV in respect of Common Shares, which may include the repurchase of such shares in
the open market or in private transactions, the making of a tender offer for such shares at NAV, or the conversion of the Fund to an
open-end investment company. The Fund cannot assure you that its Board of Trustees will decide to take any of these actions, or that
share repurchases or tender offers will actually reduce market discount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; visibility: hidden; vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_488_ecef--HighestPriceOrBid_pip0_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaTjawnlijIk" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_486_ecef--LowestPriceOrBid_pip0_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zyomduCtHsVe" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_489_ecef--HighestPriceOrBidNav_pip0_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zstYx6w3jhS9" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_487_ecef--LowestPriceOrBidNav_pip0_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z0xGJsvwXc0f" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_484_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_pid_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zSapAyDehcpf" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_488_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_pid_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zooEAgHxynki" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Closing Market Price per</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">NAV per Common Share on</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Premium/(Discount) on</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Date of Market Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Date of Market Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">Fiscal Quarter Ended</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_41E_20250701__20250930_zdzUC7bdKc03" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left">September 2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2025-07-012025-09-30_us-gaap_CommonStockMember" id="Fact000046" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.64</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2025-07-012025-09-30_us-gaap_CommonStockMember" id="Fact000047" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">12.92</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2025-07-012025-09-30_us-gaap_CommonStockMember" id="Fact000048" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">14.02</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2025-07-012025-09-30_us-gaap_CommonStockMember" id="Fact000049" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.73</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-07-012025-09-30_us-gaap_CommonStockMember" id="Fact000050" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">2.71</ix:nonFraction></td><td style="width: 1%; text-align: left">)%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-07-012025-09-30_us-gaap_CommonStockMember" id="Fact000051" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">5.90</ix:nonFraction></td><td style="width: 1%; text-align: left">)%</td></tr>
  <tr id="xdx_413_20250401__20250630_zNVxSYsSweLb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">June 2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember" id="Fact000052" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember" id="Fact000053" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">11.48</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember" id="Fact000054" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.53</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember" id="Fact000055" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">12.89</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember" id="Fact000056" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">3.92</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember" id="Fact000057" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">10.94</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_416_20250101__20250331_zhPNlNZQwh07" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">March 2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember" id="Fact000058" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.42</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember" id="Fact000059" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">12.80</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember" id="Fact000060" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.97</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember" id="Fact000061" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.57</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember" id="Fact000062" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">3.94</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember" id="Fact000063" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">5.67</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_419_20241001__20241231_ztLmcHbugR35" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">December 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000064" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.38</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000065" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">12.72</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000066" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.94</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000067" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.82</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000068" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">4.02</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember" id="Fact000069" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">7.96</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_41D_20240701__20240930_zxYlfw1xxEV7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">September 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000070" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.38</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000071" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">12.42</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000072" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.95</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000073" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.33</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000074" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">4.09</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000075" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">6.83</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_417_20240401__20240630_zu3Th7tVGVi3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">June 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact000076" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact000077" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">12.18</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact000078" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.51</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact000079" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact000080" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">3.40</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact000081" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">7.16</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_41B_20240101__20240331_z6Km33QRVof9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">March 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000082" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">12.92</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000083" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">11.96</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000084" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.51</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000085" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.17</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000086" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">4.37</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000087" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">9.19</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_41D_20231001__20231231_zfymxGebu8Y1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">December 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000088" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">12.24</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000089" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">10.40</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000090" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.38</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000091" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">12.09</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000092" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">8.52</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember" id="Fact000093" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">13.98</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_41C_20230701__20230930_zYVuOdEuj0V2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">September 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000094" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">11.99</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000095" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">11.17</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000096" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">12.91</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000097" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">12.72</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000098" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">7.13</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000099" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">12.19</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_415_20230401__20230630_z482sluLYF29" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">June 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="Fact000100" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">11.39</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="Fact000101" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">10.65</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="Fact000102" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">12.73</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="Fact000103" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">12.42</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="Fact000104" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">10.53</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="Fact000105" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">14.25</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_414_20230101__20230331_z8oR9EjfSsIa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">March 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="Fact000106" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">12.62</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="Fact000107" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">10.67</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="Fact000108" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">13.55</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="Fact000109" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">12.44</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="Fact000110" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">6.86</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="Fact000111" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">14.23</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The NAV per Common Share, the market price and
percentage of premium/(discount) to NAV per Common Share on October 8, 2025,  was <span id="xdx_90A_eus-gaap--NetAssetValuePerShare_iI_c20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zeD00yrjY0M">$<ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2025-10-08_us-gaap_CommonStockMember" id="Fact000112" format="ixt:numunitdecimalin" decimals="INF" unitRef="USDPShares">14.05,</ix:nonFraction>
</span> <span id="xdx_909_eus-gaap--SharePrice_iI_c20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbF0DfEChS13">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-10-08_us-gaap_CommonStockMember" id="Fact000113" format="ixt:numunitdecimalin" decimals="INF" unitRef="USDPShares">13.62,</ix:nonFraction>
</span>and <span id="xdx_90B_ecef--LatestPremiumDiscountToNavPercent_dp_c20251008__20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zPwAZbEjvA1j">(<ix:nonFraction name="cef:LatestPremiumDiscountToNavPercent" contextRef="From2025-10-082025-10-08_us-gaap_CommonStockMember" id="Fact000114" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">3.06</ix:nonFraction>)</span>%,
respectively. As of October 8, 2025, the Fund had&#160;<span id="xdx_904_ecef--OutstandingSecurityNotHeldShares_c20251008__20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zgwSi8IFiXDd"><ix:nonFraction name="cef:OutstandingSecurityNotHeldShares" contextRef="From2025-10-082025-10-08_us-gaap_CommonStockMember" id="Fact000115" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,177,393</ix:nonFraction></span>&#160;Common
Shares outstanding, and net assets applicable to Common Shares of $325,657,313. See &#8220;Repurchase of Fund Shares; Conversion to Open-End
Fund&#8221; in the accompanying prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

</ix:nonNumeric><p id="xdx_818_zaKbimVKkPC3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="jdc424b2a006"></span>USE OF PROCEEDS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Assuming the sale of all of the Common Shares
offered through Rights under this Prospectus Supplement and the accompanying prospectus, based on the estimated Subscription Price
of $12.84 and that the estimated expenses related to the Rights offering of $375,000 are paid by Nuveen Fund Advisors, the Fund estimates the net
proceeds of the offering will be approximately $74,848,828. There is no guarantee that there will be any sales of Common Shares through
Rights pursuant to this Prospectus Supplement and the accompanying prospectus. Actual sales, if any, of Common Shares through Rights
under this Prospectus Supplement and the accompanying prospectus may be less than as set forth above. In addition, the price per
share of any such sale may be greater or less than the price set forth above, depending on the market price of Common Shares at the
time of any such sale. As a result, the actual net proceeds the Fund receives may be more or less than the amount of net proceeds
estimated in this Prospectus Supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Fund intends to invest the net proceeds
from the issuance of Rights hereunder in accordance with the Fund&#8217;s investment objective and policies as set forth in the
accompanying prospectus. The Fund currently anticipates that it will be able to invest substantially all of the net proceeds in investments
that meet the Fund&#8217;s investment objective and policies within approximately three months of the receipt of such proceeds;
however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in
market conditions may cause the investment period to extend as long as six months (the &#8220;invest-up period&#8221;). Pending
investment, it is anticipated that the proceeds will be invested in short-term or long-term securities issued by the U.S. Government
and its agencies or instrumentalities or in high-quality, short-term money market instruments. Current market conditions may change
and the Fund may not be able to invest the proceeds as planned. Immediately after the initial invest-up period, the Fund&#8217;s portfolio
allocations may vary over time consistent with the Fund&#8217;s investment policies as described in the accompanying prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 23; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="jdc424b2a007"></span>CAPITALIZATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Fund is issuing Rights to its Common Shareholders to subscribe for an aggregate of 5,829,348 of its Common Shares, $0.01 par value
per share. There is no guarantee that there will be any sales of the Common Shares through Rights pursuant to this Prospectus Supplement
and the accompanying prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table sets forth the
Fund&#8217;s capitalization (1) on a historical basis as of October 8, 2025 (unaudited); and (2) on a pro forma basis as adjusted
to reflect the assumed sale of 5,829,348 Common Shares at $12.84 per share (the estimated Subscription Price), through a Rights
offering under this Prospectus Supplement and the accompanying prospectus, and assuming that the expenses related to the Rights
offering estimated at approximately $375,000 are paid by Nuveen Fund Advisors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of October 8, 2025 (unaudited)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Adjusted for Offering (unaudited)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%">Common shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span id="xdx_90F_ecef--OutstandingSecurityNotHeldShares_c20251008__20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zRqbZ5Dbmzrg"><ix:nonFraction name="cef:OutstandingSecurityNotHeldShares" contextRef="From2025-10-082025-10-08_us-gaap_CommonStockMember" id="Fact000116" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,177,393</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span id="xdx_90C_ecef--OutstandingSecurityNotHeldShares_c20251008__20251008__us-gaap--StatementClassOfStockAxis__custom--CommonStockAdjustedForOfferingMember_zyzU6zRvDIUc"><ix:nonFraction name="cef:OutstandingSecurityNotHeldShares" contextRef="From2025-10-082025-10-08_custom_CommonStockAdjustedForOfferingMember" id="Fact000117" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,006,741</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Paid in Capital *</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">440,988,847</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">515,837,675</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Undistributed net investment income</td><td style="color: #FF0000">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(26,728,284</td><td style="text-align: left">)</td><td style="color: #FF0000">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(26,728,284</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accumulated gain/(loss)</td><td style="color: #FF0000">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(97,814,803</td><td style="text-align: left">)</td><td style="color: #FF0000">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(97,814,803</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net appreciation/depreciation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9,211,553</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9,211,553</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">325,657,313</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">400,506,141</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Net asset value</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--NetAssetValuePerShare_iI_c20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zhT5UTlXBtu8"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2025-10-08_us-gaap_CommonStockMember" id="Fact000118" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.05</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--NetAssetValuePerShare_iI_c20251008__us-gaap--StatementClassOfStockAxis__custom--CommonStockAdjustedForOfferingMember_zqvS2XSxE6Ge"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2025-10-08_custom_CommonStockAdjustedForOfferingMember" id="Fact000119" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.81</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">* As adjusted Paid in Capital reflects the issuance of 5,829,348 Common shares issued in the primary subscription at the estimated Subscription Price of $12.84.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&#160;</p>

<!-- Field: Page; Sequence: 24; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="background-color: white"><b><span id="jdc424b2a008"></span>SPECIAL CHARACTERISTICS AND RISKS OF THE RIGHTS OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Risk is inherent in all investing. Therefore, before investing in the Common Shares you should consider the risks associated with such an investment carefully. See &#8220;Risk Factors&#8221; in the accompanying prospectus. The following summarizes some of the matters that you should consider before investing in Common Shares through the Rights offering: </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 66pt"><b>Dilution Risk. </b>Record Date Shareholders
who do not fully exercise their Rights will, at the completion of the Rights offering, own a smaller proportional interest in the
Fund than owned prior to the Rights offering. The completion of the Rights offering will result in immediate voting dilution for
such shareholders. You will also experience an immediate dilution of the aggregate NAV per Common Share if you do not
fully participate in the Rights offering.  You may also experience a reduction in the NAV per Common Share whether or not
you exercise your Rights, as the Subscription Price may be below the Fund's NAV per Common Share on the Expiration Date,
because:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"/>
    <td style="width: 0.25in">&#9679;</td>
    <td>the offered Common Shares may be sold at less than their current NAV; and</td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"/>
    <td style="width: 0.25in">&#9679;</td>
    <td>the number of Common Shares outstanding after the Rights offering may have increased proportionately more than the increase in the amount of the Fund's net assets.</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The amount of such potential dilution is not currently determinable because it is not known how many Common Shares will be subscribed for, what the NAV per Common Share or market price of the Common Shares will be on the Expiration Date or what the Subscription Price per Common Share will be.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Furthermore, if you do not participate in an over-subscription privilege, if it is available, your percentage ownership may also be diluted. The Fund cannot state precisely the amount of dilution because it is not known at this time what the NAV per Common Share will be on the Expiration Date or what proportion of the Rights will be exercised or what the Subscription Price per Common Share will be. The impact of the Rights offering on NAV per Common Share pursuant to the Primary Subscription is shown by the following example, assuming the Rights offering is fully subscribed and the estimated Subscription Price of $12.84:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td colspan="4" style="border-bottom: Black 1pt solid; padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><b>Assumes the Primary Subscription is fully subscribed<sup>(1)</sup></b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; width: 82%"><span style="font-size: 10pt">NAV<sup>(2)</sup></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">$</td>
    <td style="text-align: right; width: 14%"><span style="font-size: 10pt">14.05</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-size: 10pt">Subscription Price<sup>(3)</sup></span></td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font-size: 10pt">12.84</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">Reduction in NAV ($)</span></td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font-size: 10pt">(0.24</span></td>
    <td>)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-size: 10pt">Reduction in NAV (%)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">(1.71</span></td>
    <td>)%</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0"/>
    <td style="width: 0.25in"><span style="background-color: white">(1)</span></td>
    <td><span style="background-color: white">Actual amounts may vary due to rounding. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 0"/>
    <td style="width: 0.25in"><span style="background-color: white">(2)</span></td>
    <td><span style="background-color: white">For illustrative purposes only&#894; reflects the Fund&#8217;s NAV per Common Share as of
    October 8, 2025. It is not known at this time what the NAV per Common Share will be on the Expiration Date. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 0"/>
    <td style="width: 0.25in"><span style="background-color: white">(3)</span></td>
    <td><span style="background-color: white">For illustrative purposes only&#894; reflects an estimated Subscription Price of $12.84
    based upon 95% of the average of the last reported sales price of the Common Shares on the NYSE on October 8, 2025, and the four (4)
    immediately preceding trading days. It is not known at this time what the Subscription Price will be on the Expiration
    Date.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 25; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The impact of the Rights offering on NAV per Common Share pursuant to the Primary Subscription and Primary and Secondary Over-Subscription Privileges is shown by the following example that assumes that the Primary Subscription and Primary and Secondary Over-Subscription Privileges are fully subscribed with a $12.84 Subscription Price:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Assumes full subscription and 25% over-subscription<sup>(1)</sup></b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-top: Black 1pt solid; width: 83%">NAV<sup>(2)</sup></td>
    <td style="border-top: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-top: Black 1pt solid; width: 1%; text-align: left">$</td>
    <td style="border-top: Black 1pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.05</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription Price<sup>(3)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.84</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Reduction in NAV ($)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">(<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.29</span></td>
    <td>)&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Reduction in NAV (%)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2.06</span></td>
    <td>)%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0pt"/>
    <td style="width: 20pt">(1)</td>
    <td style="padding-right: 0.45in">Actual amounts may vary due to rounding.</td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0pt"/>
    <td style="width: 20pt">(2)</td>
    <td style="padding-right: 26.4pt">For illustrative purposes only&#894; reflects the Fund&#8217;s NAV per Common Share as of October 8, 2025. It is not known at this time what the NAV per Common Share will be on the Expiration Date.</td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0pt"/>
    <td style="width: 20pt">(3)</td>
    <td style="padding-right: 26.4pt">For illustrative purposes only&#894; reflects an estimated Subscription Price of $12.84 based upon 95% of the average of the last reported sales price of the Common Share on the NYSE on October 8, 2025, and the four (4) immediately preceding trading days. It is not known at this time what the Subscription Price will be on the Expiration Date.</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">If you
do not wish to exercise your Rights, you should consider selling them as set forth in this Prospectus Supplement. Any cash you
receive from selling your Rights may serve as partial compensation for dilution of your interest in the Fund. The Fund cannot give
assurance, however, that a market for the Rights will develop or be maintained or that the Rights will have any marketable value. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The Fund&#8217;s largest shareholders could increase their percentage ownership in the Fund through the exercise of the primary subscription and over-subscription privilege. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Risks of Investing in Rights.</b> Shares of closed-end funds, such
as the Fund, frequently trade at a discount to NAV. Accordingly, the Subscription Price may be greater than the market price of the Common
Shares on the Expiration Date. If that is the case, the Rights will have no value, and a person who exercises their Rights will experience
an immediate loss of value. Further, because the exercise of Rights is irrevocable, you will not be able to revoke your subscription if
the market price of the Common Shares decreases below the Subscription Price prior to delivery of your Common Shares. Moreover, the Fund
cannot assure you that you will ever be able to sell the Common Shares that you received in the Rights offering at a price equal to or
greater than the Subscription Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>No Assurance of Active Trading Market Risk.</b> Although the Rights
are approved for listing on the NYSE, there can be no assurance that an active trading market will develop or be maintained for the Rights.
If a trading market is not developed or maintained, you may not be able to transfer your Rights or may have to sell them at an unfavorable
price. The transferability of Rights is not guaranteed and investors who do not exercise their Rights prior to the Expiration Date and
are unable or unwilling to sell their Rights in the secondary market will realize no value for their Rights.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Risks of Increases in Share Price Volatility and Decreases in Share
Price.</b> The Rights offering may result in an increase in trading of the Common Shares, which may increase volatility in the market
price of the Common Shares. The Rights offering may result in an increase in the number of Common Shareholders wishing to sell their Common
Shares, which would exert downward price pressure on the price of Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Risk of Decreased Liquidity Despite Larger Float.</b> Although the
Rights offering will increase the number of Common Shares outstanding, there can be no assurance that the volume of trading in the Common
Shares will increase proportionately. As a result, the Rights offering may not materially improve the liquidity of the Common Shares on
the secondary market, which could lead to wider bid/ask spreads, increased volatility and greater variances between the market price of
the Common Shares and their underlying value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Under-Subscription Risk.</b> It is possible that the Rights offering
will not be fully subscribed. Under-subscription of the Rights offering would have an impact on the net proceeds of the Rights offering
and whether the Fund achieves any benefits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Over-Subscription Risk. </b>Record Date Shareholders who fully exercise
all Rights initially issued to them will be entitled to subscribe for an additional number of Common Shares by exercising their over-subscription
privileges. The over-subscription privileges will generally be allocated pro rata among Record Date Shareholders who over-subscribed based
on the number of Rights issued to them by the Fund. The Fund cannot guarantee that you will receive any or the entire number of Common
Shares for which you over-subscribed. If the pro-rated number of Common Shares allocated to you in connection with your over-subscription
privileges is less than your request, then the excess funds held by the Subscription Agent on your behalf will be returned to you, without
interest, as soon as practicable after the Rights offering has expired and all pro-rating calculations and reductions contemplated by
the terms of the Rights offering have been effected, and the Fund will have no further obligation to you.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>No Assurance or Accretion in NAV or Distributions.</b> Although
the Rights offering will increase the Fund's assets, there can be no assurance that the Rights offering will be accretive to the Fund's
NAV per Common Share or its ability to sustain or increase distributions. Investment returns on the proceeds from the Rights offering
may be lower than current portfolio returns, and the Fund's distribution rate per Common Share may decline.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Risk of Delayed Delivery of Common Shares. </b>If you exercise Rights,
you may not be able to resell the Common Shares that you receive in the Rights offering until you, or your custodian bank, broker, dealer
or other nominee, if applicable, have received those Common Shares. Moreover, you will have no rights as a shareholder of the Common Shares
you received in the Rights offering until the Fund issues those Common Shares to you. Although the Fund will endeavor to issue the Common
Shares as soon as practicable after completion of the Rights offering, and after all necessary calculations have been completed, there
may be a delay between the Expiration Date and the time that the Common Shares are issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Risk that Market Conditions May Impact Use of Proceeds.</b> Although
the Fund intends to invest the proceeds from the Rights offering as described herein, market or other conditions at the time of investment
may result in the Fund making investments with different risk or return characteristics, or at less favorable yields, than currently anticipated,
which could adversely affect the Fund's performance and distribution levels.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Risk of Rejection of Exercise of Rights.</b> Record Date Shareholders
who desire to subscribe for Common Shares in the Rights offering must act promptly to ensure that all required forms and payments are
actually received by the Subscription Agent prior to the Expiration Date. If you are a beneficial owner of Common Shares, you must act
promptly to ensure that your custodian bank, broker, dealer or other nominee acts for you and that all required forms and payments are
actually received by the Subscription Agent prior to the Expiration Date. Your nominee may establish a deadline prior to the Expiration
Date by which you must provide it with your instructions to exercise your subscription rights and payment for your Common Shares. The
Fund will not be responsible if your custodian bank, broker, dealer or nominee fails to ensure that all required forms and payments are
actually received by the Subscription Agent prior to the Expiration Date. If you fail to complete and sign the required Subscription Certificate,
send an incorrect payment amount, or otherwise fail to follow the subscription procedures that apply to your desired transaction, the
Fund or the Subscription Agent may, depending on the circumstances, reject your subscription or accept it to the extent of the payment
received. Neither the Fund nor the Subscription Agent will be under any duty to give notification of any defect or irregularity in connection
with the submission of Subscription Certificates or incur any liability for failure to give such notification. The Fund has the sole discretion
to determine whether a subscription exercise properly follows the subscription procedures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>Risk of Termination of Rights Offering.</b> The Fund reserves the
right to terminate, amend or extend the Rights offering at any time for any reason before the Expiration Date. You will not earn any
interest on any payment of the Subscription Price you have made while it is being held by the Subscription Agent pending the termination
of the Rights offering, even if the Fund amends the terms of the Rights offering to extend the Subscription Period. If the Fund terminates
the Rights offering, neither the Fund, the Subscription Agent, your broker, nor any other party will have any obligation to you, except
to return any payment of the Subscription Price you have made, which will not accrue interest.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="background-color: white"><b><span id="jdc424b2a009"></span>TAXATION </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">The following is a general summary of the U.S. federal income tax consequences of the Rights offering to Record Date Shareholders who are U.S. persons for U.S. federal income tax purposes. The following summary supplements the discussion set forth in the accompanying prospectus and SAI and is subject to the qualifications and assumptions set forth therein. The discussion set forth herein does not constitute tax advice and potential investors are urged to consult their own tax advisers to determine the tax consequences of investing in the Fund. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 26; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white">Please refer to the &#8220;Tax Matters&#8221; sections in the accompanying prospectus and SAI for a description of the consequences of investing in the Common Shares. Special tax considerations relating to this Rights offering are summarized below: </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"/>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td><span style="background-color: white">The value of a Right will not be includible in the income of a Common Shareholder at the time the subscription Right is issued. </span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"/>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td><span style="background-color: white">The basis of a Right issued to a Common Shareholder will be zero, and the basis of the share with respect to which the Right was issued (the old share) will remain unchanged, unless either (a) the fair market value of the Right on the date of distribution is at least 15% of the fair market value of the old share, or (b) such Common Shareholder affirmatively elects (in the manner set out in Treasury regulations under the Code) to allocate to the Right a portion of the basis of the old share. If either (a) or (b) applies, such Common Shareholder must allocate basis between the old share and the Right in proportion to their fair market values on the date of distribution. </span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"/>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td><span style="background-color: white">The basis of a Right purchased in the market will generally be its purchase price. </span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"/>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td><span style="background-color: white">The holding period of a Right issued to a Common Shareholder will include the holding period of the old share. </span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"/>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td><span style="background-color: white">No loss will be recognized by a Common Shareholder if a Right distributed to such Common Shareholder expires unexercised because the basis of the old share may be allocated to a Right only if the Right is exercised. If a Right that has been purchased in the market expires unexercised, there will be a recognized loss equal to the basis of the Right. </span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"/>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td><span style="background-color: white">Any gain or loss on the sale of a Right will be a capital gain or loss if the Right is held as a capital asset (which in the case of a Right issued to Record Date Shareholders will depend on whether the old share is held as a capital asset), and will be a long term capital gain or loss if the holding period is deemed to exceed one year. </span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"/>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td><span style="background-color: white">No gain or loss will be recognized by a Common Shareholder upon the exercise of a Right, and the basis of any Common Share acquired upon exercise (the new Common Share) will equal the sum of the basis, if any, of the Right and the subscription price for the new Common Share. The holding period for the new Common Share will begin on the date when the Right is exercised (or, in the case of a Right purchased in the market, potentially the day after the date of exercise). </span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="background-color: white"><i>The foregoing is a general and abbreviated summary of the provisions of the Code and the Treasury regulations in effect as they directly govern the taxation of the Fund and holders of its Common Shares, with respect to U.S. federal income taxation only. Other tax issues such as state and local taxation may apply. Investors are urged to consult their own tax advisers to determine the tax consequences of investing in the Fund. These provisions are subject to change by legislative or administrative action, and any such change may be retroactive.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 27; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="jdc424b2a010"></span>LEGAL MATTERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain legal matters in connection with the Common Shares will be passed upon for the Fund by Stradley Ronon Stevens &amp; Young, LLP, located at 2005 Market Street, Suite 2600, Philadelphia, Pennsylvania. Stradley Ronon Stevens &amp; Young, LLP may rely as to certain matters of Massachusetts law on the opinion of Morgan, Lewis&#160;&amp; Bockius LLP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="jdc424b2a011"></span>AVAILABLE INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Fund is subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) and the 1940 Act and is required to file reports, proxy statements and other information with the SEC. Reports, proxy statements, and other information about the Fund can be inspected at the offices of the NYSE.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Prospectus Supplement does not contain all of the information in the Fund&#8217;s Registration Statement, including amendments, exhibits, and schedules. Additional information about the Fund and the Common Shares can be found in the Fund&#8217;s Registration Statement (including amendments, exhibits, and schedules) on Form N-2 filed with the SEC. The SEC maintains a website (www.sec.gov) that contains the Fund&#8217;s Registration Statement, other documents incorporated by reference, and other information the Fund has filed electronically with the SEC, including proxy statements and reports filed under the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 28; Value: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b><span style="text-decoration: underline">BASE PROSPECTUS</span></b></p> <p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; text-align: right">


<img src="nuveenlogo.jpg" alt="LOGO"/>
 </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 13pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>$100,000,000</b></p>
<p style="font: 13pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Common Shares </b></p> <p style="font: 13pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Preferred
Shares </b></p> <p style="font: 13pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Rights to Purchase Common Shares </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 17pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Nuveen Global High
Income Fund </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;&#160;</p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 3pt; margin-bottom: 3pt"/>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Offering</i></b><i>.</i>&#160;Nuveen Global High Income Fund (the &#8220;Fund&#8221;) is offering, on an immediate,
continuous or delayed basis, in one or more offerings, with a maximum aggregate dollar offering price of up to $100,000,000, common shares (&#8220;Common Shares&#8221;), preferred
shares (&#8220;Preferred Shares&#8221;), and/or subscription rights to purchase Common Shares (&#8220;Rights,&#8221; and collectively
with Common Shares and Preferred Shares, &#8220;Securities&#8221;), in any combination. The Fund may offer and sell such Securities
directly to one or more purchasers, to or through underwriters, through dealers or agents that the Fund designates from time to
time, or through a combination of these methods. The prospectus supplement relating to any offering of Securities will describe
such offering, including, as applicable, the names of any underwriters, dealers or agents and information regarding any applicable
purchase price, fee, commission or discount arrangements made with those underwriters, dealers or agents or the basis upon which
such amount may be calculated. The prospectus supplement relating to any Rights offering will set forth the number of Common Shares
issuable upon the exercise of each Right (or number of Rights) and the other terms of such Rights offering. For more information
about the manners in which the Fund may offer Securities, see &#8220;Plan of Distribution.&#8221;</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Fund</i>.</b>&#160;The Fund is a diversified, closed-end management investment company. The Fund&#8217;s investment objective is to provide a high level of current income. There can be no
assurance that the Fund will achieve its investment objective or that the Fund&#8217;s investment strategies will be successful.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>This
Prospectus, together with any related prospectus supplement, sets forth concisely information about the Fund that a prospective
investor should know before investing, and should be retained for future reference. Investing in Securities involves risks, including
the risks associated with the Fund&#8217;s use of leverage. You could lose some or all of your investment. You should consider
carefully these risks together with all of the other information in this Prospectus and any related prospectus supplement before
making a decision to purchase any of the Securities. See &#8220;<a href="#toc780884_9">Risk&#160;Factors</a>&#8221; beginning on
page 14.</b></span><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Shares are listed on the New York Stock Exchange (the &#8220;NYSE&#8221;). The trading or &#8220;ticker&#8221; symbol of the Common
Shares is &#8220;JGH.&#8221; The closing price of the Common Shares, as reported by the NYSE on August 8, 2025, was $<span>13.34 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
Common Share. The net asset value of the Common Shares at the close of business on that same date was $<span>13.90 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
Common Share. Preferred Shares and/or Rights issued by the Fund may also be listed on a securities exchange.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&#8195;*&#8195;*</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this Prospectus, together with any related prospectus supplement, which contains important information about the Fund,
before deciding whether to invest and retain it for future reference. A Statement of Additional Information, dated August 19, 2025 (the &#8220;SAI&#8221;), containing additional information about the Fund has been filed with the U.S. Securities and Exchange
Commission (the &#8220;SEC&#8221;) and is incorporated by reference in its entirety into this Prospectus. You may request a free
copy of the SAI, the table of contents of which is on the last page of this Prospectus, annual and semi-annual reports to shareholders
and other information about the Fund and make shareholder inquiries by calling (800)&#160;257-8787, by writing to the Fund at
333 West Wacker Drive, Chicago, Illinois 60606 or from the Fund&#8217;s website (http://www.nuveen.com). The information contained
in, or that can be accessed through, the Fund&#8217;s website is not part of this Prospectus, except to the extent specifically
incorporated by reference herein. You also may obtain a copy of the SAI (and other information regarding the Fund) from the SEC&#8217;s
web site (http://www.sec.gov).</span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>
<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 3pt; margin-bottom: 3pt"/>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this Prospectus is August 19, 2025.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Securities do not represent a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution,
and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other governmental agency.
</b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neither
the SEC nor any state securities commission has approved or disapproved of these securities or determined if this Prospectus is truthful
or complete. Any representation to the contrary is a criminal offense. </b></span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc"></span>TABLE OF CONTENTS </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>
<p style="margin-top: 0pt; margin-bottom: -6pt; font-size: 10pt">&#160;</p>
<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-left: auto; border-collapse: collapse; margin-right: auto">


<tr>

<td style="width: 97%"/>

<td style="vertical-align: bottom; width: 1%"/>
<td/>
<td/>
<td/></tr>


<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_1">Prospectus
                                 Summary</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">1</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_2">Summary
                                 of Fund Expenses</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">7</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_3">Financial
                                 Highlights</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">8</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_4">Trading
                                 and Net Asset Value Information</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">9</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_5">The
                                 Fund</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">9</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_6">Use
                                 of Proceeds</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">10</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_7">The
                                 Fund&#8217;s Investments</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">10</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_8">Use
                                 of Leverage</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">11</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_9">Risk
                                 Factors</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">14</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_10">Management
                                 of the Fund</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">14</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_11">Net
                                 Asset Value</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">17</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_12">Distributions</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">17</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_13">Dividend
                                 Reinvestment Plan</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">18</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_14">Plan
                                 of Distribution</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">18</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_15">Description
                                 of Shares</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">21</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_16">Rights
                                 Offerings</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">24</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_17">Certain
                                 Provisions in the Declaration of Trust and By-Laws</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">25</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_18">Repurchase
                                 of Fund Shares; Conversion to Open-End  Fund</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">27</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_19">Tax
                                 Matters</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">28</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_20">Custodian
                                 and Transfer Agent</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">29</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_21">Independent
                                 Registered Public Accounting Firm</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_22">Legal
                                 Matters</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_23">Available
                                 Information</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_24">Incorporation
                                 By Reference</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
</table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 3pt; margin-bottom: 3pt"/>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>You should rely only on the information contained or incorporated by reference into this Prospectus and any related prospectus supplement. The Fund has not
authorized anyone to provide you with different information. The Fund is not making an offer of these securities in any state where the offer is not permitted. You should not assume that the information contained in this Prospectus and any related
prospectus supplement is accurate as of any date other than the dates on their covers. The Fund will update this Prospectus to reflect any material changes to the disclosures herein. </b></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORWARD-LOOKING STATEMENTS </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Any projections, forecasts and estimates contained or incorporated by
reference herein are forward looking statements and are based upon certain assumptions. Projections, forecasts and estimates are necessarily speculative in nature, and it can be expected that some or all of the assumptions underlying any
projections, forecasts or estimates will not materialize or will vary significantly from actual results. Actual results may vary from any projections, forecasts and estimates and the variations may be material. Some important factors that could
cause actual results to differ materially from those in any forward looking statements include changes in interest rates, market, financial or legal uncertainties, including changes in tax law, and the timing and frequency of defaults on underlying
investments. Consequently, the inclusion of any projections, forecasts and estimates herein should not be regarded as a representation by the Fund or any of its affiliates or any other person or entity of the results that will actually be achieved
by the Fund. Neither the Fund nor its affiliates has any obligation to update or otherwise revise any projections, forecasts and estimates including any revisions to reflect changes in economic conditions or other circumstances arising after the
date hereof or to reflect the occurrence of unanticipated events, even if the underlying assumptions do not come to fruition. The Fund acknowledges that, notwithstanding the foregoing, the safe harbor for forward-looking statements under the Private
Securities Litigation Reform Act of 1995 does not apply to investment companies such as the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_1"></span>PROSPECTUS SUMMARY </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>This is only a summary. You should review the more detailed
information contained elsewhere in this Prospectus and any related prospectus supplement and in the Statement of Additional Information (the &#8220;SAI&#8221;). </i></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><b>The
                       Fund </b></p></td>
<td>Nuveen Global High Income Fund (the &#8220;Fund&#8221;) is a diversified, closed-end management investment
company. See &#8220;The Fund.&#8221; The Fund&#8217;s common shares, $0.01 par value per share (&#8220;Common Shares&#8221;), are traded
on the New&#160;York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;JGH.&#8221; Preferred Shares and/or Rights issued
by the Fund may also be listed on a securities exchange.</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%">&#160;</td>
<td style="text-align: left; vertical-align: top">The closing price of the Common Shares, as reported by the NYSE on August 8, 2025,
was <span>$13.34
</span> per Common Share. The net asset value (&#8220;NAV&#8221;) of the Common Shares at the close of business on that same date was
$<span>13.90</span>
per Common Share. As of August 8, 2025, the Fund had <span>23,177,393</span>
Common Shares outstanding and net assets applicable to Common Shares of $322,104,556. See &#8220;Description of Shares.&#8221;</td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><b>The
                       Offering </b></p></td>
<td>The Fund may offer, from time to time, in one or more offerings, with a maximum aggregate dollar offering price of up to $100,000,000, Common Shares, preferred shares
(&#8220;Preferred Shares&#8221;), and/or subscription rights to purchase Common Shares (&#8220;Rights,&#8221; and collectively with
Common Shares and Preferred Shares, &#8220;Securities&#8221;), in any combination, on terms to be determined at the time of the
offering. The Fund may offer and sell such Securities directly to one or more purchasers, to or through underwriters, through
dealers or agents that the Fund designates from time to time, or through a combination of these methods. The prospectus supplement
relating to any offering of Securities will describe such offering, including, as applicable, the names of any underwriters, dealers
or agents and information regarding any applicable purchase price, fee, commission or discount arrangements made with those underwriters,
dealers or agents or the basis upon which such amount may be calculated. For more information about the manners in which the Fund
may offer Securities, see &#8220;Plan of Distribution.&#8221; The prospectus supplement relating to any Rights offering will set
forth the number of Common Shares issuable upon the exercise of each Right (or number of Rights) and the other terms of such Rights
offering. The minimum price on any day at which the Common Shares may be sold will not be less than the NAV per Common Share at
the time of the offering plus the per share amount of any underwriting commission or discount; provided that Common Shares offered pursuant to Rights offerings
that meet certain conditions may be offered at a price below the then current NAV. See &#8220;Rights Offerings.&#8221;</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                               Fund may not sell any Securities through agents, underwriters or dealers without delivery, or deemed delivery,
                               of a prospectus, including the appropriate prospectus supplement, describing the method and terms of the
                               particular offering of such Securities. You should
                               read this Prospectus and the applicable prospectus supplement carefully before you invest in our Securities.</span></p>
                              <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr></table>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>



<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment&#160;Objective
                 and Policies </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please refer to the section of the Fund&#8217;s most recent
<a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment Objective, Investment Policies and Principal Risks
of the Fund&#151;Investment Objective&#8221; and &#8220;&#151;Investment Policies,&#8221; as such investment objective and investment
policies may be supplemented from time to time, which are incorporated by reference herein, for a discussion of the Fund&#8217;s investment
objective and policies.</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There can be no assurance that
such strategies will be successful. For a more complete discussion of the Fund&#8217;s portfolio composition and its corresponding risks,
see &#8220;The Fund&#8217;s Investments&#8221; and &#8220;Risk Factors.&#8221;</span></td></tr><tr>
<td>&#160;</td>
<td style="text-align: left; vertical-align: top">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment&#160;Adviser
                       </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Fund Advisors, LLC (&#8220;Nuveen Fund
Advisors&#8221;), the Fund&#8217;s investment adviser, is responsible for overseeing the Fund&#8217;s overall investment strategy and
its implementation. Nuveen Fund Advisors offers advisory and investment management services to a broad range of investment company
clients. Nuveen Fund Advisors has overall responsibility for management of the Fund, oversees the management of the Fund&#8217;s
portfolio,&#160;manages the Fund&#8217;s business affairs and provides certain clerical, bookkeeping and other administrative
services. Nuveen Fund Advisors is located at 333 West Wacker Drive, Chicago, Illinois 60606. Nuveen Fund Advisors is an indirect
subsidiary of Nuveen, LLC (&#8220;Nuveen&#8221;), the investment management arm of Teachers Insurance and Annuity Association of
America (&#8220;TIAA&#8221;). TIAA is a life insurance company founded in 1918 by the Carnegie Foundation for the Advancement of
Teaching and is the companion organization of College Retirement Equities Fund. As of June 30, 2025, Nuveen managed approximately $1.3 trillion in assets, of which approximately $151.1 billion was managed by Nuveen Fund Advisors.</span></td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sub-Adviser</b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Asset Management, LLC (&#8220;Nuveen Asset
Management&#8221;), located at 333 West Wacker Drive, Chicago, Illinois 60606, serves as the Fund&#8217;s sub-adviser. Nuveen Asset Management,
a registered investment adviser, is a wholly-owned subsidiary of Nuveen Fund Advisors. Nuveen Asset Management oversees the
day-to-day investment operations of the Fund.</span></td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
                       of Leverage</b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund uses leverage to pursue its investment
objective. The Fund may use leverage to the extent permitted by the Investment Company Act of 1940, as amended (the &#8220;1940
Act&#8221;). Accordingly, the Fund may source leverage through a number of methods including the issuance of &#8220;senior securities&#8221; as defined
under the 1940 Act. &#8220;Senior securities&#8221; include (1) certain borrowings, including certain loans from financial institutions;
(2) issuance of debt securities; and (3) issuance of preferred shares of beneficial interest (&#8220;Preferred Shares&#8221;). Additionally,
the Fund may use certain derivatives and other financing investments that have the economic effect of leverage by creating additional
investment exposures, such as investments in inverse floating rate securities and reverse repurchase agreements. The amount and sources
of leverage will vary depending on market conditions. See &#8220;Use of Leverage&#8221; for more information.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
the Fund employs leverage through borrowings and through the use of reverse repurchase agreements. The Fund has entered into a
364-day revolving line of credit. Interest is charged on these borrowings to the drawn amount at a rate per annum equal to one-month
Term SOFR (&#8220;Secured Overnight Financing Rate&#8221;) plus 0.90%. The Fund also accrued a 0.15% per annum commitment fee based
on the undrawn balance.</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reverse repurchase agreements involve the sale of securities held by
the Fund with an agreement to repurchase the securities at an agreed-upon price, date and interest payment. Selling a portfolio
security and agreeing to buy it back under a reverse repurchase agreement is economically equivalent to borrowing.</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
pursuit of its investment objective, the Fund may reduce or increase the amount and type of leverage based upon changes in
market conditions and  composition of the Fund&#8217;s holdings.
The Fund&#8217;s leverage ratio varies from time to time based upon such changes in the amount of leverage used and
variations in the value of the Fund&#8217;s holdings. So long as the net income received on the Fund&#8217;s investments
purchased with leverage proceeds exceeds the then current expense on any leverage, the investment of leverage proceeds will
generate more net income than if the Fund had not used leverage. Under these circumstances, the excess net income will be
available to pay higher distributions to Common Shareholders. However, if the net income received from the Fund&#8217;s
portfolio investments purchased with leverage is less than the then current expense on outstanding leverage, the Fund may be
required to utilize other Fund assets to make expense payments on outstanding leverage, which may result in a decline in
Common Share NAV and reduced net investment income available for distribution to Common Shareholders.</span></td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Fund may borrow for temporary or emergency purposes as permitted by the 1940 Act. There is no assurance that the Fund will continue to use leverage.
                                            The Fund&#8217;s use of leverage may not work as planned or achieve its goals.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund pays a management fee to Nuveen Fund Advisors (which in turn pays a portion of such fee to Nuveen Asset Management) based on a percentage
of Managed Assets. Managed Assets include the proceeds realized and managed from the Fund&#8217;s use of most types of leverage (excluding
the leverage exposure attributable to the use of futures, swaps and similar derivatives). Because Managed Assets include the Fund&#8217;s
net assets as well as assets that are attributable to the Fund&#8217;s investment of the proceeds of its leverage, the Fund&#8217;s Managed
Assets are greater than its net assets. Nuveen Fund Advisors and Nuveen Asset Management are responsible for using leverage to pursue
the Fund&#8217;s investment objective. Nuveen Fund Advisors and Nuveen Asset Management base their decision regarding whether and how
much leverage to use for the Fund, and the terms of that leverage, on their assessment of whether such use of leverage is in the best
interests of the Fund. However, a decision to employ or increase leverage has the effect, all other
things being equal, of increasing Managed Assets, and in turn Nuveen Fund Advisors&#8217; and Nuveen Asset Management&#8217;s management
fees. Thus, Nuveen Fund Advisors and Nuveen Asset Management have a conflict of interest in determining whether to use or increase leverage. Nuveen Fund Advisors and Nuveen Asset Management seek to manage that conflict by recommending to the
Board of Trustees to leverage the Fund (or increase such leverage) only when they determine that such action would be in the best interests
of the Fund and its Common Shareholders, and by periodically reviewing with the Board of Trustees the Fund&#8217;s performance and the
impact of the use of leverage on that performance.</span></p>
                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr></table>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


 <p style="margin-top: 0pt; margin-bottom: -6pt; font-size: 6pt">&#160;</p>
 <p style="margin-top: 0pt; margin-bottom: -6pt; font-size: 6pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Distributions
                       </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund pays regular monthly cash distributions
to Common Shareholders (stated in terms of a fixed cents per Common Share dividend distribution rate which may be set from time
to time). The Fund intends to distribute all or substantially all of its net investment income each year through its regular monthly
distributions and to distribute realized capital gains at least annually. In addition, in any monthly period, to maintain its
declared per common share distribution amount, the Fund may distribute more or less than its net investment income during the
period. In the event the Fund distributes more than its net investment income during any yearly period, such distributions may
also include realized gains and/or a return of capital. To the extent that a distribution includes a return of capital the NAV
per share may erode. If a distribution includes anything other than net investment income, the Fund provides a notice of the best
estimate of its distribution sources at the time. See &#8220;Distributions.&#8221;</span></td></tr>                                                                                                                                                                                                                                                                                                   <tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
<td><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Fund reserves the right to change its distribution policy and the basis for establishing the rate of its monthly distributions
    at any time and may do so without prior notice to Common Shareholders.</span></p> </td></tr>
</table>
<p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Custodian
                 and Transfer Agent </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State Street Bank and Trust Company serves as the Fund&#8217;s
custodian, and Computershare Inc. and Computershare Trust Company, N.A. serves as the Fund&#8217;s transfer agent for the Common Shares.
The corresponding agent for any Preferred Shares to be offered pursuant to this Prospectus  will be identified in the related prospectus supplement. See &#8220;Custodian and Transfer
Agent.&#8221;</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
                 Factors </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in the Fund involves risk. The Fund is designed
as a long-term investment and not as a trading vehicle. The Fund is not intended to be a complete investment program. Please refer to
the section of the Fund&#8217;s most recent <a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment Objective,
Investment Policies and Principal Risks of the Fund&#151;Principal Risks of the Funds,&#8221; as such principal risks may be supplemented
from time to time, which is incorporated by reference herein, for a discussion of the principal risks you should consider before making
an investment in the Fund. Any additional risks applicable to a particular offering of Securities will be set forth in the related prospectus
supplement.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
                 of Proceeds </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise specified in a prospectus supplement,
the Fund will use the net proceeds from any offering of Securities, pursuant to this Prospectus, to make investments in accordance with
the Fund&#8217;s investment objective. See &#8220;Use of Proceeds.&#8221;</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Federal
                       Income Tax </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund has elected to be treated, and intends to qualify each year,
as a regulated investment company (&#8220;RIC&#8221;) under Subchapter M of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;).
To qualify for the favorable U.S. federal income tax treatment generally accorded to a RIC under Subchapter M of the Code the Fund must,
among other requirements, derive in each taxable year at least 90% of its gross income from certain prescribed sources and satisfy a diversification
test on a quarterly basis. If the Fund fails to satisfy the qualifying income or diversification requirements in any taxable year, the
Fund may be eligible for relief provisions if the failures are due to reasonable cause and not willful neglect and if a penalty tax is
paid with respect to each failure to satisfy the applicable requirements. Additionally, relief is provided for certain&#160;<i>de minimis</i>&#160;failures
of the diversification requirements where the Fund corrects the failure within a specified period. In order to be eligible for the relief
provisions with respect to a failure to meet the diversification requirements, the Fund may be required to dispose of certain assets.
If these relief provisions were not available to the Fund and it were to fail to qualify for treatment as a RIC for a taxable year, all
of its taxable income (including its net capital gain) would be subject to tax at the 21% regular corporate rate without any deduction
for distributions to shareholders, and such distributions would be taxable as ordinary dividends to the extent of the Fund&#8217;s current
and accumulated earnings and profits. To qualify to pay exempt-interest dividends, which are treated as items of interest excludable from
gross income for federal income tax purposes, at least 50% of the value of the total assets of the Fund must consist of obligations exempt
from regular income tax as of the close of each quarter of the Fund&#8217;s taxable year. If the proportion of taxable investments held
by the Fund exceeds 50% of the Fund&#8217;s total assets as of the close of any quarter of any Fund taxable year, the Fund will not for
that taxable year satisfy the general eligibility test that otherwise permits it to pay exempt-interest dividends.</span></td></tr>                                                                                                                                                                                                                                                                                                                                                                                                                                                <tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
<td><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
                                         &#8220;Fund Tax Risk&#8221; as contained in the section of the Fund&#8217;s most recent
                                         <a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment Objective,
                                         Investment Policies and Principal Risks of the Fund&#151;Principal Risks of the Funds&#151;Fund
                                         Level and Other Risks.&#8221;</span></p></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td></tr>
</table>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governing
                       Law </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s Declaration of Trust (the &#8220;Declaration
of Trust&#8221;) is, and each Statement and Statement Supplement for Preferred Shares will be, governed by the laws of the Commonwealth
of Massachusetts.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_2"></span>SUMMARY
OF FUND EXPENSES</b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the table below and the Examples below are to help you understand all fees and expenses that you, as a Common Shareholder,
would bear directly or indirectly. The table shows the expenses of the Fund as a percentage of the average net assets applicable
to Common Shares, and not as a percentage of total assets or Managed Assets.</span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr>
    <td style="vertical-align: top; font-size: 8pt; width: 75%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder
    Transaction Expenses</b></span></td>
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 8pt">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maximum
    Sales Charge (<span>as a percentage of offering price</span>)</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%<sup>*</sup></span></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: top; font-size: 8pt">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; font-size: 8pt">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
    Reinvestment Plan Fees <sup>(1)</sup></span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; font-size: 8pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maximum sales
    charge for offerings made at-the-market is 1.00%. If the Common Shares are sold to or through underwriters
    in an offering that is not made at-the-market, the applicable Prospectus Supplement will set forth any other applicable sales
    load and the estimated offering expenses. Fund shareholders will pay all offering expenses involved with an offering.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>
<div></div>
<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="font-size: 8pt; font-weight: bold; text-align: right; padding-bottom: 1pt; padding-left: 10pt"><p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    a Percentage of Net Assets</b></span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Attributable
    to</b></span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common Shares<sup>(2)</sup></b></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Annual Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 75%; text-align: left">Management Fees</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18%</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest and Other Related Expenses <sup>(3)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.41%</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other Expenses <sup>(4)</sup></td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.14%</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Annual Expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.73%</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>
<div></div>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<div><div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be charged a $2.50 service charge and pay brokerage charges if you direct Computershare
                                         Inc. and Computershare Trust Company, N.A., as agent for the Common Shareholders (the
                                         &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment
                                         account.</span></td>
</tr></table></div></div>
<div><div><p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stated
                                         as annualized percentages of average net assets attributable to Common Shares for the
                                         fiscal year ended December 31, 2024.</span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
                                            and Other Related Expenses reflect actual expenses and fees for leverage incurred by the
                                            Fund for the fiscal year ended December 31, 2024. The types of leverage used by the Fund during
                                            the fiscal year ended December 31, 2024 are described in the Fund Leverage and the Notes to Financial
                                            Statements sections of the Fund&#8217;s annual report. Actual Interest and Other Related
                                            Expenses incurred in the future maybe higher or lower. If short-term market interest rates
                                            rise in the future, and if the Fund continues to maintain leverage, the cost of which is
                                            tied to short-term interest rates, the Fund&#8217;s Interest and Other Related Expenses on its short-term borrowings
                                            can be expected to rise in tandem. The Fund&#8217;s use of leverage will increase the amount
                                            of management fees paid to the Fund&#8217;s adviser and sub-advisor(s).</span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>Other
                                         Expenses is based on estimated amounts for the current fiscal year. Expenses attributable
                                         to the Fund&#8217;s investments, if any, in other investment companies are currently
                                         estimated not to exceed 0.01%. See &#8220;Investment Objective and Policies&#8212;Other
                                         Investment Companies&#8221; in the SAI.</span></span></td>
</tr></table></div></div>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Example
</b></span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following example illustrates the expenses, including the transaction fee (referred to as the &#8220;Maximum Sales Charge&#8221; in
the Shareholder Transaction Expenses table above), if any, that a common shareholder would pay on a $1,000 investment that is held
for the time periods provided in the table. The example assumes that all dividends and other distributions are reinvested in the
Fund and that the Fund&#8217;s Annual Expenses, as provided above, remain the same. The example also assumes a 5% annual return.
Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less
than the hypothetical 5% return shown in the example.</span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1
    Year</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3
    Years</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5
    Years</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10
    Years</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123</span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">201</span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">404</span></td><td style="text-align: left; width: 1%">&#160;</td></tr>
</table>



<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The example should not
be considered a representation of future expenses. Actual expenses may be greater or less than those shown above.</b></span></p>

<p style="margin: 0pt 0"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<p style="margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_3"></span>FINANCIAL HIGHLIGHTS </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial highlights table is intended to help you understand the Fund&#8217;s financial performance for the periods presented.
Certain information reflects financial results for a single Common Share of the Fund. The information for the fiscal years or
periods, as applicable, ended December 31, 2024, December 31, 2023, December 31, 2022, December 31, 2021 and December 31, 2020 has
been audited by PricewaterhouseCoopers LLP (&#8220;PwC&#8221;), an independent registered public accounting firm. The report of PwC,
is included in the Fund&#8217;s December 31, 2024 <a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">Annual
Report</a>, which is incorporated by reference herein. The information in the table below for the fiscal years ended December 31,
2019 December 31, 2018, December 31, 2017, December 31, 2016 and December 31, 2015 is derived from the Fund's financial statements
for the fiscal year ended December 31, 2019. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="display: none; vertical-align: top">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: middle; white-space: nowrap; text-align: left">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td colspan="29" style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Ended December 31</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: Black 1pt solid; vertical-align: middle; white-space: nowrap; width: 37%; text-align: left">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 6%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2024</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2020</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2019</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2018</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2017</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2016</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2015</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Beginning Common Share Net Asset Value (&#8220;NAV&#8221;)</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">13.37</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12.79</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.63</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.97</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">18.14</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.01 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$ </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">18.51 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17.82 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.05 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19.46 </span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investment Operations: </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Net Investment Income (Loss)(a)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.99</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.82</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.95</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.04</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.10</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.19 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.26 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.42 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.47 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.58 </span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Net Realized/Unrealized Gain (Loss) </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.72</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.00</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3.43</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.08</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.16</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.17 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2.42</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.71 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.83 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3.64</span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Total </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.71</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.82</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2.48</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.96</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.06</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.36 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$ </span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.16</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.13 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.30 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2.06</span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Less Distributions to Common Shareholders: </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">From Net Investment Income </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.13</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.95</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.99</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.98</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.07</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.20</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.27</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.34</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.51</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.23</span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">From Accumulated Net Realized Gains</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Return of Capital</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.11</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.29</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.37</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.32</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.04</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.03</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.08</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.10</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.03</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.34</span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Total </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.24</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.24</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.36</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.30</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.11</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.23</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.35</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.44</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.54</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.57</span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Common Share:</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
    <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Discount Per Share Repurchased and Retired</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.01</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.01</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.09</span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Discount Per Share Repurchased and Retired through Tender Offer</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#8211;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.13</span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Ending NAV</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">13.84</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">13.37</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12.79</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.63</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.97</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">18.14</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.01</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">18.51</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17.82</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="border-bottom: Black 2.25pt double; font: 12pt Arial, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.05</span></td>
    <td style="border-right: Black 1.5pt solid; white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Ending Share Price</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12.84</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12.20</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">11.25</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15.88</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15.55</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;$ </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.38</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">13.65</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.91</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15.99</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">13.74</span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Common Share Total Returns: </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Based on NAV(b)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">13.39</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15.15</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(15.10</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5.82</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">0.39</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">21.54</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6.67</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12.25</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">21.85</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(10.36</span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)%</span></td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Based on Share Price(b)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15.87</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">20.80</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(21.07</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.84</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.88</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">29.93</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(11.97</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15.14</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">29.26</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(12.07</span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)%</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Common Share Supplemental Data/Ratios Applicable to Common Shares</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Ending Net Assets (000) </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">320,863</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">309,940</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">296,494</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">385,474</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">393,299</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">420,480 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">371,082 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">430,058 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">414,084 </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">374,403 </span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Ratios to Average Net Assets(c)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Expenses</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.73</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.82</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.43</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.68</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.87</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.64 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.51 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.08 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.97 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.86 </span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Net Investment Income (Loss) </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7.29</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6.43</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6.82</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6.16</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6.94</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6.84 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7.10 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7.70 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">8.91 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">8.36 </span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Portfolio Turnover Rate</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">93</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">35</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">26</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">87</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">35</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">43 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">61 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">77 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">49 </span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; padding-right: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">61 </span></td>
    <td style="border-right: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">%</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Borrowings at the End of Period:</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Aggregate Amount Outstanding (000)<sup>(d)</sup></span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">104,000</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">119,000</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">127,000</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">159,000</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">149,200</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">175,200</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">175,200</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">175,200</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">164,800</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">170,500</span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: left; vertical-align: middle; padding-left: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Asset Coverage Per $1,000 Share<sup>(e)</sup></span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,085</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,605</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,335</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,424</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,636</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,400</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,118</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,455</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,513</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="border-left: Black 1.5pt solid; font: 12pt Arial, Helvetica, Sans-Serif; padding-left: 3pt; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td>
    <td style="font: 12pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,196</span></td>
    <td style="border-right: Black 1.5pt solid; vertical-align: bottom">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="width: 97%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on average shares outstanding.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Return Based on Common Share NAV is the combination of changes in common share NAV, reinvested dividend income at NAV and reinvested capital gains distributions at NAV, if any. The last dividend declared in the period, which is typically paid on the first business day of the following month, is assumed to be reinvested at the ending NAV. The actual reinvest price for the last dividend declared in the period may often be based on the Fund&#8217;s market price (and not its NAV), and therefore may be different from the price used in the calculation. Total returns are not annualized. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Return Based on Common Share Price is the combination of changes in the market price per share and the effect of reinvested dividend income and reinvested capital gains distributions, if any, at the average price paid per share at the time of reinvestment. The last dividend declared in the period, which is typically paid on the first business day of the following month, is assumed to be reinvested at the ending market price. The actual reinvestment for the last dividend declared in the period may take place over several days, and in some instances may not be based on the market price, so the actual reinvestment price may be different from the price used in the calculation. Total returns are not annualized. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="text-align: left; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; Net Investment Income (Loss) ratios reflect income earned and expenses incurred on assets attributable to preferred shares and/or borrowings and/or reverse repurchase agreements, where applicable.<br/>
&#9679; Each ratio includes the effect of all interest expenses paid and other costs related to preferred shares and/or borrowings and/or reverse repurchase agreements, where applicable, as follows:</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 3%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold">Ratios of Interest<br/> Expense to Average<br/> Net Assets<br/> Applicable to<br/> Common Shares</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration: underline">Year Ended 12/31:</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%; text-align: left">2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">2.41</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.46</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.04</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.35</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.59</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.33</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.19</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2017</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.78</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2016</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.66</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2015</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.49</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top; width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="vertical-align: top; width: 97%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate Amount Outstanding: Aggregate amount outstanding represents the principal amount outstanding or liquidation preference as of the end of the relevant fiscal year.</span></td>
    </tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset Coverage Per $1,000: Asset coverage per $1,000 is calculated by subtracting the Fund&#8217;s liabilities and indebtedness not represented by senior securities from the Fund&#8217;s total assets, dividing the result by the aggregate amount of the Fund&#8217;s senior securities representing indebtedness then outstanding (if applicable), plus the aggregate of the involuntary liquidation preference of the outstanding preferred shares, if applicable, and multiplying the result by 1,000.</span></td>
    </tr>
  </table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_4"></span>TRADING AND NET ASSET VALUE INFORMATION </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 9pt; text-indent: 0.5in"><span style="font-size: 10pt">The
following table shows for the periods indicated: (i) the high and low sales prices for Common Shares reported as of the end of
the day on the NYSE, (ii) the corresponding NAV per share, and (iii) the premium/(discount) to NAV per share at which the Common
Shares were trading as of such date. The Fund&#8217;s Common Shares have historically traded both at premiums and discounts in
relation to the Fund&#8217;s NAV per share. The Fund cannot predict whether its Common Shares will trade at a premium or discount
to NAV in the future. The Board of Trustees has currently determined that, at least annually, it will consider action that might
be taken to reduce or eliminate any material discount from NAV in respect of Common Shares, which may include the repurchase of
such shares in the open market or in private transactions, the making of a tender offer for such shares at NAV, or the conversion
of the Fund to an open-end investment company. The Fund cannot assure you that its Board of Trustees will decide to take any of
these actions, or that share repurchases or tender offers will actually reduce market discount.</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">Closing Market Price per</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">NAV per Common Share on</td><td style="font-weight: bold">&#160;</td>
    <td colspan="7" style="font-weight: bold; text-align: center">Premium/(Discount) on</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Share</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Date of Market Price</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Date of Market Price</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left">Fiscal Quarter Ended</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 27%; text-align: left">June 2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">13.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">11.48</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">13.53</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">12.89</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">(3.92</td><td style="width: 1%; text-align: left">)%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">(10.94</td><td style="width: 1%; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">March 2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.42</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.80</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.97</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.57</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3.94</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.67</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">December 2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.94</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.82</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.02</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7.96</td><td style="text-align: left">)%</td></tr>
    <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">September 2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.42</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.95</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.33</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.09</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6.83</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">June 2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.05</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.18</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.51</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3.40</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7.16</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">March 2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.92</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.96</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.51</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.17</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.37</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9.19</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">December 2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.24</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.09</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8.52</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13.98</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">September 2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.99</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.17</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7.13</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12.19</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">June 2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.65</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.42</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10.53</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14.25</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">March 2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.62</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.67</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.55</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6.86</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14.23</td><td style="text-align: left">)%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"></span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-size: 10pt">The
net asset value per Common Share, the market price, and percentage of premium/(discount) to net asset value per Common Share on
August 8, 2025, $<span>13.90</span>,
$<span>13.34</span>
and <span>(4.03)</span>%,
respectively. As of August 8, 2025, the Fund had <span>23,177,393</span>
Common Shares outstanding and net assets applicable to Common Shares of $322,104,556.</span></p>

<p style="margin: 0pt 0"><span style="font-size: 10pt">&#160;</span>&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_5"></span>THE FUND </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                         Fund is a diversified, closed-end management investment company registered under the
                                         1940 Act. The Fund was organized as a Massachusetts business trust on August 5, 2014
                                         and commenced investment operations on November 24, 2014. The Fund&#8217;s Common Shares
                                         are listed on the NYSE under the symbol &#8220;JGH.&#8221; Preferred Shares and/or Rights
                                         issued by the Fund may also be listed on a securities exchange.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The following
provides information about the Fund&#8217;s outstanding Common Shares and Preferred Shares as of August 8, 2025:</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Title of Class</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount<br/>Authorized</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount&#160;Held<br/>by&#160;the&#160;Fund&#160;or<br/>for
    its Account</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount<br/>Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%"><span>Common Shares</span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlimited</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span>0</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>23,177,393</span></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span>Preferred Shares</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlimited</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span>0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span>0</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">&#160;&#160;</p></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="toc780884_6"></span>USE
 OF PROCEEDS </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise specified in a prospectus supplement, the net proceeds from any offering will be invested in accordance with the Fund&#8217;s
investment objective and policies as stated below. The Fund currently anticipates that it will be able to invest substantially
all of the net proceeds in investments that meet the Fund&#8217;s investment objective and policies within approximately three
months of the receipt of such proceeds. Pending investment, it is anticipated that the proceeds will be invested in short-term
or long-term securities issued by the U.S. Government and its agencies or instrumentalities or in high-quality, short-term money
market instruments.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="toc780884_7"></span>THE
FUND&#8217;S INVESTMENTS </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
Objective and Policies </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to the section of the Fund&#8217;s most recent <a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment
Objective, Investment Policies and Principal Risks of the Fund&#151;Investment Objective&#8221; and &#8220;&#151;Investment Policies,&#8221;
as such investment objective and investment policies may be supplemented from time to time, which is incorporated by reference herein,
for a discussion of the Fund&#8217;s investment objective and policies.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Portfolio
Composition and Other Information </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to the section of the Fund&#8217;s most recent <a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment
Objective, Investment Policies and Principal Risks of the Fund&#151;Investment Policies&#151;Portfolio Contents,&#8221; as such portfolio
contents may be supplemented from time to time, which is incorporated by reference herein, for a discussion of the investments principally
included in the Fund&#8217;s portfolio. More detailed information about the Fund&#8217;s portfolio investments are contained in the SAI
under &#8220;The Fund&#8217;s Investments.&#8221;</span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Portfolio
                                            Turnover </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Fund may engage in portfolio trading when considered appropriate, but short-term trading
                                         will not be used as the primary means of achieving the Fund&#8217;s investment objective.
                                         For the fiscal year ended December 31, 2024, the Fund&#8217;s portfolio turnover rate was
                                         93%. However, there are no limits on the Fund&#8217;s
                                         rate of portfolio turnover, and investments may be sold without regard to length of time
                                         held when, in Nuveen Asset Management&#8217;s opinion, investment considerations warrant
                                         such action. A higher portfolio turnover rate would result in correspondingly greater
                                         brokerage commissions and other transactional expenses that are borne by the Fund. Although
                                         these commissions and expenses are not reflected in the Fund&#8217;s &#8220;Annual Expenses,&#8221;
                                         they will be reflected in the Fund&#8217;s total return. In addition, high portfolio turnover
                                         may result in the realization of net short-term capital gains by the Fund which, when
                                         distributed to shareholders, will be taxable as ordinary income. See &#8220;Tax Matters.&#8221;</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
                                            Policies </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
                                            investment policies specifically identified in the SAI as such are considered fundamental
                                            and may not be changed without shareholder approval. See &#8220;Investment Restrictions&#8221;
                                            in the SAI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="toc780884_8"></span><b>USE
OF LEVERAGE</b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                                                           Fund uses leverage to pursue its investment objective. The Fund may use leverage to the extent permitted by the 1940 Act. Accordingly, the Fund
                                                                           may source leverage through a number of methods including the issuance of &#8220;senior securities&#8221; as defined under the 1940 Act. Additionally, the Fund may use certain derivatives and other financing investments that have the economic effect of leverage by creating additional investment exposures, such as investments in inverse floating rate securities and reverse repurchase agreements. See &#8220;Investment Restrictions&#8221; in the SAI. For a discussion of risks, see &#8220;Fund Level and Other Risks&#151;Reverse Repurchase Agreement Risk,&#8221; as such risk
                                                                           is contained in the section of the Fund&#8217;s most recent <a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment Objective, Investment Policies and Principal
                                                                           Risks of the Fund&#151;Principal Risks of the Funds.&#8221;</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
the Fund employs leverage through borrowings and through the use of reverse repurchase agreements. The Fund has entered into a
364-day revolving line of credit. Interest is charged on these borrowings to the drawn amount at a rate per annum equal to one-month
Term SOFR (&#8220;Secured Overnight Financing Rate&#8221;) plus 0.90%. The Fund also accrued a 0.15% per annum commitment fee based
on the undrawn balance.</span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reverse repurchase agreements involve the sale of securities held by
the Fund with an agreement to repurchase the securities at an agreed-upon price, date and interest payment. Selling a portfolio
security and agreeing to buy it back under a reverse repurchase agreement is economically equivalent to borrowing.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may use derivatives, such as interest rate swaps with varying terms, in order to hedge duration risk or manage the interest rate
expense associated with all or a portion of its leverage. Interest rate swaps are bi-lateral agreements whereby parties agree to exchange
future payments, typically based upon the differential of a fixed rate and a variable rate, on a specified notional amount. Interest
rate swaps can enable the Fund to effectively convert its variable leverage expense to fixed, or vice-versa. For example, if the Fund
issues leverage having a short-term floating rate of interest, the Fund could use interest rate swaps to hedge against a rise in the
short-term benchmark interest rates associated with its outstanding leverage. In doing so, the Fund would seek to achieve lower leverage
costs, and thereby enhance Common Share distributions, over an extended period, which would be the result if short-term market interest
rates on average exceed the fixed interest rate over the term of the swap. To the extent the fixed swap rate is greater than short-term
market interest rates on average over the period, overall costs associated with leverage will be greater (and thereby reduce distributions
to Common Shareholders) than if the Fund had not entered into the interest rate swap(s).</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund also may borrow for temporary or emergency purposes as permitted by the 1940 Act. There is not assurance
that the Fund will use leverage. The Fund&#8217;s use of leverage may not work as planned or achieve its goals.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
pursuit of its investment objective, the Fund may reduce or increase the amount and type of leverage based upon changes in
market conditions and composition of the Fund&#8217;s holdings. The Fund&#8217;s leverage ratio will vary from time to time
based upon such changes in the amount of leverage used and variations in the value of the Fund&#8217;s holdings. So long as
the net income received from the Fund&#8217;s investments purchased with leverage proceeds exceeds the then current expense
of any leverage, the investment of the proceeds of leverage will generate more net income than if the Fund had not leveraged
itself. Under these circumstances, the excess net income will be available to pay higher distributions to Common
Shareholders. However, if the net income received from the Fund&#8217;s portfolio investments purchased with the proceeds
of leverage is less than the current expense of any leverage, the Fund may be required to utilize other Fund assets to make
interest or dividend payments on its leveraging instruments which may result in a decline in Common Share NAV and reduced net
investment income available for distribution to Common Shareholders.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund pays a management fee to Nuveen Fund Advisors (which in turn pays a portion of such fee to Nuveen Asset Management) based on a percentage
of Managed Assets. Managed Assets include the proceeds realized and managed from the Fund&#8217;s use of most types of leverage (excluding
the leverage exposure attributable to the use of futures, swaps and similar derivatives). Because Managed Assets include the Fund&#8217;s
net assets as well as assets that are attributable to the Fund&#8217;s investment of the proceeds of its leverage, it is anticipated
that the Fund&#8217;s Managed Assets will be greater than its net assets. Nuveen Fund Advisors and Nuveen Asset Management are responsible
for using leverage to pursue the Fund&#8217;s investment objective. Nuveen Fund Advisors and Nuveen Asset Management will base their
decision regarding whether and how much leverage to use for the Fund, and the terms of that leverage, on their assessment of whether
such use of leverage is in the best interests of the Fund. However, a decision to employ or increase leverage will have the effect, all other things being equal, of increasing Managed Assets and in turn Nuveen Fund Advisors&#8217; and
Nuveen Asset Management&#8217;s management fees. Thus, Nuveen Fund Advisors and Nuveen Asset Management have a conflict of interest
in determining whether to use or increase leverage, including the use of the Facility. Nuveen Fund Advisors and Nuveen Asset Management
will seek to manage that conflict by using leverage only when they determine that it would be in the best interests of the
Fund and its Common Shareholders, and by periodically reviewing with the Board of Trustees the Fund&#8217;s performance and the Fund&#8217;s
degree of overall use of leverage and the impact of the use of leverage on that performance.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
 1940 Act generally defines a &#8220;senior security&#8221; as any bond, debenture, note, or similar obligation or instrument constituting
 a security and evidencing indebtedness, and any stock of a class having priority over any other class as to distribution of assets or
 payment of dividends; however, the term does not include any promissory note or other evidence of indebtedness issued in consideration
 of any loan, extension, or renewal thereof, made for temporary purposes and in an amount not exceeding five percent of the value of
 the Fund&#8217;s total assets. A loan shall be presumed to be for temporary purposes if it is repaid within 60 days and is not extended
 or renewed. Accordingly, &#8220;senior securities&#8221; include (i) the issuance of Preferred Shares; (ii) certain borrowings (including certain loans from financial
institutions); and (iii) the issuance of debt securities.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 1940 Act, the Fund is not permitted to issue &#8220;senior securities&#8221; that are Preferred Shares if, immediately after the
issuance of Preferred Shares, the asset coverage ratio with respect to such Preferred Shares would be less than 200%. With respect to
any such Preferred Shares, asset coverage means the ratio which the value of the total assets of the Fund, less all liabilities and indebtedness
not represented by senior securities, bears to the aggregate amount of senior securities representing indebtedness of the Fund plus the
aggregate liquidation preference of such Preferred Shares.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 1940 Act, the Fund is not permitted to issue &#8220;senior securities representing indebtedness&#8221; if, immediately after the
issuance of such senior securities representing indebtedness, the asset coverage ratio with respect to such senior securities would
be less than 300%. &#8220;Senior securities representing indebtedness&#8221; include certain borrowings (including certain loans
from financial institutions) and debt securities. &#8220;Senior securities representing indebtedness&#8221; may also include other
investments or transactions in accordance with the 1940 Act, such as reverse repurchase agreements or similar financing transactions depending upon their treatment under Rule 18f-4 of the 1940
Act. In accordance with Rule 18f-4 under the 1940 Act, when the Fund engages in reverse repurchase agreements or similar financing transactions,
such as transactions in inverse floating rate securities, the Fund may either (i) maintain asset coverage in accordance with Section 18
of the 1940 Act with respect to such transactions and any other senior securities, including Preferred Shares and borrowings, or (ii)
treat such transactions as &#8220;derivatives transactions&#8221; and comply with Rule 18f-4 with respect to such transactions. With respect to any such senior securities representing debt, asset
coverage means the ratio which the value of the total assets of the Fund, less all liabilities and indebtedness not represented by
senior securities (as defined in the 1940 Act), bears to the aggregate amount of such borrowing represented by senior securities
issued by the Fund.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Fund issues senior securities and the asset coverage with respect to such senior securities declines below the required ratios discussed
above (as a result of market fluctuations or otherwise), the Fund may sell portfolio securities when it may be disadvantageous to do
so.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
types of leverage used by the Fund may result in the Fund being subject to certain covenants, asset coverage or other portfolio composition
limits by its lenders, debt or preferred securities purchasers, rating agencies that may rate the debt or preferred securities, or reverse
repurchase counterparties. Such limitations may be more stringent than those imposed by the 1940 Act and may impact whether the Fund
is able to maintain its desired amount of leverage. At this time Nuveen Fund Advisors does not believe that any such potential investment
limitations will impede it from managing the Fund&#8217;s portfolio in accordance with its investment objective and policies.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utilization
of leverage is a speculative investment technique and involves certain risks to the Common Shareholders, including increased variability
of the Fund&#8217;s net income, distributions and NAV in relation to market changes. See &#8220;Leverage Risk,&#8221; as such risk is
contained in the section of the Fund&#8217;s most recent <a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#8212;Current
Investment Objective, Investment Policies and Principal Risks of the Fund&#8212;Principal Risks of the Funds&#8212;Fund Level and Other
Risks.&#8221; There is no assurance that the Fund will use leverage or that the Fund&#8217;s use of leverage will work as planned or
achieve its goals.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Effects of Leverage </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Please refer to the section of the Fund&#8217;s most recent <a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a>
on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment Objective, Investment Policies and Principal Risks of the Fund&#151;Effects of Leverage,&#8221; as such may be supplemented from time to time, which is incorporated by
reference herein, for a discussion of the effects of leverage.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="toc780884_9"></span>RISK
 FACTORS </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
                                            is inherent in all investing. Investing in any investment company security involves risk,
                                            including the risk that you may receive little or no return on your investment or even that
                                            you may lose part or all of your investment. Please refer to the section of the Fund&#8217;s
                                            most recent <a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Current Investment
                                            Objective, Investment Policies and Principal Risks of the Fund&#151;Principal Risks of
                                            the Funds,&#8221; as such principal risks may be supplemented from time to time, which is
                                            incorporated by reference herein, for a discussion of the principal risks you should consider
                                            before making an investment in the Fund. Any additional risks applicable to a particular offering
                                            of Securities will be set forth in the related prospectus supplement.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="toc780884_10"></span>MANAGEMENT
                                            OF THE FUND </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trustees
                                            and Officers </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board of Trustees is responsible for the management of the Fund, including supervision of
                                            the duties performed by Nuveen Fund Advisors and Nuveen Asset Management. The names and business
                                            addresses of the trustees and officers of the Fund and their principal occupations and other
                                            affiliations during the past five years are set forth under &#8220;Management of the Fund&#8221;
                                            in the SAI.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
                                            Adviser, Sub-Adviser and Portfolio Managers </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investment
Adviser.</i>&#160;Nuveen Fund Advisors, LLC, the Fund&#8217;s investment adviser, is responsible for overseeing the Fund&#8217;s
overall investment strategy and implementation. Nuveen Fund Advisors offers advisory and investment management services to a broad
range of investment company clients. Nuveen Fund Advisors has overall responsibility for management of the Fund, oversees the
management of the Fund&#8217;s portfolio, manages the Fund&#8217;s business affairs and provides certain clerical, bookkeeping and
other administrative services. Nuveen Fund Advisors is located at 333 West Wacker Drive, Chicago, Illinois 60606. Nuveen Fund
Advisors is an indirect subsidiary of Nuveen, the investment management arm of TIAA. TIAA is a life insurance company founded
in 1918 by the Carnegie Foundation for the Advancement of Teaching and is the companion organization of College Retirement Equities
Fund. As of June 30, 2025, Nuveen managed approximately $1.3 trillion in assets, of which approximately
$151.1 billion was managed by Nuveen Fund Advisors.</span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sub-Adviser.</i>&#160;Nuveen
Asset Management, LLC, located at 333 West Wacker Drive, Chicago, Illinois 60606, serves as the Fund&#8217;s sub-adviser pursuant to a
sub-advisory agreement between Nuveen Fund Advisors and Nuveen Asset Management (the &#8220;Sub-Advisory Agreement&#8221;). Nuveen Asset
Management, a registered investment adviser, is a wholly owned subsidiary of Nuveen Fund Advisors. Nuveen Asset Management oversees day-to-day
investment operations of the Fund. Pursuant to the Sub-Advisory Agreement, Nuveen Asset Management is compensated for the services it
provides to the Fund with a portion of the management fee Nuveen Fund Advisors receives from the Fund. Nuveen Fund Advisors and Nuveen
Asset Management retain the right to reallocate investment advisory responsibilities and fees between themselves in the future.</span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Portfolio
                                         Managers.</i> Nuveen Asset Management is responsible for the execution of specific investment
                                         strategies and day-to-day investment operations of the Fund. Nuveen Asset Management
                                         manages the Nuveen funds using a team of analysts and portfolio managers that focuses
                                         on a specific group of funds. The day-to-day operation of the Fund and the execution
                                         of its specific investment strategies is the primary responsibility of Katherine Renfrew, John Espinosa, Brenda A. Langenfeld, CFA, James Kim, and Mark Zheng, CFA, the designated portfolio managers of the Fund. Mses. Langenfeld and Renfrew and Mr. Espinosa have served as
portfolio managers of the Fund since March 2023, and Messrs. Kim and Zheng have served as portfolio managers of the Fund since February
2025.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Katherine Renfrew&#160;is a portfolio manager for Nuveen&#8217;s
global fixed income team and the sector lead for emerging markets corporates and quasi-sovereigns and all developed market quasi-sovereigns.
She is a member of Nuveen&#8217;s emerging and&#160;non-U.S.&#160;developed markets fixed income team and serves as a lead and&#160;co-portfolio&#160;manager
across Nuveen&#8217;s suite of emerging markets debt strategies. Katherine joined the firm in 1997 and has held several roles relating
to emerging markets debt including South American regional analyst, trader, manager for the firm&#8217;s investments in Eastern Europe,
Middle East and Africa (EMEA) regions, and Asian and EMEA regional analyst. Prior to joining the firm, she was a fixed income securities
analyst at MONY Capital Management and a financial analyst at Mattel Toys.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">John Espinosa&#160;is a portfolio manager for Nuveen&#8217;s
global fixed income team and is the sector lead for sovereigns. He also oversees all investment research across Nuveen&#8217;s global
fixed income and is a member of Nuveen&#8217;s emerging and&#160;non-U.S.&#160;developed markets fixed income team. John serves as a lead
and&#160;co-portfolio&#160;manager across Nuveen&#8217;s suite of emerging markets debt and&#160;non-U.S.&#160;developed fixed income
strategies. John is a member of the Investment Committee, which establishes investment policy for all global fixed income products. John
has nearly two decades of fixed income investment industry experience and previously managed the organization&#8217;s global sovereign
and emerging markets debt research teams. John joined the firm in 2004 as a quantitative analyst and associate portfolio manager for the
CREF Bond Total Return strategy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Brenda A. Langenfeld, CFA, is a portfolio manager for Nuveen&#8217;s
global fixed income team and a member of the preferred securities sector team. She is the lead manager for Nuveen&#8217;s preferred and
income-focused&#160;closed-end&#160;funds and portfolio manager of the Preferred Securities and Income strategy. She joined the preferred
securities sector team in 2011. Brenda has been a&#160;co-manager&#160;for the Real Asset Income strategy since 2015, which invests in
income generating debt and equity securities from both the real estate and infrastructure segments. In 2020 she became&#160;co-manager&#160;of
the Credit Income strategy. Prior to her portfolio management roles, Brenda was a member of the high-grade credit sector team, responsible
for trading corporate bonds. Previously, she was a member of the securitized debt sector team, trading mortgage-backed securities, asset-backed
securities and commercial mortgage-backed securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">James Kim&#160;is a portfolio manager for Nuveen&#8217;s leveraged
finance team with a focus on the management of high yield mandates. James is the lead manager of the High Yield Income strategy and a&#160;co-manager&#160;on
the High Yield, Real Asset Income and Credit Income strategies. He is also head of special situations, leading workouts and opportunistic
investing for the leveraged finance platform. Previously, James was&#160;co-head&#160;of global fixed income research and head of the
leveraged finance research team, overseeing its daily investment process. He also served as the&#160;co-head&#160;of research at Nuveen
affiliate Symphony Asset Management, leading the firm&#8217;s research team, daily investment process and opportunistic investments across
its various mandates. Prior to this, he was a distressed generalist and an industry analyst responsible for a number of different industries,
including energy, power, metals&#160;&amp; mining and chemicals, providing long and short ideas across the capital structure. Prior to
joining the firm, James was an associate at Greywolf Capital in its special situations group and an analyst at Watershed Asset Management.
He began his career at Goldman Sachs, as an investment banking analyst both in the Strategy Group and Energy&#160;&amp; Power Group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Mark Zheng, CFA, is a portfolio manager for Nuveen, focused on Multi-Sector
portfolio management. He is currently lead manager of a diversified, total return component portfolio for the CREF Real Estate Account.
He is also a&#160;co-manager&#160;for the Stable Value Account. Mark is a member of the Core and Core-Plus Strategy teams. Mark provides
strategic and quantitative analysis across a broad set of Multi-Sector Fixed Income strategies incorporating emerging markets, mortgage-backed
securities, high yield bond and loans and&#160;non-agency&#160;structured products. Since joining the firm in 2010, he has held several
positions, including&#160;co-manager&#160;of fixed income ETFs. He also served as a research analyst for investments in mortgage-backed
securities and as a business analyst for fixed income business applications. Prior to working in the financial services industry, Mark
worked in the engineering industry, providing consulting services for global pharmaceutical, chemical, and manufacturing firms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Additional information about the Portfolio Managers&#8217; compensation, other accounts managed by the Portfolio Managers and the Portfolio
Managers&#8217; ownership of securities in the Fund is provided in the SAI. The SAI is available free of charge by calling (800) <span style="white-space: nowrap">257-8787</span> or by visiting the Fund&#8217;s website at www.nuveen.com. The
information contained in, or that can be accessed through, the Fund&#8217;s website is not part of this Prospectus or the SAI, except to the extent specifically incorporated by reference herein or in the SAI. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Investment Management and <span style="white-space: nowrap">Sub-Advisory</span>
Agreements </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Investment Management
Agreement.</i>&#8195;Pursuant to an investment management agreement between Nuveen Fund Advisors and the Fund (the &#8220;Investment Management Agreement&#8221;), the Fund has agreed to pay an annual management fee for the services and facilities
provided by Nuveen Fund Advisors, payable on a monthly basis, based on the sum of a fund-level fee and a complex-level fee, as described below. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Fund-Level Fee.</i>&#8195;The annual fund-level fee for the Fund, payable monthly, is calculated according to the following schedule: </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 85%; border-collapse: collapse; margin-right: auto">


<tr>
<td style="border-bottom: Black 1pt solid; vertical-align: bottom; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
                                         Daily Managed Assets*</b></span></p></td>
<td style="padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><br/>
<span style="font-family: Times New Roman, Times, Serif"><b>Fund Level</b></span><br/>
<span style="font-family: Times New Roman, Times, Serif"><b>Fee Rate</b></span></span></td>
<td style="padding-bottom: 1pt; vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td></tr>


<tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 86%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the first $500 million</span></p></td>
<td style="vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right; width: 10%">0<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.7000%</span></td>
<td style="white-space: nowrap; vertical-align: bottom; width: 1%"/></tr>
<tr>
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the next $500 million</span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">0<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.6750%</span></td>
<td style="white-space: nowrap; vertical-align: bottom"/></tr>
<tr style="background-color: #cceeff">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the next $500 million</span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">0<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.6500%</span></td>
<td style="white-space: nowrap; vertical-align: bottom"/></tr>
<tr>
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the next $500 million</span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">0<span style="font-size: 10pt">.6250%</span></td>
<td style="white-space: nowrap; vertical-align: bottom"/></tr>
<tr style="background-color: #cceeff">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                managed assets over $2 billion</span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">0<span style="font-size: 10pt">.6000%</span></td>
<td style="white-space: nowrap; vertical-align: bottom"/></tr>
</table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Complex-Level
Fee.</i>&#8195;The overall complex-level fee, payable monthly, begins at a maximum rate of 0.1600% of the Fund&#8217;s
average daily managed assets, with breakpoints for eligible complex-level assets above $124.3 billion. Therefore, the maximum management
fee rate for the Fund is the Fund-level fee plus 0.1600%. The current overall complex-level fee schedule is as follows:</p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 85%; border-collapse: collapse; margin-right: auto">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; padding-right: 0; padding-left: 0"><b>Complex-Level
    Asset Breakpoint Level*</b></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 50%; padding-right: 0; padding-left: 0"><b>Complex-Level
    Fee</b></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0">For the first $124.3 billion</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0; padding-left: 0">0.1600%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0">For the next $75.7 billion</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0; padding-left: 0">0.1350%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0">For the next $200 billion</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0; padding-left: 0">0.1325%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0">For eligible assets over $400 billion</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0; padding-left: 0">0.1300%</td></tr>
  </table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">*</td>
<td style="text-align: left; vertical-align: top">See &#8220;Investment Adviser, Sub-Adviser and Portfolio Managers&#8221; in the
SAI for more detailed information about the complex-level fee and eligible complex-level assets.</td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">As
                                         of June 30, 2025, the complex-level fee rate for the Fund was 0.1569%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In addition to the fee of Nuveen Fund Advisors, the Fund pays all other
costs and expenses of its operations, including compensation of its trustees (other than those affiliated with Nuveen Fund Advisors and Nuveen Asset Management), custodian, transfer agency and dividend disbursing expenses, legal fees, expenses of
independent auditors, expenses of repurchasing shares, expenses associated with any borrowings, expenses of issuing any Preferred Shares, expenses of preparing, printing and distributing shareholder reports, notices, proxy statements and reports to
governmental agencies, and taxes, if any. All fees and expenses are accrued daily and deducted before payment of dividends to investors. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">A discussion regarding
the basis for the Board of Trustees&#8217; most recent approval of the Investment Management Agreement for the Fund may be found in
the Fund&#8217;s semi-annual report to shareholders dated June 30, 2024.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Sub-Advisory
Agreement. </i>Pursuant to the Sub-Advisory Agreement, Nuveen Asset Management will receive from Nuveen Fund Advisors a management
fee equal to 44.4444% of Nuveen Fund Advisors&#8217; net management fee from the Fund. Nuveen Fund Advisors and Nuveen Asset Management
retain the right to reallocate investment advisory responsibilities and fees between themselves in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">A discussion regarding
the basis for the Board&#8217;s most recent decision to approve the Sub-Advisory Agreement for the Fund may be found in the
Fund&#8217;s semi-annual report to shareholders dated June 30, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Control Persons and Principal Holders of Common Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as noted below in the table, to the Fund&#8217;s knowledge,
no persons own of record or beneficially, five percent or more of any class of shares of the Fund as of July 31, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8192;Class</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder
    Name and Address</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of<br/>
    Shares Owned</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage
    Owned</b></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Shares</span></td>
    <td style="vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 43%"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">McGowan
    Group Asset Management,&#160;Inc.</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200
    Crescent Court</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suite
    657</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dallas,
    TX 75201</span></p></td>
    <td style="vertical-align: bottom; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,706,721</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.99%</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    Trust Portfolios L.P.</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    Trust Advisors L.P.</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Charger Corporation</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120
    East Liberty Drive, Suite 400</span></p>
    <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wheaton,
    IL 60187</span></p></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,180,236</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.41%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>



<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_11"></span>NET ASSET VALUE </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund&#8217;s NAV per Common Share is determined
as of the close of trading (normally 4:00 p.m. Eastern time) on each day the NYSE is open for business. NAV is calculated by taking the
market value of the Fund&#8217;s total assets, less all liabilities, and dividing by the total number of Common Shares outstanding. The
result, rounded to the nearest cent, is the NAV per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund utilizes independent pricing services approved
by its valuation designee to value portfolio instruments at their market value. Independent pricing services typically value non-equity
portfolio instruments utilizing a range of market-based inputs and assumptions, including readily available market quotations obtained
from broker-dealers making markets in such instruments, cash flows and transactions for comparable instruments. In pricing certain securities,
particularly less liquid and lower quality securities, the pricing services may consider information about a security, its issuer or market
activity provided by Nuveen Fund Advisors or Nuveen Asset Management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The valuations for fixed-income securities and certain
derivative instruments are typically the prices supplied by independent third party pricing services, which may use market prices or broker/dealer
quotations or a variety of fair valuation techniques and methodologies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Specific types of investments are valued as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="padding-bottom: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collateralized Loan Obligations (&#8220;CLOs&#8221;). The
Fund generally uses non-binding indicative prices provided by independent pricing service(s) and/or broker(s) as the primary basis for
determining the value of the CLOs, which may be adjusted for pending distributions, as applicable, as of the applicable valuation date.
These prices are non-binding and may not be determinative of an actual transaction price. In valuing the Fund&#8217;s CLO holdings, Nuveen
Fund Advisors may also consider a variety of other factors it deems relevant, including recent trading prices for specific investments,
recent purchases and sales known to the Fund in similar securities, other information known to the Fund relating to the securities, and
discounted cash flows based on output from a third-party financial model, using projected future cash flows.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign Investments. For non-U.S. traded investments whose
principal local markets close before the close of the NYSE, the Fund may adjust the local closing price based upon such factors as developments
in non-U.S. markets, the performance of U.S. securities markets and the performance of instruments trading in U.S. markets that represent
non-U.S. investments. The Fund may rely on an independent fair valuation service in making any such fair value determinations. If the
Fund holds portfolio instruments that are primarily listed on non-U.S. exchanges, the value of such instruments may change on days when
the Fund&#8217;s NAV is calculated.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">If a price cannot be obtained from a pricing service
or other pre-approved source, or if the Fund&#8217;s valuation designee deems such price to be unreliable, or if a significant event occurs
after the close of the local market but prior to the time at which the Fund&#8217;s NAV is calculated, a portfolio instrument will be
valued at its fair value as determined in good faith by the Fund&#8217;s valuation designee. The Fund&#8217;s valuation designee may determine
that a price is unreliable in various circumstances. For example, a price may be deemed unreliable if it has not changed for an identified
period of time, or has changed from the previous day&#8217;s price by more than a threshold amount, and recent transactions and/or broker
dealer price quotations differ materially from the price in question.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Board of Trustees has designated Nuveen Fund Advisors
as the Fund&#8217;s valuation designee pursuant to Rule 2a-5 under the 1940 Act and delegated to Nuveen Fund Advisors the day-to-day responsibility
of making fair value determinations. All fair value determinations made by Nuveen Fund Advisors are subject to review by the Board of
Trustees. As a general principle, the fair value of a portfolio instrument is the amount that an owner might reasonably expect to receive
upon the instrument&#8217;s current sale. A range of factors and analysis may be considered when determining fair value, including relevant
market data, interest rates, credit considerations and/or issuer specific news. However, fair valuation involves subjective judgments,
and it is possible that the fair value determined for a portfolio instrument may be materially different from the value that could be
realized upon the sale of that instrument.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_12"></span>DISTRIBUTIONS </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund pays
regular monthly cash distributions to Common Shareholders (stated in terms of a fixed cents per Common Share dividend distribution
rate which may be set from time to time). The Fund intends to distribute all or substantially all of its net investment income
each year through its regular monthly distributions and to distribute realized capital gains at least annually. In addition, in
any monthly period, to maintain its declared per common share distribution amount, the Fund may distribute more or less than its
net investment income during the period. In the event the Fund distributes more than its net investment income during any yearly
period, such distributions may also include realized gains and/or a return of capital.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">To the extent that a distribution includes a return of capital the NAV per share may erode. A return of capital may occur, for example, when
some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund&#8217;s investment performance and should not be confused with &#8220;yield&#8221; or &#8220;income.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">If the Fund&#8217;s distribution includes anything other than net investment income, the Fund will
provide a notice to Common Shareholders of its best estimate of the distribution sources at the time of the distribution. These estimates may not match the final tax characterization (for the full year&#8217;s distributions) contained in the Common
Shareholders&#8217; <span style="white-space: nowrap">1099-DIV</span> forms after the end of the year. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">While the Fund intends to distribute all realized capital gains at least annually, the Fund may elect to retain all or a portion of any net
capital gain (which is the excess of net long-term capital gain over net short-term capital loss) otherwise allocable to Common Shareholders and pay U.S. federal income tax on the retained gain. As provided under U.S. federal income tax law, Common
Shareholders of record as of the end of the Fund&#8217;s taxable year will include their share of the retained net capital gain in their income for the year as a long-term capital gain (regardless of their holding period in the common shares), and
will be entitled to an income tax credit or refund for the federal income tax deemed paid on their behalf by the Fund. If the Fund&#8217;s total distributions during a given year is an amount that exceeds the Fund&#8217;s current and accumulated
earnings and profits, the excess would be treated by Common Shareholders as return of capital for federal income tax purposes to the extent of the Common Shareholder&#8217;s basis in their shares and thereafter as capital gain. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Distributions
                                         will be reinvested in additional shares under the Fund&#8217;s Dividend Reinvestment Plan
                                         unless a shareholder elects to receive cash. The Fund reserves the right to change its
                                         distribution policy and the basis for establishing the rate of its monthly distributions
                                         at any time and may do so without prior notice to Common Shareholders.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_13"></span>DIVIDEND REINVESTMENT PLAN </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Please refer to the section of the Fund&#8217;s most recent <a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#151;Dividend
Reinvestment Plan,&#8221; which is incorporated by reference herein, for a discussion of the Fund&#8217;s dividend reinvestment plan. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_14"></span>PLAN OF DISTRIBUTION </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer and sell Securities from time to time on an immediate, continuous or delayed basis, in one or more offerings under this
Prospectus and a related prospectus supplement, on terms to be determined at the time of the offering. The Fund may offer and sell such Securities directly to one or more purchasers, to or through underwriters, through dealers or agents that the
Fund designates from time to time, or through a combination of these methods. Sales of Securities may be made in transactions that are deemed to be &#8220;at the market&#8221; as defined in Rule 415 under the Securities Act of 1933, as amended (the
&#8220;1933 Act&#8221;), including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The prospectus supplement relating to any offering of Securities will describe the terms of such offering, including, as applicable: </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the names of any agents, underwriters or dealers; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">any sales loads, underwriting discounts and commissions or agency fees and
other items constituting underwriters&#8217; or agents&#8217; compensation;</td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">any discounts, commissions, fees or concessions allowed or reallowed or paid to dealers or agents; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the public offering or purchase price of the offered Securities, the estimated net proceeds the Fund will receive from the sale and the use of proceeds; and </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">any securities exchange on which the offered Securities may be listed. </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The prospectus supplement relating to any Rights offering will set forth the number of Common Shares issuable upon the exercise of each Right
(or number of Rights) and the other terms of such Rights offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Direct Sales </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer and sell Securities directly to, and solicit offers from, institutional investors or others who may be deemed to be
underwriters as defined in the 1933 Act for any resales of Securities. In this case, no underwriters or agents would be involved. The Fund may use electronic media, including the Internet, to sell offered Securities directly. The Fund will describe
the terms of any of those sales in a prospectus supplement. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>By Agents </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer and sell Securities through an agent or agents
designated by the Fund from time to time. An agent may sell Securities it has purchased from the Fund as principal to other dealers for resale to investors and other purchasers, and may reallow all or any portion of the discount received in
connection with the purchase from the Fund to the dealers. After the initial offering of Securities, the offering price (in the case of Securities to be resold at a fixed offering price), the concession and the discount may be changed. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>By Underwriters </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">If any underwriters are involved in the offer and sale of Securities,
such Securities will be acquired by the underwriters and may be resold by them, either at a fixed public offering price established at the time of offering or from time to time in one or more negotiated transactions or otherwise, at prices related
to prevailing market prices determined at the time of sale. Unless otherwise set forth in the applicable prospectus supplement, the obligations of the underwriters to purchase Securities will be subject to conditions precedent and the underwriters
will be obligated to purchase all Securities described in the prospectus supplement if any are purchased. Any initial public offering price and any discounts or concessions allowed or <span style="white-space: nowrap">re-allowed</span> or paid to
underwriters may be changed from time to time. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with
an offering of Common Shares, if a prospectus supplement so indicates, the Fund may grant the underwriters an option to purchase additional Common Shares at the public offering price, less the underwriting discounts and commissions, within 45 days
from the date of the prospectus supplement, to cover any overallotments. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>By
Dealers </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer and sell Securities from time to
time through one or more dealers who would purchase the securities as principal. The dealers then may resell the offered Securities to the public at fixed or varying prices to be determined by those dealers at the time of resale. The Fund will set
forth the names of the dealers and the terms of the transaction in the prospectus supplement. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>General </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Any underwriters, dealer or agent participating in an offering of Securities may be deemed to be an &#8220;underwriter,&#8221; as that term is
defined in the 1933 Act, of Securities so offered and sold, and any discounts and commission received by them, and any profit realized by them on resale of the offered Securities for whom they act as agent, may be deemed to be underwriting discounts
and commissions under the 1933 Act. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Underwriters, dealers and
agents may be entitled, under agreements entered into with the Fund, to indemnification by the Fund against some liabilities, including liabilities under the 1933 Act. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer to sell Securities either at a fixed price or at prices that may vary, at market prices prevailing at the time of sale, at
prices related to prevailing market prices or at negotiated prices. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">To facilitate an offering of Common Shares in an underwritten transaction and in accordance with industry practice, the underwriters may engage
in transactions that stabilize, maintain, or otherwise affect the market price
of the Common Shares or any other Security. Those transactions may include overallotment, entering stabilizing bids, effecting syndicate covering transactions, and reclaiming selling concessions
allowed to an underwriter or a dealer. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">An overallotment in connection with an offering creates a short position in the Common Shares for the underwriter&#8217;s own account. </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">An underwriter may place a stabilizing bid to purchase the Common Shares for the purpose of pegging, fixing, or maintaining the price of the Common Shares. </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">Underwriters may engage in syndicate covering transactions to cover overallotments or to stabilize the price of the Common Shares by bidding for, and purchasing, the Common Shares or any other Securities in the open
market in order to reduce a short position created in connection with the offering. </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">The managing underwriter may impose a penalty bid on a syndicate member to reclaim a selling concession in connection with an offering when the Common Shares originally sold by the syndicate member are purchased in
syndicate covering transactions or otherwise. </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Any of
these activities may stabilize or maintain the market price of the Securities above independent market levels. Underwriters are not required to engage in these activities and may end any of these activities at any&#160;time. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with any Rights offering, the Fund may also enter into a
standby underwriting arrangement with one or more underwriters pursuant to which the underwriter(s) will purchase Common Shares remaining unsubscribed for after the Rights offering. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Unless otherwise indicated in the prospectus supplement, each series of
offered Preferred Shares will be a new issue of securities for which there currently is no market. Any underwriters to whom Preferred Shares are sold for public offering and sale may make a market in such Preferred Shares as permitted by applicable
laws and regulations, but such underwriters will not be obligated to do so, and any such market making may be discontinued at any time without notice. Accordingly, there can be no assurance as to the development or liquidity of any market for the
Preferred Shares. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Underwriters, agents and dealers may engage in
transactions with or perform services, including various investment banking and other services, for the Fund and/or any of the Fund&#8217;s affiliates in the ordinary course of business. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The maximum amount of compensation to be received by any Financial
Industry Regulatory Authority (&#8220;FINRA&#8221;) member or independent broker-dealer will not exceed the applicable FINRA limit for the sale of any securities being offered pursuant to Rule 415 under the Securities Act. We will not pay any
compensation to any underwriter or agent in the form of warrants, options, consulting or structuring fees or similar arrangements. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">To the extent permitted under the 1940 Act and the rules and regulations promulgated thereunder, the underwriters may from time to time act as
a broker or dealer and receive fees in connection with the execution of the Fund&#8217;s portfolio transactions after the underwriters have ceased to be underwriters and, subject to certain restrictions, each may act as a broker while it is an
underwriter. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">A prospectus and accompanying prospectus supplement
in electronic form may be made available on the websites maintained by underwriters. The underwriters may agree to allocate a number of Securities for sale to their online brokerage account holders. Such allocations of Securities for Internet
distributions will be made on the same basis as other allocations. In addition, Securities may be sold by the underwriters to securities dealers who resell Securities to online brokerage account holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="toc780884_15"></span>DESCRIPTION OF SHARES </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Common Shares </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
Declaration of Trust authorizes the issuance of an unlimited number of Common Shares. The Common Shares have a par value of $0.01 per
share and, subject to the rights of holders of any Preferred Shares, have equal rights to the payment of dividends and the distribution
of assets upon liquidation. The Common Shares when issued, are fully paid and, subject to matters discussed in &#8220;Certain Provisions
in the Declaration of Trust and By-Laws,&#8221; non-assessable, and have no preemptive or conversion rights or rights to cumulative voting.
A copy of the Declaration of Trust is filed with the SEC as an exhibit to the Fund&#8217;s registration statement of which this Prospectus
is a part.&#160;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span>Each
whole Common Share has one vote with respect to matters submitted for a vote by the Fund&#8217;s Common Shareholders and on which
the shareholder is entitled to vote, and each fractional share shall be entitled to a proportional fractional vote consistent with
the requirements of the 1940 Act and the rules promulgated thereunder, and will vote together as a single class.</span> <span>Whenever
the Fund incurs borrowings and/or Preferred Shares are outstanding, Common Shareholders will not be entitled to receive any cash
distributions from the Fund unless all interest on such borrowings has been paid and all accumulated dividends on Preferred Shares
have been paid, and unless asset coverage (as defined in the 1940 Act) with respect to any borrowings would be at least 300% after
giving effect to the distributions and asset coverage (as defined in the 1940 Act) with respect to Preferred Shares would be at
least 200% after giving effect to the distributions. See &#8220;&#151;Preferred Shares&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Common Shares
are listed on the NYSE and trade under the ticker symbol &#8220;JGH.&#8221; The Fund intends to hold annual meetings of shareholders
so long as the Common Shares are listed on a national securities exchange and such meetings are required as a condition to such
listing. The Fund does not issue share certificates.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Unlike open-end funds, closed-end funds like the Fund do not provide
daily redemptions. Rather, if a shareholder determines to buy additional Common Shares or sell shares already held, the shareholder may conveniently do so by trading on the exchange through a broker or otherwise. Common shares of closed-end
investment companies may frequently trade on an exchange at prices lower than NAV. Common shares of closed-end investment companies like the Fund have during some periods traded at prices higher than NAV and have during other periods traded at
prices lower than NAV. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Because the market value of the Common
Shares may be influenced by such factors as distribution levels (which are in turn affected by expenses), call protection, dividend stability, portfolio credit quality, NAV, relative demand for and supply of such shares in the market, general market
and economic conditions, and other factors beyond the control of the Fund, the Fund cannot assure you that Common Shares will trade at a price equal to or higher than NAV in the future. The Common Shares are designed primarily for long-term
investors, and investors in the Common Shares should not view the Fund as a vehicle for trading purposes. See &#8220;Repurchase of Fund Shares; Conversion to Open-End Fund.&#8221; </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Preferred Shares </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                         Fund&#8217;s Declaration of Trust authorizes the issuance of an unlimited number of Preferred
                                         Shares in one or more classes or series, with rights as determined by the Board of Trustees,
                                         by action of the Board of Trustees without the approval of the Common Shareholders. The Fund currently has no Preferred Shares outstanding. The discussion below generally describes the rights of the
                                         holders of Preferred Shares, although the terms of any Preferred Shares that
                                         may be issued by the Fund may be the same as, or different from, the terms described
                                         below, subject to the applicable Statement, applicable law and the Declaration of Trust.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Under
                                            the 1940 Act, the Fund is not permitted to issue &#8220;senior securities&#8221; that are Preferred
                                            Shares if, immediately after the issuance of Preferred Shares, the asset coverage ratio would
                                            be less than 200%. See &#8220;Use of Leverage.&#8221; Additionally, the Fund will generally
                                            not be permitted to purchase any of its Common Shares or declare dividends (except a dividend
                                            payable in Common Shares) or other distributions on its Common Shares unless, at the time
                                            of such purchase or declaration, the asset coverage ratio with respect to such Preferred
                                            Shares, after taking into account such purchase or distribution, is at least 200%. Preferred
                                            Shares issued by the Fund have priority over the Common Shares.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">For so long as any Preferred Shares are outstanding, the Fund will not:
(1) declare or pay any dividend or other distribution (other than a dividend or distribution paid in Common Shares) in respect of the Common Shares, (2) call for redemption, redeem, purchase or otherwise acquire for consideration any Common Shares,
or (3) pay any proceeds of the liquidation of the Fund in respect of the Common Shares, unless, in each case, (A) immediately thereafter, the Fund shall be in compliance with the 200% asset coverage limitations set forth under the 1940 Act after
deducting the amount of such dividend or other distribution or redemption or purchase price or liquidation proceeds and (B) all cumulative dividends and other distributions of shares of all series of Preferred Shares of the Fund due on or prior to
the date of the applicable dividend, distribution, redemption, purchase or acquisition shall have been declared and paid. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Dividends and Distributions and Priority of Payment</i></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">If the Fund issues Preferred Shares, the Fund&#8217;s Preferred Shares will rank equally with each other and have priority over the Common Shares
as to the payment of dividends and other distributions. The holders of Preferred Shares of each series will be entitled to receive, when,
as and if declared by the Board, out of funds legally available therefor in accordance with the Declaration of Trust and applicable law,
cumulative cash dividends at the dividend rate for the Preferred Shares of such series payable on the dividend payment dates with respect
to the Preferred Shares of such series. Holders of Preferred Shares will not be entitled to any dividend, whether payable in cash, property
or shares, in excess of full cumulative dividends on the Preferred Shares. No interest, or sum of money in lieu of interest, shall be
payable in respect of any dividend payment or payments on Preferred Shares which may be in arrears, and no additional sum of money will
be payable in respect of such arrearage. Dividends on a series of Preferred Shares may be determined at a fixed rate, by reference to
an index or pursuant to a formula, established by a remarketing agent or otherwise. Dividends may be subject to a maximum rate as set
forth in the applicable statement establishing and fixing the rights and preferences of such Preferred Shares.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Liquidation Preference </i></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In the event of any voluntary or involuntary liquidation, dissolution
or winding up of the affairs of the Fund, holders of Preferred Shares would be entitled to receive a preferential liquidating distribution (expected to equal the original purchase price per share plus accumulated and unpaid dividends thereon,
whether or not earned or declared) before any distribution of assets is made to Common Shareholders. After payment of the full amount of the liquidating distribution to which they are entitled, holders of Preferred Shares will not be entitled to any
further participation in any distribution of assets by the Fund. A consolidation or merger of the Fund with or into another entity or a sale of all or substantially all of the assets of the Fund shall not be deemed to be a liquidation, dissolution
or winding up of the Fund. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Voting Rights </i></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with any issuance of Preferred Shares, the Fund must
comply with Section&#160;18(i) of the 1940&#160;Act, which requires, among other things, that Preferred Shares be voting shares and have equal voting rights with Common Shares. Except with respect to certain matters affecting only the holders of the
Preferred Shares and except as discussed further below, holders of Preferred Shares vote together with Common Shareholders as a single class on matters submitted to Fund shareholders. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with the election of the Fund&#8217;s trustees, holders of
Preferred Shares, voting as a separate class, are entitled to elect two of the Fund&#8217;s trustees, and the remaining trustees are elected by Common Shareholders and holders of Preferred Shares, voting together as a single class. In addition, if at
any time dividends on the Fund&#8217;s outstanding Preferred Shares are unpaid in an amount equal to two full years&#8217; dividends thereon, the holders of all outstanding Preferred Shares, voting as a separate class, would be entitled to elect a
majority of the Fund&#8217;s trustees until all dividends in arrears have been paid or declared and set apart for payment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund&#8217;s Preferred Shares, if any, will be issued pursuant to a Statement that sets forth certain voting and consent rights of the holders of such Shares, including with respect
 to certain actions that would affect the preferences, rights, or powers of such class or series or the authorization or issuance of
 any class or series ranking prior to the Preferred Shares. Except as may otherwise be required by law, the Fund&#8217;s Declaration of
 Trust requires that (1)&#160;the affirmative vote of the holders of at least two-thirds of the Fund&#8217;s Preferred Shares outstanding
 at the time, voting as a separate class, would be required to approve any conversion of the Fund from a closed-end to an open-end investment
 company and (2)&#160;the affirmative vote of the holders of at least two-thirds of the outstanding Preferred Shares, voting as a separate
 class, would be required to approve any plan of reorganization (as such term is used in the 1940 Act) adversely affecting such shares;
 provided however, that such separate class vote would be a majority vote if the action in question has previously been approved, adopted
 or authorized by the affirmative vote of two-thirds of the total number of trustees fixed in accordance with the Declaration of Trust
 or the By-laws. The affirmative vote of the holders of a majority of the outstanding Preferred Shares, voting as a separate class, would
 be required to approve any action not described in the preceding sentence requiring a vote of security holders under Section&#160;13(a)
 of the 1940 Act including, among other things, changes in the Fund&#8217;s investment objective or changes in the investment restrictions
 described as fundamental policies under &#8220;Investment Restrictions&#8221; in the SAI. The class or series vote of holders of Preferred
 Shares described above would in each case be in addition to any separate vote of the requisite percentage of Common Shares and Preferred
 Shares necessary to authorize the action in question.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The foregoing voting provisions would not apply with respect to any
Fund Preferred Shares if, at or prior to the time when a vote was required, such shares have been (1)&#160;redeemed or (2)&#160;called for redemption and sufficient funds would have been deposited in trust to effect such redemption. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Redemption, Purchase and Sale of Preferred Shares </i></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The terms of the Preferred Shares may provide that they are redeemable by the Fund at certain times, in whole or in part, at the liquidation
preference of such share plus accumulated dividends, that the Fund may tender for or purchase Preferred Shares and that the Fund may subsequently
resell any shares so tendered for or purchased. Any redemption or purchase of Preferred Shares by the Fund would reduce the leverage applicable
to Common Shares, while any resale of such shares by the Fund would increase such leverage.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_16"></span>RIGHTS OFFERINGS </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                         Fund may in the future, and at its discretion, choose to make offerings of Rights to
                                         its shareholders to purchase Common Shares. Rights may be issued independently or together
                                         with any other offered security and may or may not be transferable by the person purchasing
                                         or receiving the rights. In connection with a Rights offering to shareholders, the Fund
                                         would distribute certificates or other documentation evidencing the Rights and a prospectus
                                         supplement to the Fund&#8217;s shareholders as of the record date that the Fund sets for
                                         determining the shareholders eligible to receive Rights in such Rights offering. Any
                                         such future Rights offering will be made in accordance with the 1940 Act and, to the
                                         extent such Rights are transferable, will comply with applicable interpretations of the
                                         SEC or its staff, as such interpretations may be modified in the future, which currently
                                         require that: (i) the Fund&#8217;s Board of Trustees make a good faith determination that
                                         such offering would result in a net benefit to existing shareholders; (ii) the offering
                                         fully protects shareholders&#8217; preemptive rights and does not discriminate among shareholders
                                         (except for the possible effect of not offering fractional rights); (iii) management
                                         uses its best efforts to ensure an adequate trading market in the Rights for use by shareholders
                                         who do not exercise such Rights; and (iv) the ratio of such transferable Rights offering
                                         does not exceed one new share for each three rights held.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The applicable prospectus supplement would describe the following terms
of the Rights (to the extent each is applicable) in respect of which this Prospectus is being delivered: </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the period of time the offering would remain open; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the underwriter or distributor, if any, of the Rights and any associated underwriting fees or discounts applicable to purchases of the Rights; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the title of such Rights; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the exercise price for such Rights (or method of calculation thereof); </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the number of such Rights issued in respect of each share; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the number of Rights required to purchase a single share;</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the extent to which such Rights are transferable and the market on which they may be traded if they are transferable; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">if such Rights are transferable, a discussion regarding
the Board of Trustees&#8217; basis for determining that such offering would result in a net benefit to existing shareholders;</td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">if applicable, a discussion of the material U.S. federal income tax considerations applicable to the issuance or exercise of such Rights; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the date on which the right to exercise such Rights will commence, and the date on which such right will expire (subject to any extension); </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the extent to which such Rights include an over-subscription privilege with respect to unsubscribed securities and the terms of such over-subscription privilege; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">termination rights the Fund may have in connection with such Rights offering;
and</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">any other terms of such Rights, including exercise, settlement and other procedures and limitations relating to the transfer and exercise of such Rights. </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">A certain number of Rights would entitle the holder of the Right(s) to
purchase for cash such number of shares at such exercise price as in each case is set forth in, or be determinable as set forth in, the prospectus supplement relating to the Rights offered thereby. Rights would be exercisable at any time up to the
close of
business on the expiration date for such Rights set forth in the prospectus supplement. After the close of business on the expiration date, all unexercised Rights would become void. Upon
expiration of the Rights offering and the receipt of payment and the Rights certificate or other appropriate documentation properly executed and completed and duly executed at the corporate trust office of the Rights agent, or any other office
indicated in the prospectus supplement, the Common Shares purchased as a result of such exercise will be issued as soon as practicable. To the extent permissible under applicable law, the Fund may determine to offer any unsubscribed offered
securities directly to persons other than shareholders, to or through agents, underwriters or dealers or through a combination of such methods, as set forth in the applicable prospectus supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_17"></span>CERTAIN PROVISIONS IN THE DECLARATION OF
TRUST AND <span style="white-space: nowrap">BY-LAWS</span> </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General</i>. The By-laws of the Fund provide that by becoming a shareholder of the Fund, each shareholder shall be deemed to have agreed to
be bound by the terms of the Declaration of Trust and By-laws. However, neither the Declaration of Trust nor the By-laws purport to require the waiver of a shareholder&#8217;s rights under the federal securities laws. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Shareholder and Trustee Liability</i>. Under Massachusetts law,
shareholders could, under certain circumstances, be held personally liable for the Fund&#8217;s obligations. However, the Declaration of Trust contains an express disclaimer of shareholder liability for the Fund&#8217;s debts or obligations and
requires that notice of such limited liability be given in each agreement, obligation or instrument entered into or executed by the Fund or the trustees. The Declaration of Trust further provides for indemnification out of the Fund&#8217;s assets and
property for all loss and expense of any shareholder held personally liable for the Fund&#8217;s obligations. Thus, the risk of a shareholder incurring financial loss on account of shareholder liability is limited to circumstances in which the Fund
would be unable to meet its obligations. The Fund believes that the likelihood of such circumstances is remote. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Declaration of
Trust provides that the Fund&#8217;s obligations are not binding upon the Fund&#8217;s trustees individually, but only upon the
Fund&#8217;s assets and property, and that the trustees shall not be liable for errors of judgment or mistakes of fact or law.
Nothing in the Declaration of Trust, however, protects a trustee against any liability to which the trustee would otherwise be
subject by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct
of the trustee&#8217;s office. &#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Anti-Takeover
Provisions</i>. The Declaration of Trust and By-laws include provisions that could limit the ability of other entities or persons to
acquire control of the Fund or to convert the Fund to open-end status. The By-laws require the Board of Trustees be divided into
three classes with staggered terms. See &#8220;Management of the Fund&#8221; in the SAI. This provision of the By-laws could delay
for up to two years the replacement of a majority of the Board of Trustees. When Preferred Shares are issued, holders of Preferred
Shares, voting as a separate class, are entitled to elect two of the Fund&#8217;s trustees. In addition, the Declaration of Trust
requires a vote by holders of at least two-thirds of the Common Shares and, if issued, Preferred Shares, voting together as a single
class, except as described below, to authorize (1) a conversion of the Fund from a closed-end to an open-end investment company, (2)
a merger or consolidation of the Fund, or a series or class of the Fund, with any corporation, association, trust or other
organization or a reorganization of the Fund, or a series or class of the Fund, (3) a sale, lease or transfer of all or
substantially all of the Fund&#8217;s assets (other than in the regular course of the Fund&#8217;s investment activities), (4) in
certain circumstances, a termination of the Fund, or a series or class of the Fund or (5) a removal of trustees by shareholders, and
then only for cause, unless, with respect to (1) through (5), such transaction has already been authorized by the affirmative vote
of two-thirds of the total number of trustees fixed in accordance with the Declaration of Trust or the By-laws, in which case the
affirmative vote of the holders of at least a majority of the Fund&#8217;s Common Shares and, if issued, Preferred Shares
outstanding at the time, voting together as a single class, would be required; provided, however, that where only a particular class
or series is affected (or, in the case of removing a trustee, when the trustee has been elected by only one class), only the
required vote by the applicable class or series will be required. However, approval of shareholders would not be required for any
transaction, whether deemed a merger, consolidation, reorganization or otherwise whereby the Fund issues shares in connection with
the acquisition of assets (including those subject to liabilities) from any other investment company or similar entity. In the case
of the conversion of the Fund from a closed-end investment company to an open-end investment company, or in the case of any of the
foregoing transactions constituting a plan of reorganization that adversely affects the holders of any outstanding Preferred Shares,
the action in question also would require the affirmative vote of the holders of at least two-thirds of the Preferred Shares
outstanding at the time, voting as a separate class, unless such transaction has already been authorized by the affirmative vote of
two-thirds of the total number of trustees fixed in accordance with the Declaration of Trust or the By-laws, in which case the
affirmative vote of the holders of at least a majority of the Fund&#8217;s Preferred Shares outstanding at the time would be
required. None of the foregoing provisions may be amended except by the vote of at least two-thirds of the Common Shares and any
Preferred Shares voting together as a single class. The votes required to approve the conversion of the Fund from a closed-end to an
open-end investment company or to approve transactions constituting a plan of reorganization which adversely affects the holders of
preferred shares are higher than those required by the 1940 Act. The Board of Trustees believes that the provisions of the
Declaration of Trust relating to such higher votes are in the best interest of the Fund and its shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Procedural Requirements on Derivative Actions, Exclusive
Jurisdiction and Jury Trial Waiver</i>. The By-laws of the Fund contain certain provisions affecting potential shareholder claims against the Fund, including procedural requirements for derivative actions, an exclusive forum provision, and the
waiver of shareholder rights to a jury trial. Massachusetts is considered a &#8220;universal demand&#8221; state, meaning that under Massachusetts corporate law a shareholder must make a demand on the company before bringing a derivative action (i.e.,
a lawsuit brought by a shareholder on behalf of the company). The By-laws of the Fund provide detailed procedures for the bringing of derivative actions by shareholders which are modeled on the substantive provisions of the Massachusetts corporate
law derivative demand statute. The procedures are intended to permit legitimate inquiries and claims while avoiding the time, expense, distraction, and other harm that can be caused to the Fund or its shareholders as a result of spurious shareholder
demands and derivative actions. Among other things, these procedures: </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">provide that before bringing a derivative action, a shareholder must make a written demand to the Fund; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">establish a 90-day review period, subject to extension in certain circumstances, for the Board of Trustees to evaluate the shareholder&#8217;s demand; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">establish a mechanism for the Board of Trustees to submit the question of whether to maintain a derivative action to a vote of shareholders; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">provide that if the Fund does not notify the requesting shareholder of the rejection of the demand within the applicable review period, the shareholder may commence a derivative action; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">establish bases upon which a trustee will not be considered to be not independent for purposes of evaluating a derivative demand; and </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">provide that if the trustees who are independent for purposes of considering a shareholder demand determine in good faith within the applicable review period that the maintenance of a derivative action is not in the
best interest of the Fund, the shareholder shall not be permitted to maintain a derivative action unless the shareholder first sustains the burden of proof to the court that the decision of the trustees not to pursue the requested action was not a
good faith exercise of their business judgment on behalf of the Fund. </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">These procedures may be more restrictive than procedures for bringing derivative suits applicable to other investment companies. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The By-laws also
                                                                           require that actions by shareholders against the Fund, except for actions under the U.S. federal securities laws, be brought only in
                                                                           a certain federal court in Massachusetts, or if not permitted to be brought in federal court, then in the Business Litigation
                                                                           Session of the Massachusetts Superior Court in Suffolk County (the &#8220;Exclusive Jurisdictions&#8221;), and that the right to jury
                                                                           trial be waived to the fullest extent permitted by law. Other investment companies may not be subject to similar restrictions. The
                                                                           designation of Exclusive Jurisdictions may make it more expensive for a shareholder to bring a suit than if the shareholder were
                                                                           permitted to select another jurisdiction. In the event a shareholder selects another jurisdiction to bring its suit and the venue
                                                                           for such suit is subsequently changed back to an Exclusive Jurisdiction through the legal process, then such shareholder shall be
                                                                           required to reimburse all expenses incurred by the Fund or any other person in effecting such change of venue back to the Exclusive
                                                                           Jurisdiction. Also, the designation of Exclusive Jurisdictions and the waiver of jury trials limit a shareholder&#8217;s ability to
                                                                           litigate a claim in the jurisdiction and in a manner that may be more favorable to the shareholder. It is possible that a court may
                                                                           choose not to enforce these provisions of the Fund&#8217;s By-laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Preemptive
Rights</i>. The Declaration of Trust provides that Common Shareholders shall have no right to acquire, purchase or subscribe for any
shares or investments of the Fund, other than such right, if any, as the Fund&#8217;s Board of Trustees in its discretion may determine. As of the
date of this Prospectus, no preemptive rights have been granted by the Board of Trustees.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Reference should be made to the Declaration of Trust and By-laws on
file with the SEC for the full text of these provisions. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;
</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_18"></span>REPURCHASE OF FUND SHARES; CONVERSION TO <span style="white-space: nowrap">OPEN-END</span> FUND </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                            Fund is a closed-end investment company and as such its shareholders will not have the right
                                            to cause the Fund to redeem their shares. Instead, the Common Shares will trade in the open
                                            market at a price that will be a function of several factors, including dividend levels (which
                                            are in turn affected by expenses), NAV, call protection, dividend stability, portfolio credit
                                            quality, relative demand for and supply of such shares in the market, general market and
                                            economic conditions and other factors. Because shares of closed-end investment companies
                                            may frequently trade at prices lower than NAV, the Fund&#8217;s Board of Trustees has currently
                                            determined that, at least annually, it will consider action that might be taken to reduce
                                            or eliminate any material discount from NAV in respect of Common Shares, which may include
                                            the repurchase of such shares in the open market or in private transactions, the making of
                                            a tender offer for such shares at NAV, or the conversion of the Fund to an open-end investment
                                            company. The Fund cannot assure you that its Board of Trustees will decide to take any of
                                            these actions, or that share repurchases or tender offers will actually reduce market discount.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">If
                                         the Fund converted to an open-end investment company, it would be required to redeem
                                         all Preferred Shares, if any, then outstanding (requiring in turn that
                                         it liquidate a portion of its investment portfolio), and the Common Shares would no longer
                                         be listed on the NYSE or elsewhere and it would likely have to significantly reduce any
                                         leverage it is then employing, which may require a repositioning of its investment portfolio,
                                         which may in turn generate substantial transaction costs, which would be borne by Common
                                         Shareholders, and may adversely affect Fund performance and Fund distributions. In contrast
                                         to a closed-end investment company, shareholders of an open-end investment company may
                                         require the company to redeem their shares at any time (except in certain circumstances
                                         as authorized by the 1940 Act or the rules thereunder) at their NAV, less any redemption
                                         charge that is in effect at the time of redemption. The Fund currently expects that any
                                         such redemptions would be made in cash. The Fund may charge sales or redemption fees
                                         upon conversion to an open-end fund. In order to avoid maintaining large cash positions
                                         or liquidating favorable investments to meet redemptions, open-end investment companies
                                         typically engage in a continuous offering of their shares. Open-end investment companies
                                         are thus subject to periodic asset in-flows and out-flows that can complicate portfolio
                                         management. The Board of Trustees may at any time propose conversion of the Fund to an
                                         open-end investment company depending upon its judgment as to the advisability of such
                                         action in light of circumstances then prevailing.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Before
                                            deciding whether to take any action if the Common Shares trade below NAV, the Fund&#8217;s
                                            Board of Trustees would consider all relevant factors, including the extent and duration
                                            of the discount, the liquidity of the Fund&#8217;s portfolio, the impact of any action that
                                            might be taken on the Fund or its shareholders, and market considerations. Based on these
                                            considerations, even if the Fund&#8217;s shares should trade at a discount, the Board of Trustees
                                            may determine that, in the interest of the Fund and its shareholders, no action should be
                                            taken.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_19"></span>TAX MATTERS </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The following information is meant as a general summary
for U.S. Common Shareholders. Please see the SAI for additional information. Investors should rely on their own tax adviser for advice
about the particular federal, state and local tax consequences to them of investing in the Fund. This summary does not discuss the tax
consequences of an investment in Rights or Preferred Shares. The tax consequences of such an investment will be discussed in the relevant
prospectus supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund has elected and intends to qualify each year
to be treated as a RIC under Subchapter M of the Internal Revenue Code. In order to qualify for treatment as a RIC, the Fund must satisfy
certain requirements regarding the sources of its income, the diversification of its assets and the distribution of its income. Provided
that the Fund timely distributes its income it is not expected to be subject to federal income tax. Dividends paid out of the Fund&#8217;s
investment company taxable income (which includes dividends the Fund receives, interest income and net short-term capital gain) will generally
be taxable to shareholders as ordinary income, except as described below with respect to qualified dividend income. Net capital gain distributions
(the excess of net long-term capital gain over net short-term capital loss) are generally taxable at rates applicable to long-term capital
gains regardless of how long a shareholder has held its shares. Long-term capital gains for non-corporate shareholders are currently taxable
at a maximum federal income tax rate of 20%. In addition, certain individuals, estates and trusts are subject to a 3.8% Medicare tax on
net investment income, including net capital gains and other taxable dividends. Corporate shareholders are taxed on capital gain at the
same rates as apply to ordinary income. Distributions derived from qualified dividend income and received by a non- corporate shareholder
will be taxed at the rates applicable to long-term capital gain. In order for some portion of the dividends received by a shareholder
to be qualified dividend income, the Fund must meet certain holding period and other requirements with respect to the dividend-paying
stocks in its portfolio and the non-corporate shareholder must meet certain holding period and other requirements with respect to its
shares of the Fund. Taxable distributions are taxable whether or not such distributions are reinvested in the Fund. Dividend distributions
may be subject to state and local taxation, depending on a shareholder&#8217;s situation. The Fund&#8217;s investment strategies may significantly
limit its ability to make distributions eligible to be reported as qualified dividend income or for the dividends-received deduction for
corporate shareholders. While the Fund may invest in municipal securities the interest income from which is exempt from regular federal
income tax, the Fund does not expect to satisfy the requirements to pay exempt-interest dividends to shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">If the Fund&#8217;s total distributions exceed both
the current taxable year&#8217;s earnings and profits and accumulated earnings and profits from prior years, the excess generally will
be treated as a tax-free return of capital up to and including the amount of a shareholder&#8217;s tax basis in its shares of the Fund,
and thereafter as capital gain. Upon a sale of shares of the Fund, the amount, if any, by which the sales price exceeds the basis in the
shares of the Fund is gain subject to federal income tax. Because a return of capital reduces basis in the shares of the Fund, it will
increase the amount of gain or decrease the amount of loss on a shareholder&#8217;s subsequent disposition of the shares of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">As a regulated investment company, the Fund will not
be subject to federal income tax in any taxable year provided that it meets certain distribution requirements. The Fund may retain for
investment some (or all) of its net capital gain. If the Fund retains any net capital gain or investment company taxable income, it will
be subject to tax at the regular corporate rate on the amount retained. If the Fund retains any net capital gain, it may designate the
retained amount as undistributed capital gains in a notice to its shareholders who if subject to federal income tax on long-term capital
gains, (i) will be required to include in income for federal income tax purposes, as long-term capital gain, their share of such undistributed
amount; (ii) will be entitled to credit their proportionate shares of the federal income tax paid by the Fund on such undistributed amount
against their federal income tax liabilities, if any; and (iii) may claim refunds to the extent the credit exceeds such liabilities. For
federal income tax purposes, the basis of shares owned by a shareholder of the Fund will be increased by an amount equal to the difference
between the amount of undistributed capital gains included in the shareholder&#8217;s gross income and the tax deemed paid by the shareholder
under clause (ii) of the preceding sentence. Unless a shareholder&#8217;s investment in the Fund is through a tax-exempt entity or tax
deferred retirement account, such as a 401(k) plan, the shareholder will normally have to pay federal income taxes, and any applicable
state or local taxes, on the dividends and other distributions the shareholder receives from the Fund, whether it takes the distributions
in cash or reinvest them in additional shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">If the Fund utilizes leverage through borrowings, or
otherwise, asset coverage limitations imposed by the 1940 Act as well as additional restrictions that may be imposed by certain lenders
on the payment of dividends or distributions potentially could limit or eliminate the Fund&#8217;s ability to make distributions on its
common shares and/or preferred shares, if any, until the asset coverage is restored. These limitations could prevent the Fund from distributing
at least 90% of its investment company taxable income as is required under the Code and therefore might jeopardize the Fund&#8217;s qualification
as a regulated investment company and/or might subject the Fund to a nondeductible 4% federal excise tax. The Fund endeavors to avoid
restrictions on its ability to distribute dividends.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Dividends declared by the Fund in October, November
or December, payable to shareholders of record in such a month, and paid during the following January will be treated as having been received
by shareholders in the year the distributions were declared.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Investments by the Fund in zero coupon or other discount
securities will result in income to the Fund equal to a portion of the excess of the face value of the securities over their issue price
(the &#8220;original issue discount&#8221; or &#8220;OID&#8221;) each year that the securities are held, even though the Fund may receive
no cash interest payments or may receive cash interest payments that are less than the income recognized for tax purposes. In addition,
any market discount recognized on a market discount bond is taxable as ordinary income. A market discount bond is a bond acquired in the
secondary market at a price below redemption value, or below adjusted issue price if issued with original issue discount. Absent an election
by the Fund to include the market discount in income as it accrues, gain on the Fund&#8217;s disposition of such an obligation will be
treated as ordinary income rather than capital gain to the extent of the accrued market discount. Because the income required to be recognized
by the Fund as a result of the OID and/or market discount rules may not be matched by a corresponding cash payment to the Fund, the Fund
may be required to borrow money or dispose of securities to be able to make distributions to its shareholders in order to qualify for
treatment as a RIC and eliminate taxes at the Fund level.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Each shareholder will receive an annual statement summarizing
the U.S. federal income tax status of all distributions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Unless your investment in the Fund is through a tax-exempt
entity or tax deferred retirement account, the repurchase, sale or exchange of Common Shares normally will result in capital gain or loss
to Common Shareholders who hold their shares as capital assets. Generally, a shareholder&#8217;s gain or loss will be long-term capital
gain or loss if the shares have been held for more than one year even though the increase in value in such Common Shares may be at least
partly attributable to tax-exempt interest income. For non-corporate taxpayers, long-term capital gains are currently taxed at rates of
up to 20%. Short-term capital gains and other ordinary income are taxed to non-corporate taxpayers at ordinary income rates. If a shareholder
sells or otherwise disposes of Common Shares before holding them for six months, any loss on the sale or disposition will be treated as
a long-term capital loss to the extent of any amounts treated as distributions to the common shareholder of long-term capital gain (including
any amount credited to the common shareholder as undistributed capital gain). Any loss realized by a shareholder on the disposition of
shares held 6 months or less is disallowed to the extent of the amount of exempt-interest dividends received by the shareholder with respect
to Common Shares. Any loss realized on a sale or exchange of shares of the Fund will be disallowed to the extent those shares of the Fund
are replaced by substantially identical shares of the Fund (including shares acquired by reason of participation in the Plan) within a
period of 61 days beginning 30 days before and ending 30 days after the date of disposition of the original shares, or to the extent the
shareholder enters into a contract or option to repurchase shares within such period. In that event, the basis of the replacement shares
of the Fund will be adjusted to reflect the disallowed loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund may be required to withhold (as &#8220;backup
withholding&#8221;) U.S. federal income tax for distributions (including exempt-interest dividends) and repurchase proceeds payable to
a shareholder if the shareholder fails to provide the Fund with the shareholder&#8217;s correct taxpayer identification number or to make
required certifications, or if the shareholder has been notified by the IRS that the shareholder is subject to backup withholding. The
backup withholding rate is 24%. Backup withholding is not an additional tax; rather, it is a way in which the IRS ensures it will collect
taxes otherwise due. Any amounts withheld may be credited against a shareholder&#8217;s U.S. federal income tax liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund may invest in other instruments the U.S. federal
income tax treatment of which is uncertain or subject to re-characterization by the IRS. To the extent the tax treatment of such instruments
or their income differs from the tax treatment expected by the Fund, it could affect the timing or character of income recognized by the
Fund, requiring the Fund to purchase or sell instruments, or otherwise change its portfolio, in order to comply with the tax rules applicable
to RICs under the Code. Common Shareholders may be subject to state, local and foreign taxes on their Fund distributions. Shareholders
are advised to consult their own tax advisers with respect to the particular consequences to them of an investment in the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_20"></span>CUSTODIAN AND TRANSFER AGENT </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                            custodian of the assets of the Fund is State Street Bank and Trust Company, located at One
                                            Congress Street, Suite&#160;1, Boston, Massachusetts 02114-2016 (the &#8220;Custodian&#8221;).
                                            The Custodian performs custodial, fund accounting and portfolio accounting services. The
                                            Fund&#8217;s transfer, shareholder services and dividend paying agent with respect to the
                                            Fund&#8217;s Common Shares is Computershare Inc. and Computershare Trust Company, N.A., located
                                            at 150 Royall Street, Canton, Massachusetts 02021. The transfer agent, tender and dividend
                                            paying agent and calculation agent for any Preferred Shares, will be identified in the applicable
                                            prospectus supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_21"></span>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">PricewaterhouseCoopers LLP (&#8220;PwC&#8221;),
                                         an independent registered public accounting firm, provides auditing services to the Fund. The principal business address of PwC is One North Wacker Dr, Chicago, IL 60606.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_22"></span>LEGAL MATTERS </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Certain legal
matters in connection with the offering will be passed upon for the Fund by Stradley Ronon Stevens &amp; Young, LLP, located at
2005 Market Street, Suite 2600, Philadelphia, Pennsylvania. Stradley Ronon Stevens &amp; Young, LLP may rely as to certain matters
of Massachusetts law on the opinion of Morgan, Lewis &amp; Bockius LLP. Any additional legal opinions will be described in a prospectus supplement.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_23"></span>AVAILABLE
INFORMATION </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund is subject to the informational
requirements of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) and the 1940 Act and is required to file reports, proxy statements and other information with the SEC. Reports, proxy statements, and other information
about the Fund can be inspected at the offices of the NYSE. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">This
Prospectus does not contain all of the information in the Fund&#8217;s Registration Statement, including amendments, exhibits, and schedules. Statements in this Prospectus about the contents of any contract or other document are not necessarily
complete and, in each instance, reference is made to the copy of the contract or other document filed as an exhibit to the Registration Statement, each such statement being qualified in all respects by this reference. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Additional information about the Fund and the Securities can be found
in the Fund&#8217;s Registration Statement (including amendments, exhibits, and schedules) on Form <span style="white-space: nowrap">N-2</span> filed with the SEC. The SEC maintains a website (http://www.sec.gov) that contains the Fund&#8217;s
Registration Statement, other documents incorporated by reference, and other information the Fund has filed electronically with the SEC, including proxy statements and reports filed under the Exchange Act. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_24"></span>INCORPORATION BY REFERENCE </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The documents listed below, and any reports and other documents
subsequently filed with the SEC pursuant to Section&#160;30(b)(2) of the 1940 Act and Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the termination of the offering will be incorporated by reference into this Prospectus and deemed
to be part of this Prospectus from the date of the filing of such reports and documents: </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left">The Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1615905/000199937125011457/jgh-n2a_052725.htm">SAI</a>, dated August 19,
2025; and</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">The Fund&#8217;s <a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312525049467/d916651dncsr.htm"><span style="text-decoration: underline">annual report</span></a> on Form N-CSR for the fiscal year ended December 31, 2024.</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>






<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">The description of the Common Shares contained in the Fund&#8217;s <a href="http://www.sec.gov/Archives/edgar/data/1615905/000119312514416828/d772175d8a12b.htm">Registration
Statement</a> on Form 8-A (File&#160;No.&#160;001-36753) filed with the SEC on November 18, 2014, including any amendment or report
filed for the purpose of updating such description prior to the termination of the offering registered hereby.</td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The information incorporated by reference is considered to be part of
this Prospectus, and later information that the Fund files with the SEC will automatically update and supersede this information. Incorporated materials not delivered with the Prospectus may be obtained, without charge, by calling (800) <span style="white-space: nowrap">257-8787,</span> by writing to the Fund at 333 West Wacker Drive, Chicago, Illinois 60606, or from the Fund&#8217;s website (<span style="text-decoration: underline">http://www.nuveen.com</span>).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>

    <!-- Field: /Page -->

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>jgh-20251015.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +6spw7xRiXhun8uCbn1MSayBibP9w5dzCelBtm9zHVmaXy0jiIlnQiSGGqwmsW4C -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:jgh="http://nuveen.com/20251015" elementFormDefault="qualified" targetNamespace="http://nuveen.com/20251015">
    <annotation>
      <appinfo>
        <link:linkbaseRef xlink:type="simple" xlink:href="jgh-20251015_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="jgh-20251015_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="jgh-20251015_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/cef/2025" schemaLocation="https://xbrl.sec.gov/cef/2025/cef-2025.xsd" />
    <import namespace="http://xbrl.sec.gov/cef-pre/2025" schemaLocation="https://xbrl.sec.gov/cef/2025/cef-2025_pre.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="jgh_CommonStockAdjustedForOfferingMember" name="CommonStockAdjustedForOfferingMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>jgh-20251015_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#SecurityOnly" roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#AddressTypeOnly" roleURI="http://xbrl.sec.gov/cef/role/AddressTypeOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#RiskOnly" roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="jgh-20251015.xsd#jgh_CommonStockAdjustedForOfferingMember" xlink:label="loc_jghCommonStockAdjustedForOfferingMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_jghCommonStockAdjustedForOfferingMember" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/AddressTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>jgh-20251015_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="jgh-20251015.xsd#jgh_CommonStockAdjustedForOfferingMember" xlink:label="jgh_CommonStockAdjustedForOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jgh_CommonStockAdjustedForOfferingMember" xlink:to="jgh_CommonStockAdjustedForOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jgh_CommonStockAdjustedForOfferingMember_lbl" xml:lang="en-US">Common Stock Adjusted for Offering [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jgh_CommonStockAdjustedForOfferingMember" xlink:to="jgh_CommonStockAdjustedForOfferingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jgh_CommonStockAdjustedForOfferingMember_doc" xml:lang="en-US">Common Stock Adjusted for Offering [Member]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>jgh-20251015_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#N2Cover" roleURI="http://xbrl.sec.gov/cef/role/N2Cover" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#N2" roleURI="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" xlink:title="995470 - Disclosure - N-2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#cef_ProspectusLineItems" xlink:label="loc_cefProspectusLineItems" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="1000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="jgh-20251015.xsd#jgh_CommonStockAdjustedForOfferingMember" xlink:label="loc_jghCommonStockAdjustedForOfferingMember" />
      <link:presentationArc order="1010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_jghCommonStockAdjustedForOfferingMember" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>jqc424b2001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 jqc424b2001.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  G * # 1$
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M&D&(-?HC.'_A^?#XYRIZ3TRK;G*4_-;K^J;RKGA">.>>>5..:KS\DIX^?/\
MKY^7''SY]1 W]3]UA^H__8KO;IQ5.K%#ZZT*D=+)='E=;ZJ[:QE"3G5TD:#5
M(<AVY6 G;H,*TS3MEFSI+%T(6#\BQ,,RGA\]<B!PF.U':C-2JF2:WS56[F/\
M9C/?^YQ4_P#ZI@>BZ_\ %_Q_^58W>;W^$[WF_P $R'_G@7HN5GK;\S>X0;/P
ME?\ $ST3_)[J/\T\-]%T8_H'S#L40AY9O#7WI\IN@5]5M[7]>:-BV56*\3<6
MHHG(KLW81HFX.!V7)5]L3EJ)<V2T<#:^*B/RAB P)M:)3H\)$YEN\J+)CVLR
M))O41R6ZO$'XO.[/B_ W?)9_9W"]2P"W3K3?(].1EEM@VD%KA:N :^./CK.N
MQQ>>*S)8K09%EKTQB;]RU"X=!O!I\J?*EE#WM?6"#:XMTNHO>Y'PU7=SO/V*
MO_9W;^Y_7=.BZ)S7FRT2G8]? -7&PJM60]1!C@HN59RTUB)$# X+:ESBI&;)
MD_7E2ICSSRE>BNW%:T0&NYD(C[QRX%VWZPX0#PSM'M>4;B.S"M4>AXY8\\SX
MW13PZBT\$JOL";V\1,SA]DG0Q\$##$EAXH3-<8B3'CKQ<A*XF)+)Q!,M! .1
MK50/>8#X;&Y=UNR5G[5=3M8S6@W'4$BY>J9UKOZH$567:18R&%<N-5M--KER
MGPWCX\?!=.5^?5E-+.-3SC)W^V'!\(M&8NR-EPD"Q%^'A6Y<_P##1Y(=<ZN7
M7K[Y O)'.U.JP\>M=$QO%LQX)#\Y8NO-.(!\OMNY:LFGT'6=@K>?V582SMT4
M_#EQ214 ,E%C!B'&="S2J7MF6M@S))))Y:<5QYT_^&+[C=/]MI?87)?(EG.9
MZ?2%DDC"P7 2>@#W8!L7+"'1!0):KJ!%F!183/EPI,:9'2MOZC<R$[#)18<V
M.5W8H<(+3_VB.%"C&J2.M(BF5$3>;)!N5V&5@ .N%O& $U,;:[3"%1(U@L@^
MK()&45J"=+-2RD0 @N52&8E-CDDIW$;B4Z6"'K\W?@L-^4+1,;V7'M'H.3:=
M2*H9SZ_$+P-/2X%SI[9-)RD)CKKD.7(9*5<H3MS3CDME?$X>>C,\/LI$,-/%
MIAXFQ(B0<IC[[E-7U ZX5?J'U?POK33^([@;',XKM.=(1F/MD'S\6)Q)MUK=
M8_Z<RWVR4:M$]/RXX^^+R.>$IXY]O!4)DDG-/;=\,RSLOD-^PG:ZG!N^7Z6!
M?KMMK9#EUI$N&ZXU)C2X<R,MJ8+,"",:&8!&1[\<D%,P(!4=(CS8;#R"@$@R
M*$(.6R?"]]R>L.\P=O\ &=W?JU.G@",R;39NKR;=G^@58?-2Y'?KQ&RY_3[_
M %R_P)4):H19).I5D,=ANNPB5<7'Y6E\M_U01#VSP_F_-255;Q<>5OM>)A4#
MRM>2(/;NOJ7XCMPP7J?4PU#YV&'%=;?YK^BZD)R_'S+59FN,MH-@(U<-Q23/
MSY'R 9-N,78*A<P>AI!U)F-X%:YSD;*>]S!L;=Q)?6Y6;U/C"',]5E"LL0+9
M;J'&=J"\UWFJ(&-^U+8S@/S]FGAM29"./D^E_B3QP]P6<F9SO.]!\[9\*SN&
M3;@/V_QG]OA.9S*_856>AB-;(W2I7',YW"W>40P6KYT"MTRQP6V7WH#/Y:G"
M9;HEQ0P[,/\ UYLV46XQ@1#VSJ1%>5![J0*G^-CS:]C:[^R?R(^4:K#< (1T
MCKS3>IM+KH?2M.KBT\1Y]6-:K^QG("%:'EX2GH1=QF%;H1>"[(AF A!,MQUH
MJEV&*M97]UAR!^JF9-=>[OAO5:N=?/'DYC6!SZ"-#5O/%:53+)>Z-7J\S*<?
M/2I08'9:^;-VPLY(EE73Y@Q/<)V*;--6)HQ)F2E.EG,F729O%_="9C/A4NX8
M?9!^_#^]F.L:L+TV)L$*S\939U*9T*%:6[I&/?CE3N1:N6[(T@A]DJ'S YYX
M^AS&YC_[+T6_ZS8V=DQ$7%HA$"=X>G?D-[B=*@'5E?8WK)3[)H%6L-9[47N/
MC=[=BW2.BR B=03DXUR\2T49A\2-G0[U^;CV&01ERVGJP]6F&^6>2R:6M=,$
M@5%1[TKK2.:AVZ*_#N]^_'?NT?L'UW[M==&KG^ES%),"[KB]WL=6LE2/2Q)$
MB",P&+*))HCN$P04BW+#&1!1B2-8X:GI87)8?+1V*UX@M=K0CS-%FNZI6&=9
MA8X[S-1:2%)(7B'(5']H>1!%E1PN>*:(<K]CA^,DK!*/BD)YD-!Y+)%SA,=U
MM2IBDKGFL><.Q3?TO8W,U(1X\N@6PR)E$LS!,V0>Z!C!GK#JE]YST$$CK)%H
MDN1+&%'!Y&Q*;B\L# Q8=)0Y)D2.(GH!.8SIP$H21E-MUZ?RO #L\DMH-;SD
MEG%PK!NQ5:]V[ZIN16^(PT7G]Q&4HGS)3!-3),A1.>= D@#T!B5#)@BT<CQ*
M:^F\RA&\&UIS$Z>0HDR!%YSM'@ZISTW5*Q>+=H]+#\S4F,R+"AAGF7'^C&(,
MEX+KC!4,[[U<S!C1H=9:K(D<H;^G8:H>A<)4F*EUP1$;_/LI!!)&GG=*C:K6
M- L6D5D'S-03S&SLU@VB;'^W1,<?&QY:"PK]]2Y(?DDDW743%I:Y<-5@XRVV
MIB.S(?$$03G4(#,[O/.";-EVR.*GZ/ K-+L]]=R07%(7OBNN!678TV8#39H]
M7 L%B<!1ZV?IU^ ;>&(5#A-PBHMK@JX3F('<(M4";?G0>6JHFI$3%X6R>+K4
M."K0!ZSUZ-878Z97%>D&QC1U+*H+A/E:A*Y7$[A*![+TU:OH>U,1EV3[OH-K
M7Q$&\4U5IRS383MF,J:<?3KF8J99;@O.O)OM5Y:::)NN,C77'."WL0V0>9>:
M@K5SPF6ZTXVQRXI"N.)@Z'HHD:CJLVK1L]38/TDJ^4Q-JYGI%<5E5H"<6#\F
MN'^00._#<SOR/WZH']>3#^V^X5#_ *SPWRS^_P"H@WBFJF1::Z+T5H-"3P?Y
M5=Z@GBJ1WI=IY590W'%:B1Y,N&_*/\\S?['CL2Q\^*\\1^V;;DPI;"U)=C/)
M0A)&MK[E\,;5,PFL\R(>CT*7'X.0:SR_&N%>?9XLA-GB0-K_ "ZT16C@X0CJ
M2_!$^[[^6RKAUB.XCGA7J8.AZ*)&HZIU"S08XS)D!"PPPQ#GS!4MX7/BD&8I
M,<]S'(#I+D1UY#$^#(2IB9#=4F1%>3RT^VA?'*?4*5D_1$O1$O1$O1$O1$O1
M$O1$O1%R&9PV^DS-6TJ.]78>MU_8YMZ>E<WJ\/U"92YXN34)E70&<"?C(Q"9
MG/(NIR"$>NLJ44"0;>X_(?4Z%YM(J*Q&Z9ONSF!*K!D&DSJ;6TT[+:NY42SZ
M'5J^$JR@+4P3I677R0Z?($($9<?-M KE]_'LJ'!R[JGC#E=0)^LMMM$!$Q4_
MV3%1N(,B!OT/N(4F<M1?=58VS4>_2-F :C7FJ@[& Y'?,_9'F31J(^^9N!^C
MV2,0<^RK4YO@8.ET:/!?:2_Q*F1RKTMO[5P>B+."(@S<6W3OWJ*S-+:G.-VY
M:V$X9H='ME3OM"E5I5HYRVP4C2D6V[WDP,M!Z>2CV0"?@MR T[B"V#M[MF..
M1H,8/'G,W2PCVX4)Q48@W,@T,Q-( L*=D@BHB8K)-S7NLY1<-L&>Z74+M7I$
M% Z3EJ:%J\,O=;=9)QXF-*(-U<V"47&+CM*KY&;;^5(YY#QB35V)*2.&NCVE
M31,@\9% ./6FMN* 1$:0:G[9<KY)PP,XO](T/4;+09M2FU_8"06S%H=H?+PY
M],N8RK"*7+."61@X@S;1)0+7@,IZMS9]3>CDX$SZ-B^V*I0,B1 W:9UGE[I!
MK$5UR^\\DW',&LG-DDJ_.BI->D[V(WU9A]R8S;>20FJBPO%0YC,#^1W$&41$
M1TKL*"*5LU&5(JR*XYRTV4<F>NSL[N?VU2-(OM<_SKOLM7.=6K^[1WZHJ;0T
M29/77><37-20-*::)[):H)V*<2WS5T..00L<>GF7&Y4U(GS9;O#:XZ&>'Y$[
M0DG]S3;0<=_L% :=WI(ZGAP6,' Y&K;%O.:,SP0]T)=.KUNM9%EXT^9$2\XB
M56UO1*YP^ A09RB1*MLA(QMXH-DC8TZ64X$S%-M0G4P&G<X;I,CVF3K0)!)=
MQ;GI4QX$[8777342+U)(EJ/)D6W*]AS9+L&87$#T2+]<)MG"'VJW!K;80&VV
MP1=BGQ8QE^;)(QG3Y"PV<L;G28S:%*6+3TI?W'2 $V36U01]J?3G4IMZ-GZZ
M57[1%N18('*:S7\+RO(7Z[R7*3!^YY:(MEEH1%7U00Z'"C*M,&','3ILJ)#C
MM!&&BDB(U/YXB!7E)=E0P#G^4(CG %9J+9:^!=R5<)S70 T2Y(3,EL-./E""
M6OH?E#4]]T@<+J8][G#+A8Q*G$G64K4AIR4M"/W$IXXHK"@[\<_=9_T4I>B)
0>B)>B)>B)>B)>B)>B+__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>nuveenlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 nuveenlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ^ ,\# 2(  A$! Q$!_\0
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M@4"/N&BOD[]CG]M6[_:B\7:_I4VD0Z=#IMF+I&CA*,W[Q5P297_O>@K,^/\
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M'U&UOQK]S_A+\;M)^(_P/T_XA;TAM&L#=7:!O]2R)N=#[BO@S_@K'\"_[/\
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M5^J= ;,_.W_@D?J'B'3;#X@^'=6M;JWT^)[.ZM%G0J%=O/$F,^H6/\J^6O\
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M.@_%[PQJ&G645G/?Z61<>2@17*2-AB!W^8\^PKZL_P""6W_)K=C_ -A"Z_\
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M'([=^?>NYM;.WL8_+MH([>/KLB0*/R%10Z38V]TUS%9V\5PWWIDB4.?J<9I
M>9:;XBU>;^Q;DWL[WUWJLUM=6)/R11"5E.!VVJ,Y[XK,TG5-5N3H+2:_?'[9
MJ<UG,/-&!$(RP(XX(('/O7L:Z?:K<-.MM")V^]((QN/U.*B71=/7;BPM1M)9
M<0KP3U(XI@>46/B#4;K3?#:W&M746_5[RQFF$H5I(TN'5-QQUVA>:5O%6J)I
M_P!B?4;O>NI7,%K=?=-Q$D;E=\G;L<@') &.X[/Q3\/QKU]I$MI=PZ9!8W'V
MB2W6R219SQG/(QTZX-=-)I5E-#%%):0211',:-$I5#Z@8XH$>70Z]J6K:?X*
M,FJW%L]Y)-%=&"3!;:^!G(ZX[U!!XBUBS\+Z9KK7]Y>0:=J,EI>0JV6N(2QB
M1CZL'9#GT!KU9='L%V8L;8>62R?NE^4GJ1QP:R+_ ,)27.KV,MO>1V>D1 FX
MTN.U7;</D,C;P05VL >!SBD!H>';:>UTF(7-Q+=3.3(7E;) )R!^ Q6G110,
6**** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>stradleyronon.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 stradleyronon.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "% 1(# 2(  A$! Q$!_\0
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MWX-D\=2_';7/A[KGCB<^(=3TC3+%7"23#<H=F<$L$V@\8'2O3?\ AC'XW?\
M1V/C#_P71_\ QROL:.-8D"(H55& JC  ]*=0!^,/PZ\,ZU_P3C_X*":#I&OZ
MV-4\.^)$$$NK;#&MS:W+E0[ISADF4$@$],]#7[.K]T5^>O\ P64^$:>(O@KH
M'Q$M=L6I>%=06&64-M8V]P57 ]2)!&1Z9-?0W["?[0EI^T5^SOX<UG[2LNO:
M;"NF:Q#GYDN(U W$9Z.H# ]\F@#XY_X+@?\ (-^%O_7:]_E'7Z2_#'_DFWA/
M_L$VG_HE*_-3_@N!>0>1\+;7S4^T[KV7R=WS;/W8W8],\9K]%O@?XKT;Q?\
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M ,8OVOM&\ ^-H/ '@_0K_P")WQ+F!;_A&]"=!]D7&=]U.WR0#_>YY[9%<_\
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M[#_BC4OCI:>*_A9X#U37++Q);M/J<>BVCS)#>J^'=@HQ'Y@96YZD.?6O)_\
M@FK^TMX_\'_M'>#/!B^(;[4/"FO7']G7.DWMPTL$:E&*/$K$[&4@?=P""17U
M?_P6$^.7COX2M\,]+\'>)]0\-VNJ)J$UY_9TIB>9HS J L.< 2-Q[T ?G3J'
M[%/QYTL,;CX2>+ JJ79H],DD4 >I4$5Y)K6@ZEX;OY;'5K"YTR^B.'MKN%HI
M%^JL :^@OAG_ ,%#?CQ\+]0MY;3QY?ZU91L"VGZV1=Q2 $9!+?,,@8R#7Z;?
M#N_^%O\ P54_9_OI_$?ARVTGQ?8#['<SP*&NM,N"N8YH9,9:)N2%;@X8'UH
M^L?@[_R27P7_ -@6S_\ 1*5^=_\ P7"_Y%CX4_\ 7Y??^@15^DO@G06\*^#]
M$T1YA</IME#9F91@/Y:!=V.V<9K\VO\ @N%_R*_PJ_Z_+[_T"*@!/V(/^">/
M@?XK?LU^&/&>O>(O%,&J:XL\S0Z7JC6T$*K-)&H55')PH)SGDUX+_P %"?V"
M;S]F6STKQCX:UO5_$W@V:86]PVJR"6?3ISRFY@ "C\@''!&#U%?I'_P3;_Y,
MG^&/_7I<?^E4U>Z?$;X?Z)\4_ NM^$_$5HM[HNKVKVMS$PYVL.&![,IPP/8@
M&@#YT_X)T_M3Z?\ M'_!.SM+@6UEXN\-(ECJ=E;J(U=0/W=PB#@*X'..C!O4
M5]7U^"&AZAXP_P""9O[8DD-T;BZTVTF\J=5RL>K:5(W#@=-P'(]'0BOW3\$>
M--'^(GA/2?$OA^]CU'1M4MTN;6YB;*NC#/X$=".Q&* /S%_X*':X/$W_  4(
M^!?A>\=O[,L;C32T+']VS2WH+''J0JK7ZJXQ7Y'_ /!8/0=2\!_'SX8_$NQ@
M*1?9T1+E>/\ 2;:?S%4GUVLIK]3/AKX[TWXG> ?#_BO1YEN--UBRBO(9%.>'
M4$J?<'(([$&@#I:*** /FW_@HGX%M/'G['GQ'@NSM.G6/]K0,.HDMR)!^>"/
MQKQ?_@C/KUYJ?[,NLV$\F^UTW7YH[9<?<5XXW8?]],3^->[?M_>*;'PI^Q[\
M49[Z01K=:2]A%G^*68B-%_-J\Z_X)1_"VX^''[)VE7U[&T-YXFNY=7V,V<1-
MA(CCME4!_&@"U_P4<4MH/P9"@L?^%AZ3P.O^L-5O^"AG[#-I^TYX0/B3PU!#
M:?$G1X6-K* %&HPCG[/(?[W]QCT/'0\:'[>]Y+#XE_9W@5\0S?$*T\Q?[VV*
M0C]:^MZ /S>_X)O_ +=5[JUW#\$/BM<36?B_36-EI-]J&5DN/+^7[)+D?ZU,
M$ GE@,=1S^D-?GM_P4F_8/F^)EK-\6OAQ;M;^/=,03ZA96?R/J,<?(ECQC$Z
M 9R.6 ]0*W_^"<O[>L?QYT2'X?\ CJZ2W^(VF1;(;B;"?VM"@QNP?^6R@?,.
M^-WK0!UO_!-;_DG?Q,_['[6/_1HKS/\ X+2>++O1_P!GWPOHL#[+;6-= N !
M]X11,ZC_ +Z(/X5Z9_P36_Y)W\3/^Q^UC_T:*X[_ (+$?#NZ\7?LQV6NVJ/*
M?#>KQW4R(F[$4BF)F)[ %E_.@#ZM_9YTF'0?@1\/M/MUA2&WT&R11 <I_J5Z
M'TKT*OF?_@G3\6+7XL?LF^!YXIUDO]%M1HM]'NRR2P ("W^\FQO^!5],4 %9
M7BK0;3Q3X9U;1[^!+FRU"TEM9X9!E71T*L#[8-:M5-6O(]-TN\NYF5(8(7E=
MF. %5222?H* /R=_X(ZW-SX5^/GQ9\'B9GLXK4C:&ROF0W)C#?7!-?H)^VE_
MR:7\6_\ L6KW_P!%&OBW_@C[X-?6O&7QB^)I1DL]0OOL%IE?E;=*\SE3WP"@
M_&OLK]N&1HOV0_BXR':W_".W0S]4P: /.-3_ &6_#7[5'[%/P_\ #>N1K9ZI
M;^'K2;2=7"9ELKCR%PWJ4/ 9>X]P#7QC^Q]^TUXK_81^+U_\#_C$LUIX5:ZV
M17,A+IIKN?EGB)ZVTF<G'3KV85^I?P(_Y(C\/QV_L"P_])TKQO\ ;F_8MT;]
MK#P QMU@T[QWI<;-I&J%<;^YMY3WC8_]\DY'?(!],VEW#?6T-Q;RI/!,BR1S
M1L&5U(R&!'4$=Z^5O __ "DG^)O_ &(VF?\ HYJ^5/\ @GO^VEJ_P4\8-^S_
M /&=YM)%G<M8Z5?:DVTV$P./LLK$_P"K)^XW09 Z$8^J_ __ "DG^)O_ &(V
MF?\ HYJ /J^BBB@#\V/C%I?[+G_!131[+Q+8_$&Q\!?$!8A#]HOREO<$#I%<
MQ.5$@!X#JW'8D<5\IZY_P2X\5Z5*7A^*/PXN; \I>/KBPJP]<,/3FOBJG-(6
M !/ Z#/2@#]+/V0O@O\  OX"?'KP0FK_ !(M?BA\3KR_%MIFF^&%9M/TZ4J?
MW\LQQO(7.!QSS@]M?_@N-_R&O@]_U[ZK_P"AVM?''[ __)XWPH_[#*?^@/7Z
M:_\ !4']D?QI^TU-X OO"5WHL T-;R&XCU:^%J6,QA*E"PP<>4<C.>10!^)E
M?I9_P1%^U?\ "T/B3M,GV+^QK??_ '/,\_Y?QQN_6N!\#_\ !'GXO^*K@-?>
M(/">DV*N%DN([]KML=RJQJ02/0LM;OQ:^,FC?\$^? _B7X$?"RWU.X\>ZA@>
M)?&FK6WV?.Z/ %G'DG;M8A6/ R2"QY !^S4<B2HKHRNK#(93D&OR*_X+-?&3
MPOXR\0^"/!6C:E!J>K:"UQ=:B;602);F4($B8CC?A<D=LBOTL\+^#[#XA_L\
MZ%X=U:2Z%AJOAZVMKE[6X:&8J\";BLBG<K>X.:\3T_\ X)7?LZ66YI?"-[J$
MS_?FO-7N79CG.?O@9_"@#F?^"3WQF\-^*_V7M!\&0ZI;+XE\.S7-O<Z;+,!.
M8WF>5)50\E")-N1T*FOMZODB;_@EG^SZMXMWI_A[5M%NE_Y:Z;K=U$?I]\X_
M"OJ3PSX?MO"?A[3M&LY+B6TL($MHGNYFFE*J !O=B68X'4G)H ^4/^"D?['L
MO[3GPKBU3PY;QOX[\-AY[!< ->0D9DMMWJ<;E_VACO7Q1_P3*_;67X!^)+KX
M4_$:[ET[PM?7)%E<7V5&D7F</')GE(W/7LK#/<FOV8(S7@/QH_81^"GQZUN3
M6O%7@Z(ZW*<RZCIL[V<TQP #(8R Y  Y8&@"[^UI^SSHW[67P-U#PUY]O]N=
M1>Z)JBMN2&Y .QMR]48$J<=CGL*^)OV$_P!I[4OV2->O?V??CQ%+X46UN&DT
M74[X_P"CPAR28R_0Q.V61QQEF!Z\??7P'_9O\%_LX:+>:5X+BU*&SNF1I$U#
M49KL J,#:)&(08[* *T/BY\ _ 'QVT+^R?'/AFRU^V48CDG3$\/O'*N'0_0T
M =S8WUOJ5G#=VL\5S:S*'BFA<.CJ1D,K#@@^HINI:G::/83WU_=06-G N^6X
MN9!''&OJS$X ^M?*^E?\$\=$\%LT/@/XL?$WP#I7\.EZ-KP-NG3H)8W(Z>M:
M=E_P3_\ !NJ74<WC[QCXY^*:12>8EKXJUQY+;.<X:*((KCCHP(H \C^+9U'_
M (*/>/\ 3O!7A&6>U^!/AV_$^O\ B< K'K=S&1BWM3_&J\_-TR<]AG[MT/1[
M+PYHMCI6G6Z6FGV,"6UO!&,+'&BA54?0 4FBZ%I_AO2[73=*LK?3M/M4$<%K
M:Q+'%&HZ!5 P!5N>$7$+QEF4,I7<IP1D=0?6@#XK_;Q^(WA;0?CA^S5H^M:E
M;Q20^+EU*YMW8'RX=GEI(X[#>X )]_0U]K@A@"#D&OEG6O\ @F?\"/$]Q<WF
MNZ'K&NZI<.9)=3U'7;N6Z8YS]_S. /0<5[/\&_@GH?P-T&XT?0+_ %R]L99
MX76M4EOC%A=H6,R$[5P!P* ._K\M_P#@HO\ L3ZMX!\3']H#X/)/IVH6%P-0
MUBQTW*R6\JMN^VPA>V?OJ/=NF:_4FF30QW$,D4J+)%(I5T< JP(P00>HH ^(
M/^"16M77B/\ 9QU[5K^3S;Z_\3WMU<28QND<(S'';))K[!^(7@?2/B5X'UOP
MKKUM]KT?5[62TN8NY1AC(]QP1[@5A_"'X(^$_@9I&JZ5X/L6TW3-1U&;4WM-
MY:.*63&Y8Q_"G'"]J[V@#\>?A)KGC'_@E7^T5J'A_P ;V]YJ'PC\22^6NJV\
M9:)@"?*N5])47(=.I&<9P*_6GP7XXT#XB>';37O#.L6>NZ-=('AO;&421N,9
MZCH>>AY%'C+P+X?^(GA^ZT/Q/H]GKNCW2[9K.^A66-OP/0^XYKYKC_X)O^ /
M"]_)>?#OQ;XX^%LLK;Y4\,:VR1N<Y^Y*K@=NGI0!]8,P523P!S7QK^U1\9=4
M^/%Q/\!/@G=0ZQXBUI#!XF\16S^99>'[ \2"25>/-<94(#G!/<BNG/[!>GZY
M(\7C+XO?%'QQID@"OINJ>(3'"X'8^2B-C\:]V^&GPF\(_!WPS#X?\&:#9^'M
M)C.[[/9QA=[=V=NK,?4DF@#%_9Y^"&A?L[?";1/ V@;I+33HSYMW(@62[F;F
M29P.['MV  [5Y%_P4O\ '5CX+_8[\=17-W%!<ZQ FFVL32;7F>1U#!1U;"Y)
M]@<U]25\^_$S]A/X3?&3Q=?^(_&VGZQXDOKILK%>ZS<FWMA@#$,2N%C''84
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MW\4(M?\ B1K_ (4>QEM&L;6*\LKJ0@K?Q%FCE=!V$<@"'/<B@#"_X5A\0?\
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KQ[X%GEUAIUU,:AH>IQM"=MW9Z7-FQ4_-Q(G&Z3^/'(%%% 'V+1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>N-2 - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="11">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 15, 2025</div></th>
<th class="th"><div>Oct. 08, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">0001615905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">424B2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Nuveen
Global High Income Fund<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FeeTableAbstract', window );"><strong>Fee Table [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ShareholderTransactionExpensesTableTextBlock', window );">Shareholder Transaction Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_809_ecef--ShareholderTransactionExpensesTableTextBlock_dU_gL1STETTB-XWWQ_z4tJYeLsjUfg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder Transaction Expenses</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt">Offering Costs Borne by the Common Shareholders of the Fund <span id="xdx_907_ecef--BasisOfTransactionFeesNoteTextBlock_c20251015__20251015_z5gwanZMGJml">(as a percentage of common net assets
    including proceeds of the offering)</span><sup>(1)</sup></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_983_ecef--OtherTransactionExpense1Percent_dpn_c20251015__20251015_fKDEp_zPLE8A7eBUP7" style="text-align: right">None</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 20pt; width: 92%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering Costs
    (as a percentage of the proceeds of the offering)<sup>(1)</sup></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_980_ecef--OtherTransactionExpense2Percent_dpn_c20251015__20251015_fKDEp_z71S6e6ZhwRh" style="text-align: right; width: 5%">None</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend Reinvestment Plan Fees<sup>(2)</sup> </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecef--DividendReinvestmentAndCashPurchaseFees_pp2p0_c20251015__20251015_fKDIp_z1Oltq02qti6" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F02_zle62FK0Fgf2">(1)</sup></span></td>
    <td id="xdx_F11_zQDtGIZiXKBb">Total offering costs, which will be borne by Nuveen Fund Advisors and not the Fund or Common Shareholders, are estimated to be $375,000, which assumes that the Rights offering is fully subscribed.</td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F03_zkWa65rVR6G3">(2)</sup></span></td>
    <td><span id="xdx_F1D_zX7ob0gNJsm8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment account.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify">&#160;</p>
<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td>
    <td><span id="xdx_90D_ecef--OtherTransactionFeesNoteTextBlock_c20251015__20251015_zV6ecFEyaxHg">Total offering costs, which will be borne by Nuveen Fund Advisors and not the Fund or Common Shareholders, are estimated to be $375,000, which assumes that the Rights offering is fully subscribed.</span></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(2)</sup></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment account.</span></td></tr>
</table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_DividendReinvestmentAndCashPurchaseFees', window );">Dividend Reinvestment and Cash Purchase Fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesAbstract', window );"><strong>Other Transaction Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpense1Percent', window );">Other Transaction Expense 1 [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpense2Percent', window );">Other Transaction Expense 2 [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_AnnualExpensesTableTextBlock', window );">Annual Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><div id="xdx_801_ecef--AnnualExpensesTableTextBlock_dU_gL1AETTB-WBQWO_zOYuGDr7ExJ6"></div>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="background-color: white">
    <td style="vertical-align: top; width: 87%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As a Percentage <br/> of Net Assets<br/> Attributable to<br/> Common <br/> Shares<sup>(3)</sup></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Annual Expenses</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management Fees</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_988_ecef--ManagementFeesPercent_dp_c20251015__20251015_fKDMp_zzGGfjMRB9Ug" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.20</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%&#160;&#160;</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest and Other Related Expenses<sup>(4)</sup></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_986_ecef--InterestExpensesOnBorrowingsPercent_dp_c20251015__20251015_fKDMpKDQp_zUO7xuhwzGQk" style="vertical-align: bottom; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2.16</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Expenses<sup>(5)</sup></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_986_ecef--OtherAnnualExpensesPercent_dp_c20251015__20251015_fKDMpKDUp_z2q7KxYaC2Wk" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.11</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%&#160;</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Annual Expenses</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_989_ecef--TotalAnnualExpensesPercent_dp_c20251015__20251015_fKDMp_z00ZuLpY61Rd" style="vertical-align: bottom; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3.47</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0D_zeZYgDU7X0V8">(3)</sup></span></td>
    <td><span id="xdx_F17_zqFUJIyW4KH8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stated as percentages of average net assets
    attributable to Common Shares for the six-month period ended June 30, 2025 (unaudited).</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0D_z7gP7arp7nK2">(4)</sup></span></td>
    <td><span id="xdx_F11_zKjaEorI4tU2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest and Other Related
    Expenses reflect actual expenses and fees for leverage incurred by the Fund for the six-month period ended June 30, 2025
    (annualized). The types of leverage used by the Fund for the six-month period ended June 30, 2025 (annualized) are described in the
    Fund Performance, Leverage and Holdings Summaries &#8212; Leverage and Holdings section of the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1539337/000119312525196804/d64165dncsrs.htm">semi-annual report</a>, Actual Interest and Other Related Expenses incurred in the future may be higher or lower. If short-term market interest
    rates rise in the future, and if the Fund continues to maintain leverage, the cost of which is tied to short-term interest rates,
    the Fund's interest expenses on its short-term borrowings can be expected to rise in tandem. The Fund's use of leverage will
    increase the amount of management fees paid to the Fund's adviser and sub-advisor(s).</span></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0E_zH6joYWD4Qsh">(5)</sup></span></td>
    <td><span id="xdx_F12_z9U7zJAY38hb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecef--OtherExpensesNoteTextBlock_c20251015__20251015_zheN3r5ojcp9">Other Expenses is based on estimated amounts for the current fiscal year. Expenses attributable to the Fund&#8217;s investments, if any, in other investment companies are currently estimated not to exceed 0.01%. See &#8220;The Fund&#8217;s Investments&#8212;Other Investment Companies&#8221; in the SAI.</span></span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ManagementFeesPercent', window );">Management Fees [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">1.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InterestExpensesOnBorrowingsPercent', window );">Interest Expenses on Borrowings [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="nump">2.16%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesPercent', window );">Other Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[5]</sup></td>
<td class="nump">0.11%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_TotalAnnualExpensesPercent', window );">Total Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">3.47%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleTableTextBlock', window );">Expense Example [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_809_ecef--ExpenseExampleTableTextBlock_dU_z3JZg0zh3Pvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Example</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following example illustrates the
expenses that a Common Shareholder would pay on a $1,000 investment held for the time periods provided in the table, assuming a 5%
annual total return. The example assumes that all dividends and other distributions are reinvested in the Fund and that the
Fund&#8217;s Annual Total Expenses, as provided above, remain the same.<sup>1</sup></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1&#160;Year</b></span></td>
    <td style="width: 15%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3&#160;Years</b></span></td>
    <td style="width: 15%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5&#160;Years</b></span></td>
    <td style="width: 15%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10&#160;Years</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td id="xdx_983_ecef--ExpenseExampleYear01_c20251015__20251015_fKDEp_zntPFca9yiTj" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$35</span></td>
    <td>&#160;</td>
    <td id="xdx_98C_ecef--ExpenseExampleYears1to3_c20251015__20251015_fKDEp_zCKBbwQAyJ8e" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">$107</span></td>
    <td>&#160;</td>
    <td id="xdx_98F_ecef--ExpenseExampleYears1to5_c20251015__20251015_fKDEp_z145oz8kH8P7" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">$180</span></td>
    <td>&#160;</td>
    <td id="xdx_98A_ecef--ExpenseExampleYears1to10_c20251015__20251015_fKDEp_zJOorvNNXNib" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">$375</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>The example should not be considered a representation of future expenses. Actual expenses may be greater or less than those shown above.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify"></p>

<div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 37px">
        <p id="xdx_F0E_zogCGKyrdQll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1)</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td>
    <td><span id="xdx_F16_zkBZTMB5ZdX8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The example assumes that all dividends and distributions are reinvested at Common Shares NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</span></td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYear01', window );">Expense Example, Year 01</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to3', window );">Expense Example, Years 1 to 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to5', window );">Expense Example, Years 1 to 5</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to10', window );">Expense Example, Years 1 to 10</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">$ 375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PurposeOfFeeTableNoteTextBlock', window );">Purpose of Fee Table , Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_804_ecef--PurposeOfFeeTableNoteTextBlock_dU_z1hWVATSQ52l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The purpose of the table and the example below is to help you understand all fees and expenses that you, as a shareholder of Common Shares (&#8220;Common Shareholder&#8221;), would bear directly or indirectly. The table shows the expenses of the Fund as a percentage of the average net assets applicable to Common Shares, and not as a percentage of total assets or Managed Assets.</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BasisOfTransactionFeesNoteTextBlock', window );">Basis of Transaction Fees, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">(as a percentage of common net assets
    including proceeds of the offering)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionFeesNoteTextBlock', window );">Other Transaction Fees, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Total offering costs, which will be borne by Nuveen Fund Advisors and not the Fund or Common Shareholders, are estimated to be $375,000, which assumes that the Rights offering is fully subscribed.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherExpensesNoteTextBlock', window );">Other Expenses, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Other Expenses is based on estimated amounts for the current fiscal year. Expenses attributable to the Fund&#8217;s investments, if any, in other investment companies are currently estimated not to exceed 0.01%. See &#8220;The Fund&#8217;s Investments&#8212;Other Investment Companies&#8221; in the SAI.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SharePriceTableTextBlock', window );">Share Price [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_808_ecef--SharePriceTableTextBlock_dU_znTbprxup8Ma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="jdc424b2a004"></span>TRADING AND NET ASSET VALUE INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table shows for the periods
indicated: (i)&#160;the high and low sales prices for the Common Shares reported as of the end of the day on the NYSE, (ii)&#160;the
corresponding NAV per share, and (iii)&#160;the premium/(discount) to NAV per share at which the Common Shares were trading as of such date. The Fund&#8217;s Common Shares have historically traded both at premiums and discounts in relation to the Fund&#8217;s NAV
per share. The Fund cannot predict whether its Common Shares will trade at a premium or discount to NAV in the future. The Board of Trustees has currently determined that, at least annually, it will consider action that might be taken to
reduce or eliminate any material discount from NAV in respect of Common Shares, which may include the repurchase of such shares in
the open market or in private transactions, the making of a tender offer for such shares at NAV, or the conversion of the Fund to an
open-end investment company. The Fund cannot assure you that its Board of Trustees will decide to take any of these actions, or that
share repurchases or tender offers will actually reduce market discount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; visibility: hidden; vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_488_ecef--HighestPriceOrBid_pip0_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaTjawnlijIk" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_486_ecef--LowestPriceOrBid_pip0_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zyomduCtHsVe" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_489_ecef--HighestPriceOrBidNav_pip0_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zstYx6w3jhS9" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_487_ecef--LowestPriceOrBidNav_pip0_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z0xGJsvwXc0f" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_484_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_pid_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zSapAyDehcpf" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_488_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_pid_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zooEAgHxynki" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Closing Market Price per</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">NAV per Common Share on</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Premium/(Discount) on</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Date of Market Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Date of Market Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">Fiscal Quarter Ended</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_41E_20250701__20250930_zdzUC7bdKc03" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left">September 2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">13.64</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">12.92</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">14.02</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">13.73</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">(2.71</td><td style="width: 1%; text-align: left">)%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">(5.90</td><td style="width: 1%; text-align: left">)%</td></tr>
  <tr id="xdx_413_20250401__20250630_zNVxSYsSweLb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">June 2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.53</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.89</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3.92</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10.94</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_416_20250101__20250331_zhPNlNZQwh07" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">March 2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.42</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.80</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.97</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.57</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3.94</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.67</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_419_20241001__20241231_ztLmcHbugR35" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">December 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.94</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.82</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.02</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7.96</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_41D_20240701__20240930_zxYlfw1xxEV7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">September 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.42</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.95</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.33</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.09</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6.83</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_417_20240401__20240630_zu3Th7tVGVi3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">June 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.05</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.18</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.51</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3.40</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7.16</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_41B_20240101__20240331_z6Km33QRVof9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">March 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.92</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.96</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.51</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.17</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4.37</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9.19</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_41D_20231001__20231231_zfymxGebu8Y1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">December 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.24</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.09</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8.52</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13.98</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_41C_20230701__20230930_zYVuOdEuj0V2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">September 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.99</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.17</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7.13</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12.19</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_415_20230401__20230630_z482sluLYF29" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">June 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.65</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.42</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10.53</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14.25</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_414_20230101__20230331_z8oR9EjfSsIa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">March 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.62</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.67</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.55</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6.86</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14.23</td><td style="text-align: left">)%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The NAV per Common Share, the market price and
percentage of premium/(discount) to NAV per Common Share on October 8, 2025,  was <span id="xdx_90A_eus-gaap--NetAssetValuePerShare_iI_c20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zeD00yrjY0M">$14.05,
</span> <span id="xdx_909_eus-gaap--SharePrice_iI_c20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbF0DfEChS13">$13.62,
</span>and <span id="xdx_90B_ecef--LatestPremiumDiscountToNavPercent_dp_c20251008__20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zPwAZbEjvA1j">(3.06)</span>%,
respectively. As of October 8, 2025, the Fund had&#160;<span id="xdx_904_ecef--OutstandingSecurityNotHeldShares_c20251008__20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zgwSi8IFiXDd">23,177,393</span>&#160;Common
Shares outstanding, and net assets applicable to Common Shares of $325,657,313. See &#8220;Repurchase of Fund Shares; Conversion to Open-End
Fund&#8221; in the accompanying prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBid', window );">Lowest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.92<span></span>
</td>
<td class="nump">$ 11.48<span></span>
</td>
<td class="nump">$ 12.80<span></span>
</td>
<td class="nump">$ 12.72<span></span>
</td>
<td class="nump">$ 12.42<span></span>
</td>
<td class="nump">$ 12.18<span></span>
</td>
<td class="nump">$ 11.96<span></span>
</td>
<td class="nump">$ 10.40<span></span>
</td>
<td class="nump">$ 11.17<span></span>
</td>
<td class="nump">$ 10.65<span></span>
</td>
<td class="nump">$ 10.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBid', window );">Highest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.64<span></span>
</td>
<td class="nump">13.00<span></span>
</td>
<td class="nump">13.42<span></span>
</td>
<td class="nump">13.38<span></span>
</td>
<td class="nump">13.38<span></span>
</td>
<td class="nump">13.05<span></span>
</td>
<td class="nump">12.92<span></span>
</td>
<td class="nump">12.24<span></span>
</td>
<td class="nump">11.99<span></span>
</td>
<td class="nump">11.39<span></span>
</td>
<td class="nump">12.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidNav', window );">Lowest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.73<span></span>
</td>
<td class="nump">12.89<span></span>
</td>
<td class="nump">13.57<span></span>
</td>
<td class="nump">13.82<span></span>
</td>
<td class="nump">13.33<span></span>
</td>
<td class="nump">13.12<span></span>
</td>
<td class="nump">13.17<span></span>
</td>
<td class="nump">12.09<span></span>
</td>
<td class="nump">12.72<span></span>
</td>
<td class="nump">12.42<span></span>
</td>
<td class="nump">12.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidNav', window );">Highest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.02<span></span>
</td>
<td class="nump">$ 13.53<span></span>
</td>
<td class="nump">$ 13.97<span></span>
</td>
<td class="nump">$ 13.94<span></span>
</td>
<td class="nump">$ 13.95<span></span>
</td>
<td class="nump">$ 13.51<span></span>
</td>
<td class="nump">$ 13.51<span></span>
</td>
<td class="nump">$ 13.38<span></span>
</td>
<td class="nump">$ 12.91<span></span>
</td>
<td class="nump">$ 12.73<span></span>
</td>
<td class="nump">$ 13.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent', window );">Highest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.71%)<span></span>
</td>
<td class="num">(3.92%)<span></span>
</td>
<td class="num">(3.94%)<span></span>
</td>
<td class="num">(4.02%)<span></span>
</td>
<td class="num">(4.09%)<span></span>
</td>
<td class="num">(3.40%)<span></span>
</td>
<td class="num">(4.37%)<span></span>
</td>
<td class="num">(8.52%)<span></span>
</td>
<td class="num">(7.13%)<span></span>
</td>
<td class="num">(10.53%)<span></span>
</td>
<td class="num">(6.86%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent', window );">Lowest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.90%)<span></span>
</td>
<td class="num">(10.94%)<span></span>
</td>
<td class="num">(5.67%)<span></span>
</td>
<td class="num">(7.96%)<span></span>
</td>
<td class="num">(6.83%)<span></span>
</td>
<td class="num">(7.16%)<span></span>
</td>
<td class="num">(9.19%)<span></span>
</td>
<td class="num">(13.98%)<span></span>
</td>
<td class="num">(12.19%)<span></span>
</td>
<td class="num">(14.25%)<span></span>
</td>
<td class="num">(14.23%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">NAV Per Share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LatestPremiumDiscountToNavPercent', window );">Latest Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.06%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,177,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=jgh_CommonStockAdjustedForOfferingMember', window );">Common Stock Adjusted for Offering [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">NAV Per Share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,006,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="14"></td></tr>
<tr><td colspan="14"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment account.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Total offering costs, which will be borne by Nuveen Fund Advisors and not the Fund or Common Shareholders, are estimated to be $375,000, which assumes that the Rights offering is fully subscribed.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Stated as percentages of average net assets
    attributable to Common Shares for the six-month period ended June 30, 2025 (unaudited).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Interest and Other Related
    Expenses reflect actual expenses and fees for leverage incurred by the Fund for the six-month period ended June 30, 2025
    (annualized). The types of leverage used by the Fund for the six-month period ended June 30, 2025 (annualized) are described in the
    Fund Performance, Leverage and Holdings Summaries &#8212; Leverage and Holdings section of the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1539337/000119312525196804/d64165dncsrs.htm">semi-annual report</a>, Actual Interest and Other Related Expenses incurred in the future may be higher or lower. If short-term market interest
    rates rise in the future, and if the Fund continues to maintain leverage, the cost of which is tied to short-term interest rates,
    the Fund's interest expenses on its short-term borrowings can be expected to rise in tandem. The Fund's use of leverage will
    increase the amount of management fees paid to the Fund's adviser and sub-advisor(s).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Other Expenses is based on estimated amounts for the current fiscal year. Expenses attributable to the Fund&#8217;s investments, if any, in other investment companies are currently estimated not to exceed 0.01%. See &#8220;The Fund&#8217;s Investments&#8212;Other Investment Companies&#8221; in the SAI.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">The example assumes that all dividends and distributions are reinvested at Common Shares NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AnnualExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AnnualExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BasisOfTransactionFeesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BasisOfTransactionFeesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_DividendReinvestmentAndCashPurchaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_DividendReinvestmentAndCashPurchaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYear01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYear01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FeeTableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FeeTableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_GeneralDescriptionOfRegistrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_GeneralDescriptionOfRegistrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InterestExpensesOnBorrowingsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InterestExpensesOnBorrowingsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LatestPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LatestPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherExpensesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherExpensesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpense1Percent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpense1Percent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpense2Percent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpense2Percent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionFeesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionFeesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityNotHeldShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityNotHeldShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PurposeOfFeeTableNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PurposeOfFeeTableNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SharePriceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SharePriceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ShareholderTransactionExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ShareholderTransactionExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_TotalAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_TotalAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478494/946-205-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478494/946-205-50-7<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=jgh_CommonStockAdjustedForOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=jgh_CommonStockAdjustedForOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>16</ContextCount>
  <ElementCount>33</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="jgh-424b2_101525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>jgh-20251015.xsd</File>
    <File>jgh-20251015_def.xml</File>
    <File>jgh-20251015_lab.xml</File>
    <File>jgh-20251015_pre.xml</File>
    <File doctype="424B2" isUsgaap="true" original="jgh-424b2_101525.htm">jgh-424b2_101525.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>jqc424b2001.jpg</File>
    <File>nuveenlogo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="6">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="89">http://xbrl.sec.gov/cef/2025</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "jgh-424b2_101525.htm": {
   "nsprefix": "jgh",
   "nsuri": "http://nuveen.com/20251015",
   "dts": {
    "schema": {
     "local": [
      "jgh-20251015.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/cef/2025/cef-2025.xsd",
      "https://xbrl.sec.gov/cef/2025/cef-2025_pre.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_lab.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "jgh-20251015_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "jgh-20251015_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "jgh-20251015_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "jgh-424b2_101525.htm"
     ]
    }
   },
   "keyStandard": 33,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 1,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 16,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 196,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2025": 89,
    "http://fasb.org/us-gaap/2025": 6,
    "http://xbrl.sec.gov/dei/2025": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-10-15",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jgh-424b2_101525.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-10-15",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "jgh-424b2_101525.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllCoregistrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AllCoregistrantsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Coregistrants [Member]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r97",
      "r98"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r71",
      "r74",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r182",
      "r185",
      "r187",
      "r192"
     ]
    },
    "jgh_CommonStockAdjustedForOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nuveen.com/20251015",
     "localname": "CommonStockAdjustedForOfferingMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock Adjusted for Offering [Member]",
        "documentation": "Common Stock Adjusted for Offering [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r93",
      "r189",
      "r190",
      "r191",
      "r197",
      "r201",
      "r202"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "cef_CoregistrantAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "CoregistrantAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Coregistrant [Axis]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r3",
      "r4",
      "r6",
      "r7",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r81",
      "r82",
      "r83",
      "r84",
      "r85",
      "r86",
      "r183",
      "r184",
      "r186",
      "r188",
      "r193",
      "r194",
      "r195",
      "r198",
      "r199",
      "r200"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r81",
      "r82",
      "r83",
      "r84",
      "r85",
      "r86",
      "r183",
      "r184",
      "r186",
      "r188",
      "r193",
      "r194",
      "r195",
      "r198",
      "r199",
      "r200"
     ]
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r169"
     ]
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r169"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]",
        "documentation": "The risk associated with changes in interest rates that effect the value of an interest-bearing asset or liability, and a servicing asset or liability."
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r100",
      "r166",
      "r167",
      "r168"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share",
        "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r69",
      "r70",
      "r72",
      "r73",
      "r76",
      "r94"
     ]
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r100",
      "r166",
      "r167",
      "r168"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference",
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r5",
      "r183",
      "r185",
      "r196"
     ]
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r142",
      "r148"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r143",
      "r148"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r141",
      "r148"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r71",
      "r74",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r182",
      "r185",
      "r187",
      "r192"
     ]
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001999371-25-015465-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001999371-25-015465-xbrl.zip
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MR(8!\5],J1WGPC]+5C_B5:;ZL[Z-_ 102P,$%     @ &6]/6\U[\PO  @
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M83_KM%O:;F5KX^./,[[U9IZMPP<='^]PT+]/ALJ_^MIWD;]02P,$%     @
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MSXS?EV)O-/8%2D[9B]4P]Q2'DTAV! \1A[V5$Z;)928LY;EZ4A!UU8?Z8V^
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MI/!;E'-_OB?F(>L(DAAX3!2[N63F >X25KDDK+ ;LRY6HK,)]L%HO<03"F!
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M9J+]W0W9SUDHLE_)8"6>WXK&\RL=[%WQ_'X$6\^<YS.6,#FX_0G)X!2SS"7
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M/TQA'HXQ$@.RLC] ,-M/=KYPNG"G>W*Z@VZ'3D6[)O8//[*[Q/!*.(97PLQ
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M&B"5Y!IQ[24ACY7F;V&C?4N,0$AKCT/W"/\J6),A9&3*4M\J'*);J];J+ZM
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MK JDJE]NRY;94]HT=T<;6#"?H4)0L$XW\QG\NM=^*5W0@"7>D1#_:AM^ !]
MVY#7N_E9O@A.F:O?;BY2NQ0*>VJ,YO-)ZQ4!8BF5\V@2F^3R@AW3?T?&PL_+
M-2E[7LHS]&GBFU2V.11'USY\)$=V0[O,;F#9#?4RNV'//<-;=%&A^!._P#_?
MF-B+!/_V&1V0<?'%')#^:L\6BUX;T@/"Q6&1,. >$^XQBN$;HL8Y*7V+<HC1
MO^N%,$&V.:#RGL<J+E/T[YC'"=$22ST#O#;P3HV[E=,<3H=2J+R9,R#3=A+>
MJ^;+5/]4BOF:9[D5183YEDC+Y4MW-.1:KY55?JB:WF-C:MF+-ZL(^X3>L@*!
M+LI[MBHO>B,GR,:4V#,7'$-$NH=M^W@]*0ZQ8'CUTAU1Q;M_ER'MY6.0]EBW
MW*:(.VE0:^?-7'@;9ZK!#2DV/%C'89?#/1?ULFWHJMO</?<8E&S_SM^I]PY>
M7^HH:7#_\:M4CA?1-*%F55NL#7!.1]PQ)Q3E0&HC%U(;9]46/KXU%]\NW7O/
MG.+-+5(\M^-P"T[#M7V&3^0OS&;" _9YY/-$7U(&E<8SJ!XL?\(:T:9E :>E
MT?MP'GGFS32E*?'2OM!ZW\%VN/ Y_#QO1:U3!V6QI/)MNB]\T[LG^41Y7G"9
M8+JWZ?B&2-B.Y%W3V[&4<A)_R:RM._BTAEX6#\O3*KK2.QC=+R)7#[\0SZ :
MP8.V.\/D*>R@;< 'X?\LFTKZ:]07**<3\PC9HB3CJ JX>E E!6OQV&W\XK%A
M9>HLK?9Z'!)CR316EF^<FHJG$#-2I"&YEHNC]/)!>"DC+? PR3"@FA^ZN2_5
M@A;&>5543I4Y'T,;;HS1*;::'@,.X5.8*ZL9H8I0@9-(+FS,CT4);%)?0%W,
ML.(CK+"'/Y:/P-?L165%B8#HC"\SEI>GP&K1L%,B('@YYCW+&<0@1O@LKL1)
M<UQVNGA_1.0G'Y;!XA;!+7ZRH$6II= BA1W8D01!Y2>6YZ)69$)GG OYFEB+
MY7GFO3N46:;L.[%>U/C(-RYT(^QIC;5LC GJCDQV?'RE(B,MF5.4THQ,&X0?
MMJ'F$C.R7%7_Y'JF*_NH(VMH7&B2O"18PQHKAKM[JJZ2FT)QGMHVE;_$9?]H
M29D+8SRV91/[@^.:KJ<EV"FYS:)RG7=UAJ]<O2]N(21(G[7&O^4:T"=&?:K=
MHA/=MX-)K$)-(Q4>^W?>\_Z$ML6D@:*.57B#6Z D$@K.B+S\^)6'(PKHVT+[
MXIR7?>=%+\BJ!L?4B*_ M3>^!KLHPR78T4CIT@ZK.#XP1$0IH%=YF83":%.=
M;6'NC(U[U\,E-.(?=O.+I8R!A;WFH\>4U '1#)CE";,*01=N**4D+KT8+E*A
M%D_)QM& 2)TY*S2 !^<.XI.TIQ#Z<#5^'GP9R%&) -QO6W^& DX@7[Y^:,RO
M7&!"A%G"E&!"ZU?7!G02S9 N[\WX<YHX]7 V;I?4U(2U?U2>JM3,<#Y-$ZM8
MSV$-)[2 ?.<^!,=2+S1MN7BN;@#6TDHBH3>ASI[DH<A%*N!_(!4+>1=.(.A3
M#X8W$I-MX#$2Z*XZKB9>O'2(3(6;$+PRTC]:_YM;(R3:>].?@7JJ?T1EU-,_
MV*X1).6J%J<6G3Y52\U3Z+52XN(ZP%!S7L#,>3%2B:VI=4$2@%A16,H,H#1V
M0Q&&7@&/S72QIG1A,"-?(FA))I"6)I0$AS$EWC8-ZC3]P"JMK=%K ^C@ X\9
MJ&V&)6WWT2,M[O1[ P #W* 6$SQ@H^D4[4=+ L=="I;'^FG;5#K.=+4#8]RO
M"'\T:!_>^\P),@-=U!K8"@/%**VI*F8\QE_5V2<B:N:RHFDB*K=<91X%ETWJ
M#*#T]ZG7O2@UEH:;,9Q8YCT1#<T#QQQ;AW=I)5,K5E?6DQH1+:G'R3#AK6_Q
M24N\%PY3)Z9AQ9836('-?I$<CL"'EN'0KR5B:2"_R_TV<%P2!K$F#6)^:668
MS%PDW0$-/0(<]38VZH95K>J@!AGH^L>9#UE843^">2CDE=3<^"THU;4(?G@2
MS1(73W3 @S16A.,)F9!KKXA?+RG5A?@=4YT<RCI<) 8Q-TU)+)]ZM/]E9 @Q
M!!O I4#8@TQU3!:8I!0<4G:S:(-R("S1IL?);O>9[.?3#K\/\1$R]?6):<MQ
M31'&[=_1 "R^RL"<&/98\IQG!G//D;!6"#RXWS3A8*,6 ;[KTC2]&37&8G-&
MEU<X3^!)$W5DKF?C&>!HPU\/#7N(W4!I6I)!X^IXT-9GW<&F,]8K=+"@FP!K
M>)=)(":[!GB1F/"C88"61F0P5,1C,&9FO>X.;.N.:?!LWX<FGJ(&I8?>&L]4
MX][PL_>B@2YB-JK_:*F704+_X;7EK*X\EZ:3NN: 6KX@?,R<"Y?6EA51TVPQ
M;L:1-/31C&0#Q3B H\CVN'>,&M(PGO9#A9=?8G**7_P:$X,CW0?A=A#=$.2(
M+[%HE+L .2H8* Y3ZFEQ^9$Y!'OPX+254,VVC86)IEGH58H90,A@+.80VM \
MOJ ML?WAO7PNI&4>I#E(=)O)+9=[$*B)X,A")C6<;Q5]X+G?T,LU K/:]#1X
MS"41X+A3H <K%@^G)U>8J)">*S@N?L+4"UUG\K81 L9C .(D&M4'GCX2-X^/
MC.U02C.Z&?TTL(0@B_J.0A%H FW1:4)#F7"5% ,D4]+G: %$PIX>1I$/%Q[<
M3FA)1"1^*+'YBN:(BQ9Q#@UT7M(?0Q,AQ>="/Z?PH!0_L8O8,[DJ<9#'CG;%
M78/GX03$3X"92Z:I?V6^Z&LNX%)D?,: TY5B,3J!$ EDP7:XK2;/D3*;D1.!
M2()#NZ1$UJ*.$ G8U/C&C&$Y791I1R.+.MB@*"?YXW'IBY,?D2\!/!^8TZ=3
M+WK92)>@OL!T(+JO0DD>&8PZJFBJ46N,<- Y&P,Y%A.CN'@'84Z=15DGJ%%4
MW-OHZSPXTT;(]"_F'UPEA;]<)&(;C)NRNXB9/BK4"7,E>@R72+8I"&IT1B,C
M3F<4CG)!2I&KBOFJ28O_WYST2"0"TQ9GQH*Q"OH%V1AD>Q'*T>4:<)8/E]1[
ME,?D9>=6ZQ!#T12<3%QWW)W-MZ MVT*.&TF/WTBX(#-&"!XQJ7RWV/@- 1<
MX>F% PIG"Y,(4#H;(U1FEJVA$;? IT-KBC"%KBAK9+*!Q,((8G-?N?J?2%"(
MV*7B<@VW+="4B&[=BBYSJJ<$?C/#[ :4$=8X+W$$%L:&9?M[P:,("3XC[D_Z
MI&_=L7,FP8DL?X[)330GV:QH/LTB)G>T"](1SR#')\OBJTBF?$!*B.^Q*A86
MNHCZ"^ F&<VEXH;JU(+K(QX7$B,6G6%]E>F^9_3AIGD**H#K4H:H#RUO.)^B
M]W6(I] C&9;"*W@Q#(?FC,9?<WS2$&99)\2W+#)4P,*_,JVH)\M9#ITP;-AX
M/W0RC.;,5L&<$^2XZ%1J?,"DRP5M&$#Z'2A$'@\QA-X!3<X'AMU,07GA[R^C
M)9^Q#)<<?<*VA-&$!P/I-F?RF8"BOEDJ9(HW9<)S!'S7)M.*FY,:19)9%ZVP
MJZ 1Q;4\LNBR1N<LYQ0_BU4.]=:\91W%!&'YK2:ZDX<A*L(J&CC>/4M$T$A\
M$2_R)3!W86JR0\ 'A"\+DP-M2:UBSD 4)89/[:;&K%5<N@@/I9]I>!B 6DBW
M#DW0=!;RX/-#D9)1@!*'=/8I)HN 2+=%>ZN!21Z8;+^3.+_"D\-QIRVS(4"E
MPJP(Q9T\9<KK*D]0.&4]N1&:X"U=>"R]2!#!3W.&5,!ZB0J#E"08VB#O+";N
M#8<3B%WIF,^VB*6')7Q/%?+CS0(VLY3TW TH(R.!@N3H<IF;,E&.G[=]/7"%
M=I;NR<[2M_W_T*!E_=FUBKZ=J&6GV M/^/%Y8V49!OQ:O:GJ8W-$OV.CM?3
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M*F3]RPI/2!ZP<B":1L!SAW@ICRP9HI&Y,SE#-\9 AN/,>0:Y;TZM4_YWD4F
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MU,N1T_U5&CMNZ9COQUE2=3V2WD6"5:_6:IFB=&(%YBE>6?"*XSYXQBS9+TI
MNCWN>?FC/Y^]^QM .I^]2Y4 RX_"OW$+&_+_4TF(5*IGK/(H,AVX9'G/PQ$$
MQA=3R9"XMN$3'U!M)O8YJ;]*,M !B9 ?-I$><<5MJ]*D46T7)4W65]U6S3?-
M</^L]:GX:-0O<]L\%2X&U=^1[6%HIEBX33H926\2O9!P):F *CIY _VN F9T
MB/!_JQZ1",SKH6IC\R:O@;;TXVN[EM/-@EJU05Z#+'&J/KE-V?6WK-.RO<^B
MR3]E"AEUXV8EGZS5/9M8R54O+$ 88=^S4[#T3WG;7\O746UX*>/D$0.?W!C
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MKXGPO/FO51K&)?\]9?%DR7\E_STE_V4FA1U!,.A9I!*KC4G?E U)2\!+P$O
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M3@>68P06_-(=Z\.)X=S!YRP'?X-O^.*-BNZ9%G7WA15'UKTU,IT1/$A-?HV
M%@7:J$\-C9F%P-P9EN/#.W[@68,Y?LOG;U1T:PQO+:KZ+0!C&WX0+CTRAS9\
M&[]!H,ZH%J:B/TRLX83@7\R0Q/8"+@6+=HF/C2T/5AG,?<LQ??BJL<"-T6_@
M_%&5C0X;"R857,/P_?D4OA&X^L!48>=U."9+IP50&8C&,)C#CL2#^LRSAKBR
M1T_GV0#(-80H,!W\XD 0"!_X,'=&?_U+MU'OO/51_'TSQ0=.$+..&^A6X",P
MKRJ$:WC),^'C)BT*RXVL\1A^Y 3ZV'.G[*NTP-P/X0"<#><VT1PV1>SB$;L
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M][;.^,WFOI,? W];1D)]3\G?V3KC=[I[3_ZSK2/A;(<WX#KD;V]]YZT-&;]
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MM9W()#H,R!O5;B(+XFD@SUQX"?@GS6JOL1;XKU[N"^CU6K6W/!$X"_:=9."
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M!BETR9CW)/^VB4_!G&]H4T13,WD 326MJ<1M3%PKM#(7H<'56[/?))=EU 0
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MG03E>:?S#P]L1QSL=T^)@E3K2PF;CD>U&B-H:85MN41 P)=)WH$>TI6G&C)
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M@AXP"I#.6Z'*&X];14AO)GS*?H:;4Y3I#)O,3.O(32.SNWIFUPQ7:D'@XM.
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MD% PN$_<)!/Y8C6Q:T9Y]EV4Y\7QZ=G)\:_OSH[?O#Z]93&>CZB&<LHO0A[
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M"_T,<L$Z":2G]63IFI&3'JT6:/718P*GB)R\'9G$_&4W$J_19<J2'O^ U*3
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MQ]*3 @>%9^G,IS;-%ZD+M0][HGBY3.'8<^G&)$Q(V_@$2LI)ZG(Z8,MH /[
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MD0VK(BL+?<2)F@23M#SGV).Q-;F.E#T$4U9=:"X+QBUS]8+<P (KU,%B1>I
M92)W41V9@AV;A9"L+P2,W9#(>45W)&6!.-F?E/ZK=?O? @/KPEJXWN7) 2O0
M'*D@5!7O4QZ(5[/WTU:V;;-5^<?D]N5K)=E?J&I,"I?J@ACMY_09D/NMNS70
M%&R7AJ0:/K,K^:5(4YI5(PW_B%V23=^<UA1J$G'B4 2+*?L.[)VO.\K6.1%8
M')XVJ5WOO 3?5K&.,#NW-7V7I-Q,VT6MJIW^#,O2&VOXXK=&L22"\W38=!LY
MN['66+C9^M;I]91T>&_364*Z'>UN+V#^)!MS(INKXIH/NN1LAP:BO^,A<Y=U
MM"P7?6646J:\(IT[K%S$]#_,(A*@AY:-$JS">#&[W9PBWQF85&2J2PG"O2%A
MNT!K0IM-MW6!YLTBV;/BRZO/J5,+XL-*HDGRM_.D+#TS6%6=Y30-/UEO%L5A
M$KC56:3Y 'P)A3OCA;#R\=V%QZ\+CC^Y#XYC<'S_/CC^%;M8K@9;7^IU[$E+
MHYYSYDDL+/0\N$0:5F1(BV8/@6H:RL>H>\"THAZ]-I/)<D7NQ.7\3@H%$WC)
MK!83X#<S4S08S<;!T)-OD@-JALG$_GNB693.6\,./DV)<_:'41<C+MAIO%@*
M/(U&!I;XPXZ<[D1 ]R[$-#"% B IT3G9YM^A6S,2OZ:JF+P16WO; I/&%G96
M3EQ57]JQZRY@"L)L!_32<E1URHY5N6R1C3NO*;PL.!RGV4DAE,\^M089%4,E
M-D.=P:I=%8%/6(\D8WW! :+]&]N/S45VM/:R9SFA(<+OB_(\F2KE8543T:ET
M(,%NI1WU3<D(]XQS.APPN,^X?AYIW03J6E>87B&VA[B6[1E)W:$KB(J=2D&_
MR,1F=BUS@*%7]&?J3UFFEPC<E"]8?Y E8B'9J)AAWSDRS37AU+G].P^F=0!U
M48/BY=-0G3[#CM,-@@&17O1?%SN(2,9!CG7((VYJ6)^HR$6KJ$)V&?T0':WH
ML,\=0[JC/!GJ,/0]-W]))EJX17 (-S1C'VXEVU&KZM+QX&[CE>M+7)IZP"U,
M^4A!+F4M0@[?,8]9G)O(K!9V#J- "3Z$WCGJ19SJ,B1QZ-B/<V+&T?PA^=KI
MP3&?<Y-WZUYUV2&1\CLS)4+#Y!MBH_$:7!CY"B^&JI)CMR1%1X6@,^A@1*4+
M%8]6/P2.C39G I8AUGN7"_J"WJ4EU_*N.-&7:RJH_YT7A K'EVGFRN7E$*BV
M8^9<-&'=:43RHR6^,!DNJ6TLWTDPKN^7*W255.YZ]H(R%F\E.9G+:23LYG6"
M!Q-.I$[;I#EP>0PPG&%&><\4Z>3EV+ _H3;+I2=IC[8>:SDT%S_BG7%ZD)/Q
MQ"1!O/6)=R/JM=[I-KKSCLBSBT;ON<ZPH AJ%L_.*<^$Q8#9MFU4[;3AFB>9
M85D_0@IP<!RM=)<5:!S7D5>/P^JL=I3#>0AZ;DX^EQ]+;;$@JRB#O)U.MV'[
M;?3(:_%B)&!1Q#&EU*F0\>7VF"](>]4E:4-=Y&.WC:^9X*/3SDC&J04J;81<
MJIY@K/F6],VZMO8G0(*6B/C&C^E7OBM7R=?UT:QVT3R]=]&@B^;AO8OFZ[MH
M@L-=CJSUQ"%KG1S_]OO9:?SFY<NCD^/7O]TI4*T;*FN,N7F6*<(53.B:4N0Q
M.E6FK&,,+PIJO84(.N]]DPN2Q2<*@K3^UW%X&W$*Z@<:P3@9/BR*,\"X^8);
MB'!\8_TYN% FFV4*@.L,/L75+QBI0(+9!%4*3UI= DR0"A-K71>2]2=!2BTF
M8(0Y/A23:85=FUCP5"]@=M&[O#;8!1*T+JL@!,HP"<<%:#1H9M%T4E)IACKG
M$Y^79/N KS\)TS"\"^VJ:L0UG0V(S@I.'PZ5(_6DKC\#3273)06?3(&W9 ,&
M']5T&5FS0KBW4/I!O=ID_8A(0#>P=<8!%ND2%XT%>NK)%J[_=0$:MNM 3=92
MNCBR;2#?9*]1\B%HQ)KOOFF5+6*>H;Z-3*%.QFA9BMNN.;+"T!8C(%'ORU'F
MQ3D#KHYX_1F(A4ID]'.,20DM(FQ7.@N8_WE1@'Z=X)XH%0GT]49%O[1>?^JB
M8B/Z-9UZ/$V1_TS3,4/"I1\8]R:@U.<P=9F[CK3^! 2$CY$LPDNGH5F#B&=R
M$1W>#@F,C-:?BLLK@ I:>RI:$^:ZE!5511=03'<X!?R>VRT#D,;SVJ:=@*V@
MUCR,:KSVU^=848_$.$"0,/AD43+&7SHE_ N,9(\PB%VG#B1BXCHZ&(:(TT>L
MDL'B(_<!08 %N"?]D);#3$TA_L!S]M!GEWSD7%"F1E4@J!I,90.^J&<K,/,(
M/H"--=C8Q062^ZZ^0!QGH0E$^[G[;C/#WSI1LE5RBEN3^5"!G4!)AJ"C0GN;
MRNYOU0&P.VT<EMRY#S4KL#JQ'/$5ANP?@5RZ1)WEY_O6HM]F<S%1+K."! ^#
M\QO>[J0$)@Y1*._Y?=.Y[X4N&ATUG 9?E#[[(.0_VNXGJ:IBR,W6@\Y7VE*#
MFO[,J2.-YX'&0*O"<;MH[K[SYS=)<Y0OYS2,Y<=_SW*^R>-W.BB7=E!/#F,T
M;E&=07W!T@H&&$HG&DGD'&_?T\IW0RL^R\22B//>6367BU_1H+BGC^^0/H0T
M; Z/AY+13'4FCWOJ^$ZH0TQD5UVWRC?I"BC$!Z/(_!S]5\0\!L7E[+M%:XQ[
MQO-=D%8VOL;+G5A$R3(]3ZBG*:&4M/R_ZA3EGF#CHFP$$30]]%-]NO?6U?=!
MF=[8;M"A6-L3L-A++,U^US_M@[$^(M3G;#I$[/ Z^1!"*S6-=TH7=4GXI=?E
MK[?F[LGMFR.WVL$N&6')_GMF1.U@@XL 3C"[Q9<MAL-P4B6-0\^G'V885]NR
MR!C3!<MW).Y.D_">X+Y)@ENEU'&N/,76$'UI!U,;AV4V$\2R[#++T_-V.Z?Y
M5!X<^,R-S.5+FGQ1EL3+1[XGP^^##$UX7GNWV8Q:2AWO:&;<E>/Q'%LM?#:S
MX9YV;AOM^%2QD*N<2'&D+[E4\=G#1*1:PL4>'HX &$=SS>NV2)'<"(0SNXA_
MB74BN!&=*EO_\[*N+]VN6A/R6PXB-I^D:-_4E071J*UJ&Q,1G0.)($<1F8XV
MS#@E):]>;+2&9SNIPL*DS&)X9E,JA#7X8^R%:#[#169=F0/-4[:,17OR#1;]
M<.$#YW_GS]6QPVB8SS3GB^H[<7W18%YAQZ;*]U "18P9WTBA^"Q7LW-?/G5%
M3*JI"DR^=<VG>@24,)_J'H^:ZR(#!CE'/WXW*Z:1>3\,8#I+VD-F#%.0Y/B8
M8CCIK^05D\WHDQFI1!!.&G\8)C8RA%^^D,[U MA :6^I_FTT#W[/:8?#HIP5
M)6<$89E1@95):3, >TY-$ZBYCTD[A0<CQ#T:)K4M3^S8?B:JL,;-E71PD:2X
M%Y1%.,)N%*(CM1981H4UIY@\189B/SX+4E0(WUM2K[A@L $ &4I/A\='_7[&
MS+<6H9(F1![9EN=@(0RI_U8AJ;15;'",&QFN!9>>2B,PW%$"]S4-U<D3PUW4
M[:-XC ,5_KH_'*^J>LWKR]6 UZ0 ?5>%*.M@=OQT7Q""!2&/[@M"OJF&%FO6
MECQUM26'1R=G!\>OX[<G;_X\/CU^\_HTAK^=_7X4OS@Z?'5P<B#]W*.SDW>G
M9_'!ZQ?<2]<ILA? R790HX?%3HNK,@']\]=_[;PZ^.O4-=^5<I4["_#\7]DO
MOW'S"2Q-Y<IR@1,(H"N"BL[!@A4&+M*WW20#%$P?4I;?.@AW#T;(G=7/RY3^
MBC"U@P*_)T4=0:GIJG[BC'_PN^)"3--,9->2UZ8A= +WERMK+B[0-'0LG,;D
M3L9,,"OQ+<!9I_"(\NH1-I*5IW:G4W&!2@S>&>VY!&#B5YGT5V3ZH3XS\1])
M5<'AS]'RJABD.JCE&*+2*0J#LS6&60E:(,)0$-P-D +F,(LR0G"7>4:<3!/2
M0Q"T ?"'1,"^?_?X($O.'ULMPD>EQ_NL1,T9O?UY COFC1-9<*Z+[/[V*!UP
M)WHS"=RD*$2UF19U9DJ5M2.='QR6? [T-G5V#UT,UCG]T%P578&*RUC%!#H]
M8@11CBFP4FPK>676BC7"][QS8QSN*5]XCJDA.4RFK,+3T_/:7G6W$0)"BDM7
M'&YNHPG7'@P515ZDMIV*PVOW^:,/_ QHK2?N\^I]Z[YR,W2N4@#E<SHD<-V"
MK27MR[+TS+/*G14B-UDRY5)U==U3T9<S%.=3#?M@*V6J96C,60YGD.89D&OE
MZZ>P1VV>712<Q,483^%GT4LQ*>KTSK106)[CWP"$8C)TY!?4E'4=/@60J2[0
MP=9V@20ZF!U\"H:><Q^F 5(RXH;J6]$2@G; \AIT4;0H'3= VS6$FY9EP7 L
M?\]'YXKT#A9=G;SG+%[L!$O]09*K?O2Z(&@:M7ZZ[FC/XQ^Y0J%$)P(\ _D:
M.R8\#5N(9/<HDZK%[XHT1$3([4G%7T6S=3S/<=)C^&%"H:=!(@57O?B\Q*LT
M3<_A4%();8(U^3X7KLHQ?.48HSF)18+<OO2V-G;)G0]K+=>0.?H3)Q.]']^,
MZ44D&>]>:]U]:2E[,*VSG3,@#(R21&\=1HQ7SJY3@EP0QP#,$+&2S&5&QG:U
M4 8,8E"G!3Y./0"(V2]]@SJ:$W/)KZ"=F<I/%$0*:8:@^O,J5"RMAM6NZ!LH
MWBG+M(C+FK3)*D<"ZN3\G-UTJ" &_=?^<,5F31'51E'**K]-^K1.<BB517FR
MB*B&;*9HJ024*JZO&5C/[F-M7*W6ZOKQ7XC+TPG3REZA;MSAZ/.!WS:@9Y=Q
M':_,"*C08+$FY%P+#HIJ(W2U&X'E1K)2@][L$*T$M3F D\(&7LD-P/$I&A]U
MWXH2A^1>-D'>K?W#^.T.DE$ N^P3KOI=/9=T EH:PL?!GDSQFD8!L!Y]H &V
MM^$,L,L7@\SWZ/R(=[N A\.=CY;BSG>)2]L 32X<B( YD!3>JK)*.U\VNXV^
MT$MB1MLPQ4=8DA<M,1.2V(83-UH] 5P]WN8>(ZY#LF-#BX;3$[7:&B\OZ0L<
MTYAC?$F;FC7CXDA\ZOB$[_1,2:A G"':8)*#H!TIU."UH(+19P85;& *]KR&
M2T$8U) V :!LL\3@S#=C#9&%*>Q"ZUR.K]V!7OG<X4GV&H"25QC[X6-.I $$
M$R^.%'G(O4S1YV&&6U3R):J,X#<16;&31 Z$>T<%2AC2 )V]P1BG3V.5+WT1
M*$>A[2.7H*TLN.$B;Z(":L1!WS.VL>T+'ECG'H_.HCJ..6(2&?KU;9C$H:.,
ML1>RQ5Z+2=G&A%<<:?/74AJ-5:[9>B,1@#)!;:.YPG7@V/+Q7[A(5= ,2)5A
MY"K"^UT J,WI:0]!6<)SYWX<)"?U>%5-75NT='QA#6G# &B6IJ2O*]*"QQ0T
M9U+1UL-\YZPG+ -EY6Z\#<C5JG6/\6NKL$'E+%HXJDE>%2[7UFM[GX9=NS$_
MZ-22F%W?"#-&>_7;8<:KT)'M]CI6&GFN\AJYE0SJZ=+8(%("@!"HJ-F+ B?[
MJA/?1(DD9M35E^.Z1@MG\L&PVD41:S>ZU'2#HQ4W6"PD-_CF]Y2/^[J+*E"(
M!)WD#8J+[-SI8<P.+3PWCJ"8-6*?==AB3=>4.5)A0YV$:[,KZ*;)7'CCR=IA
MOD;P'MHX+]AN:J[8P$#Y_H*]JV.]S^YCO1CK?7P?Z_VF8KUMQ]A;2=<#P7K"
M/,PURGP!HU^R #Q@UMK##@7YO((?1?^<EUDU8BQM8BGP@P4P*8P _$71O=6!
M3PD4N2B5X7\>IGY6U-*QST80*)A4.8>L-TR]DCKSRRKMLKB0R:TKT751M$J6
MA@_-)WY"KAH@\E%+.QU-M<6F%W_C)M2X"?U&L"ZK7 D+*?3B59M/<<@*YCE*
MX6B=/XUZ9O9 [4]\P=6\(P;H4[-@AQO!&6Q/ICA>/+HFL:D4E1Z# XS@L+1L
M;0ZH_OVTWXL2BK?.,] MR/*NN8MH$*2>PH 723Z.G1)/G]F^/OP]2H$(T+MF
MTD<U.N5F5XP[SJ[I3U#!7A*06IJG;M'.U7+9(6V7;6N$VVJ^*OM(WE>,$IVQ
MZ'8IKR4#QI$NQAE?Z!?.TW.PC[#&"7Y+,/RB:PDI"W@PI@DJ1A_KVQ+3DR[A
M:AWZ;%M8^$3<T GN/KM.1A9HT('/M?JGF6RZ&=SF8AX\%/%2!06MM>_]^*"S
M9UU:V0VY!V_Z1O/%P[R5Z]E(;P5OPM3&F@#MZ6X9VKVO7/XNB,FUA09B>+:[
M,THP2'J9P98R/EC/NIM<=5ULM(>&\UI%1]OPP@$N0;-G6-6T,_F(Z?"^:.J[
MH[U)BBUHLFJRFH"XORC]WOGE"-"072,$(YVQ=MNE4)&BZ#KP! "G]Q3W'5!<
M(#HSHPP[.%),:!LO)+[')!;B)JC26J9_AVU?182B\[.=YM_@J0WV1YY$K8#N
M(MQ[\OPNR-,SQ '!(5("EQA5/L/)='@W9BUW0<>?&PA[;@2+><""KB@"N*4I
MJMQ%"KXGM>^ U+HXH0OJ(#PTF]/+*4E)KYTP+XS0%VT!.S18YFLP2.^:)VF>
M3K4A?)=,SRJA>O(3+?6]MYEND-W(W@+)AUVI0TBLK3G:."LK+/JL. >;O"=S
MH$.2#[#;.)5"7#/SLO9+'*7#(%G+G0+.C#'+JGEJ)1(ZL21TG/!C260VV);S
MPEM9Z0LI?;IFTU^$6]15\'N7TW #=XB'^*>V7=*,D*)CR;3I^W+FM#E^=, U
MP6^61-JS]*Y71UBG(<:]UP=VO_X?VQ-AJ2NQ[6$VT/WZDJ]1":"+&H4J5'>A
MGE/*.LFF-[F>Q)G".@&^X?"#P+/)J0_<82!@-V9ZS4&(:[F,LU_U'K^"U7&N
M^$TNY#0-<*%"M^SIG'AS&1_JXD[GXW&1O\<?3.M%O(7OB&O=Q2IB&ZO0OI_;
MC7QS!P^$+OR;7!!% W![*7K@W%O8D((Z,)ABY+IV#9[[\9NEU]IV[#&.$<VJ
ML<U2R4%]DZL9I17(;Q>47K+'-$/R[H&=3,R.'=D276G(:J0^%>%S,JPQOW'<
MDFY7($]O<BT!_5><U)M,F9W^;9;C$I322TJB# 4XO5=UONA71@YX7)M6\,-(
M\QM=C(,\H,\@IH/IGRBM=8&X,$[-^5'=1^<2*W&2>7J.7751+%65< '?T[!1
M?/@9N/.(RP:SR8"26Q.&W,* 2"651^UR+)][)HVKL.8K['O-FX'D2Z?@-@6'
M\0'.&US./P-B.@!1UA.M:ZW+I#3CPX\^S"@E5$O**'V5RDTN)V?&GU+.3I)-
M5#+\W0P)D_(*&L&4DV7J0/T9@VE36@ _LP"X<43#KC4.BVF1:3#*32Y'NK^)
MIIM.X29QY\^J*TX8MDV2 MGO+GMF-53"P]W[]!E,GWERGSZS6>_,NV7=4?J,
M]@R+& ;GFH*RL/S2YEZJS<'BE,KWIX772J5:K&?Z&)>Q0YYQ2>22I%A8Q;%1
MF6+!9QR>I>^JDE0=;*X5!0'.'C;1#"%R0,BY-$:&T,0_!YV>>KB\=LLUW][\
MO$RFIMRZ7?%UIVW;$]=AN[K0 @IJ@BC"\-IR1+"ZQI@TXO*<L<^@AJW0N*#/
MRB$$DNQ&2YNCVX-0\I/O?GOT]MW)X>\'IT?QFY?QRW>O7\2GOQ^<')T^CP_?
MO/[SZ 112^*S-VO@DKQY>_1ZY^CU"P4FH<&^KV:Z<:SE(]=67E#ZN':W;.8<
MN9@!W7%G<V\T$:R*Q0PGK_*3A8!E,N)FK*2Q[O$4N$0RZ@(5HXD09KYJKIAI
MOM$\!(V?E%)&U>,")ZD*2N &3EU@KJ+6[CG5HQ=E *;(!;F(DPC/@#*_18&6
MC::B.=_S<NJKI@8+9REM]^+7!W_VL&5-KG7ME)#COHT!'[(30+H493T&'0RV
M&78UV^QP_CU/>!1.4O?9<BR=1@PNMG#0"[X0B;WLN*6]^)QA<]P6;]+O%_Y)
MA\6TF&1#JGO/O '%8D^.H!__FC(=J< <KZ3L+-V@KV4<DS <E\[Z9EI+:B85
M,-F**Q7!=#1K"%PLHOF(UJ^Q;_Z;LK.K9\I6IE-!:\AJ!<#F>(I+52"CC700
M;#.1O$^G<N'FP\TX" (VY*Y[ZG3A =^U(1N7@<!^-!KH!'=7N^!R;V\JR-^,
M?W!QN=.A.BD1N8'KMT&%8C-RP(=U)CVAVO><FKK9G8TI153Z<AO?C0/N)+H0
M:;ZD;&9IF=M&4Q'6;6!3AD 7&,ZIJ!_LHIA+?*[NHDLB&XP>B>I"&7U42K?I
MN50F';L0?P$W8O4'QIB'9NMD O B4;)0IAZ>DE;_AI-0OZRP/MY@*VUZ/89<
MT[5J[[.Z7<7K!>OZ7T<)TX8=4,N"W(>V]&V+OZ6H+"C -NLJC9G5&0PQ8F<4
M"B^Y)%D=U+T[L;;MH?T;.H'4Y@)OGIZG&_16)U :"H=*FOGK?X':2>RN2KG@
MF0NNY!,$0218W.2T/V?\)Q(40K[))NW5<](NSLG5GE6\RV!4Y<4"-M;R2PUY
M8>+WK. 27TFK7[9=O4VZ.7N^S&?)@KPVB?=)'A2&#HNJ=AS=$>"@**=4@<T'
MM$&C]2:J ,VF6>$G=0=I"4QW0B%]?)+SK[3+*%M)QU/&9@%1N<$%+*Y3DGNA
M5DS%P*NNYV;N3EL4;.JA.U3D &19>Y(O2ZG=@ =4'?6]6@ZI$JV<Y^0#@=M!
MX=-M*8.%R9'@H^0&G!S.>S+;+,8(DJ(\UZ22ROO_@U);*@C5L:WP4QV+]&<N
M".6-VK#9O1_=8%Q/Q.9 T&[S4<J\XUDC8DC%.$_Z/K6NW:#!^XRNEE,9&OQ_
M3#D6QX@5(+$W2C%RZ2;($7*:"B&+*Z/88 *(N"5<F8#AG)_?NJ04O<UL4V_%
M+=A( :\7,TPUPC.<GA-GG#)8#<QGCE4N#FK;):>HU?CF9F9 O;<N"$[9A6<Y
MJP@,$X)4@ _LC,$.$.-D7LO?7"T/P7(SM+=CQ^M/8.+ FI95(!-O-!P 8=@P
M#+)*V=R !E;P,T[G<HAR*'M<2E!2J0,,^#:"P3LL+;Q4&QR 0T[(R7I!^RX
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MP"QIC$Z6-Y>5J%&"P7Z_EY-&22:)TA@9R/U.1[,5#6/<C,"*#[D9=>"@@ZD
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MJE:41-&(TN?1TNX /YC5.LP9S.6,9--9:\";#"62W*PUG'=S%3PVI[ V.@_
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M?ST\9K%LEBKU^<E.(ZEU#W^Z?H1^>8<VIKSY?&E/[\!=8]<O&"&/3EYYVGI
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MS)"QJX]>A7]OJ;YU05$@N5Q'^E0PF*] CY=3)C<:^.^#.?IO4$L! A0#%
M  @ &6]/6UR&#4]D P  4PT  !               ( !     &IG:"TR,#(U
M,3 Q-2YX<V102P$"% ,4    "  9;T];4SF-Y-0"  !G#@  %
M    @ &2 P  :F=H+3(P,C4Q,#$U7V1E9BYX;6Q02P$"% ,4    "  9;T];
MS7OS"\ "   5#@  %               @ &8!@  :F=H+3(P,C4Q,#$U7VQA
M8BYX;6Q02P$"% ,4    "  9;T];C4@P%(@"  !'"@  %
M@ &*"0  :F=H+3(P,C4Q,#$U7W!R92YX;6Q02P$"% ,4    "  9;T];+["F
MCFU= 0!":PH %               @ %$#   :F=H+30R-&(R7S$P,34R-2YH
M=&U02P$"% ,4    "  9;T];!$![>;L\  !\SP  #P              @ 'C
M:0$ :G%C-#(T8C(P,#$N:G!G4$L! A0#%     @ &6]/6\P:R.5C$@  $A,
M  X              ( !RZ8! &YU=F5E;FQO9V\N:G!G4$L%!@     '  <
*OP$  %JY 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>jgh-424b2_101525_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:jgh="http://nuveen.com/20251015"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="jgh-20251015.xsd" xlink:type="simple"/>
    <context id="AsOf2025-10-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
        </entity>
        <period>
            <startDate>2025-10-15</startDate>
            <endDate>2025-10-15</endDate>
        </period>
    </context>
    <context id="AsOf2025-10-08_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-08</instant>
        </period>
    </context>
    <context id="From2025-07-012025-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2025-10-082025-10-08_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-08</startDate>
            <endDate>2025-10-08</endDate>
        </period>
    </context>
    <context id="From2025-10-082025-10-08_custom_CommonStockAdjustedForOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jgh:CommonStockAdjustedForOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-08</startDate>
            <endDate>2025-10-08</endDate>
        </period>
    </context>
    <context id="AsOf2025-10-08_custom_CommonStockAdjustedForOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jgh:CommonStockAdjustedForOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-08</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-10-15" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-10-15" id="Fact000004">0001615905</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-10-15" id="xdx2ixbrl0010">424B2</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="AsOf2025-10-15" id="Fact000011">Nuveen Global High Income Fund</dei:EntityRegistrantName>
    <us-gaap:SharePrice
      contextRef="AsOf2025-10-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000012"
      unitRef="USDPShares">13.62</us-gaap:SharePrice>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2025-10-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000013"
      unitRef="USDPShares">14.05</us-gaap:NetAssetValuePerShare>
    <cef:PurposeOfFeeTableNoteTextBlock contextRef="AsOf2025-10-15" id="Fact000015">&lt;p id="xdx_804_ecef--PurposeOfFeeTableNoteTextBlock_dU_z1hWVATSQ52l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The purpose of the table and the example below is to help you understand all fees and expenses that you, as a shareholder of Common Shares (&#x201c;Common Shareholder&#x201d;), would bear directly or indirectly. The table shows the expenses of the Fund as a percentage of the average net assets applicable to Common Shares, and not as a percentage of total assets or Managed Assets.&lt;/p&gt;

</cef:PurposeOfFeeTableNoteTextBlock>
    <cef:ShareholderTransactionExpensesTableTextBlock contextRef="AsOf2025-10-15" id="Fact000018">&lt;p id="xdx_809_ecef--ShareholderTransactionExpensesTableTextBlock_dU_gL1STETTB-XWWQ_z4tJYeLsjUfg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shareholder Transaction Expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt"&gt;Offering Costs Borne by the Common Shareholders of the Fund &lt;span id="xdx_907_ecef--BasisOfTransactionFeesNoteTextBlock_c20251015__20251015_z5gwanZMGJml"&gt;(as a percentage of common net assets
    including proceeds of the offering)&lt;/span&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecef--OtherTransactionExpense1Percent_dpn_c20251015__20251015_fKDEp_zPLE8A7eBUP7" style="text-align: right"&gt;None&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 20pt; width: 92%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering Costs
    (as a percentage of the proceeds of the offering)&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecef--OtherTransactionExpense2Percent_dpn_c20251015__20251015_fKDEp_z71S6e6ZhwRh" style="text-align: right; width: 5%"&gt;None&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividend Reinvestment Plan Fees&lt;sup&gt;(2)&lt;/sup&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecef--DividendReinvestmentAndCashPurchaseFees_pp2p0_c20251015__20251015_fKDIp_z1Oltq02qti6" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.50&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F02_zle62FK0Fgf2"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F11_zQDtGIZiXKBb"&gt;Total offering costs, which will be borne by Nuveen Fund Advisors and not the Fund or Common Shareholders, are estimated to be $375,000, which assumes that the Rights offering is fully subscribed.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; display: none; visibility: hidden; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F03_zkWa65rVR6G3"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_F1D_zX7ob0gNJsm8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#x201c;Plan Agent&#x201d;), to sell your Common Shares held in a dividend reinvestment account.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_90D_ecef--OtherTransactionFeesNoteTextBlock_c20251015__20251015_zV6ecFEyaxHg"&gt;Total offering costs, which will be borne by Nuveen Fund Advisors and not the Fund or Common Shareholders, are estimated to be $375,000, which assumes that the Rights offering is fully subscribed.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#x201c;Plan Agent&#x201d;), to sell your Common Shares held in a dividend reinvestment account.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:BasisOfTransactionFeesNoteTextBlock contextRef="AsOf2025-10-15" id="Fact000019">(as a percentage of common net assets
    including proceeds of the offering)</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:OtherTransactionExpense1Percent
      contextRef="AsOf2025-10-15"
      decimals="INF"
      id="Fact000020"
      unitRef="Ratio">0</cef:OtherTransactionExpense1Percent>
    <cef:OtherTransactionExpense2Percent
      contextRef="AsOf2025-10-15"
      decimals="INF"
      id="Fact000021"
      unitRef="Ratio">0</cef:OtherTransactionExpense2Percent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="AsOf2025-10-15"
      decimals="2"
      id="Fact000022"
      unitRef="USD">2.50</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:AnnualExpensesTableTextBlock contextRef="AsOf2025-10-15" id="Fact000027">&lt;div id="xdx_801_ecef--AnnualExpensesTableTextBlock_dU_gL1AETTB-WBQWO_zOYuGDr7ExJ6"&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="vertical-align: top; width: 87%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; width: 11%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As a Percentage &lt;br/&gt; of Net Assets&lt;br/&gt; Attributable to&lt;br/&gt; Common &lt;br/&gt; Shares&lt;sup&gt;(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Annual Expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management Fees&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecef--ManagementFeesPercent_dp_c20251015__20251015_fKDMp_zzGGfjMRB9Ug" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.20&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="vertical-align: top; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest and Other Related Expenses&lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecef--InterestExpensesOnBorrowingsPercent_dp_c20251015__20251015_fKDMpKDQp_zUO7xuhwzGQk" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2.16&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other Expenses&lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecef--OtherAnnualExpensesPercent_dp_c20251015__20251015_fKDMpKDUp_z2q7KxYaC2Wk" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.11&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total Annual Expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecef--TotalAnnualExpensesPercent_dp_c20251015__20251015_fKDMp_z00ZuLpY61Rd" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;3.47&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F0D_zeZYgDU7X0V8"&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_F17_zqFUJIyW4KH8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stated as percentages of average net assets
    attributable to Common Shares for the six-month period ended June 30, 2025 (unaudited).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F0D_z7gP7arp7nK2"&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_F11_zKjaEorI4tU2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest and Other Related
    Expenses reflect actual expenses and fees for leverage incurred by the Fund for the six-month period ended June 30, 2025
    (annualized). The types of leverage used by the Fund for the six-month period ended June 30, 2025 (annualized) are described in the
    Fund Performance, Leverage and Holdings Summaries &#x2014; Leverage and Holdings section of the Fund&#x2019;s &lt;a href="https://www.sec.gov/Archives/edgar/data/1539337/000119312525196804/d64165dncsrs.htm"&gt;semi-annual report&lt;/a&gt;, Actual Interest and Other Related Expenses incurred in the future may be higher or lower. If short-term market interest
    rates rise in the future, and if the Fund continues to maintain leverage, the cost of which is tied to short-term interest rates,
    the Fund's interest expenses on its short-term borrowings can be expected to rise in tandem. The Fund's use of leverage will
    increase the amount of management fees paid to the Fund's adviser and sub-advisor(s).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F0E_zH6joYWD4Qsh"&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_F12_z9U7zJAY38hb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecef--OtherExpensesNoteTextBlock_c20251015__20251015_zheN3r5ojcp9"&gt;Other Expenses is based on estimated amounts for the current fiscal year. Expenses attributable to the Fund&#x2019;s investments, if any, in other investment companies are currently estimated not to exceed 0.01%. See &#x201c;The Fund&#x2019;s Investments&#x2014;Other Investment Companies&#x201d; in the SAI.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="AsOf2025-10-15"
      decimals="INF"
      id="Fact000028"
      unitRef="Ratio">0.0120</cef:ManagementFeesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="AsOf2025-10-15"
      decimals="INF"
      id="Fact000029"
      unitRef="Ratio">0.0216</cef:InterestExpensesOnBorrowingsPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="AsOf2025-10-15"
      decimals="INF"
      id="Fact000030"
      unitRef="Ratio">0.0011</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="AsOf2025-10-15"
      decimals="INF"
      id="Fact000031"
      unitRef="Ratio">0.0347</cef:TotalAnnualExpensesPercent>
    <cef:OtherTransactionFeesNoteTextBlock contextRef="AsOf2025-10-15" id="Fact000032">Total offering costs, which will be borne by Nuveen Fund Advisors and not the Fund or Common Shareholders, are estimated to be $375,000, which assumes that the Rights offering is fully subscribed.</cef:OtherTransactionFeesNoteTextBlock>
    <cef:OtherExpensesNoteTextBlock contextRef="AsOf2025-10-15" id="Fact000036">Other Expenses is based on estimated amounts for the current fiscal year. Expenses attributable to the Fund&#x2019;s investments, if any, in other investment companies are currently estimated not to exceed 0.01%. See &#x201c;The Fund&#x2019;s Investments&#x2014;Other Investment Companies&#x201d; in the SAI.</cef:OtherExpensesNoteTextBlock>
    <cef:ExpenseExampleTableTextBlock contextRef="AsOf2025-10-15" id="Fact000038">&lt;p id="xdx_809_ecef--ExpenseExampleTableTextBlock_dU_z3JZg0zh3Pvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Example&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The following example illustrates the
expenses that a Common Shareholder would pay on a $1,000 investment held for the time periods provided in the table, assuming a 5%
annual total return. The example assumes that all dividends and other distributions are reinvested in the Fund and that the
Fund&#x2019;s Annual Total Expenses, as provided above, remain the same.&lt;sup&gt;1&lt;/sup&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center; width: 6%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1&#160;Year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center; width: 6%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3&#160;Years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center; width: 6%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5&#160;Years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center; width: 6%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;10&#160;Years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td id="xdx_983_ecef--ExpenseExampleYear01_c20251015__20251015_fKDEp_zntPFca9yiTj" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$35&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecef--ExpenseExampleYears1to3_c20251015__20251015_fKDEp_zCKBbwQAyJ8e" style="text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$107&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecef--ExpenseExampleYears1to5_c20251015__20251015_fKDEp_z145oz8kH8P7" style="text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$180&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecef--ExpenseExampleYears1to10_c20251015__20251015_fKDEp_zJOorvNNXNib" style="text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$375&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;b&gt;The example should not be considered a representation of future expenses. Actual expenses may be greater or less than those shown above.&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 37px"&gt;
        &lt;p id="xdx_F0E_zogCGKyrdQll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(1)&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span id="xdx_F16_zkBZTMB5ZdX8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The example assumes that all dividends and distributions are reinvested at Common Shares NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#x2019;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="AsOf2025-10-15"
      decimals="0"
      id="Fact000039"
      unitRef="USD">35</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="AsOf2025-10-15"
      decimals="0"
      id="Fact000040"
      unitRef="USD">107</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="AsOf2025-10-15"
      decimals="0"
      id="Fact000041"
      unitRef="USD">180</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="AsOf2025-10-15"
      decimals="0"
      id="Fact000042"
      unitRef="USD">375</cef:ExpenseExampleYears1to10>
    <cef:SharePriceTableTextBlock contextRef="AsOf2025-10-15" id="Fact000045">&lt;p id="xdx_808_ecef--SharePriceTableTextBlock_dU_znTbprxup8Ma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&lt;span id="jdc424b2a004"&gt;&lt;/span&gt;TRADING AND NET ASSET VALUE INFORMATION&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The following table shows for the periods
indicated: (i)&#160;the high and low sales prices for the Common Shares reported as of the end of the day on the NYSE, (ii)&#160;the
corresponding NAV per share, and (iii)&#160;the premium/(discount) to NAV per share at which the Common Shares were trading as of such date. The Fund&#x2019;s Common Shares have historically traded both at premiums and discounts in relation to the Fund&#x2019;s NAV
per share. The Fund cannot predict whether its Common Shares will trade at a premium or discount to NAV in the future. The Board of Trustees has currently determined that, at least annually, it will consider action that might be taken to
reduce or eliminate any material discount from NAV in respect of Common Shares, which may include the repurchase of such shares in
the open market or in private transactions, the making of a tender offer for such shares at NAV, or the conversion of the Fund to an
open-end investment company. The Fund cannot assure you that its Board of Trustees will decide to take any of these actions, or that
share repurchases or tender offers will actually reduce market discount.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; visibility: hidden; vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_488_ecef--HighestPriceOrBid_pip0_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zaTjawnlijIk" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_486_ecef--LowestPriceOrBid_pip0_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zyomduCtHsVe" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_489_ecef--HighestPriceOrBidNav_pip0_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zstYx6w3jhS9" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_487_ecef--LowestPriceOrBidNav_pip0_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z0xGJsvwXc0f" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_484_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_pid_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zSapAyDehcpf" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_488_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_pid_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zooEAgHxynki" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Closing Market Price per&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;NAV per Common Share on&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Premium/(Discount) on&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Common Share&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Date of Market Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Date of Market Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Fiscal Quarter Ended&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;High&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Low&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;High&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Low&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;High&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Low&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41E_20250701__20250930_zdzUC7bdKc03" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-align: left"&gt;September 2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;13.64&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;12.92&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;14.02&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;13.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;(2.71&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;(5.90&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_413_20250401__20250630_zNVxSYsSweLb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;June 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.53&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.89&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3.92&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10.94&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_416_20250101__20250331_zhPNlNZQwh07" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;March 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.42&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.80&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.97&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.57&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3.94&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.67&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_419_20241001__20241231_ztLmcHbugR35" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;December 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.94&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.82&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4.02&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7.96&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41D_20240701__20240930_zxYlfw1xxEV7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;September 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.42&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.95&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.33&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4.09&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6.83&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_417_20240401__20240630_zu3Th7tVGVi3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;June 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.51&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3.40&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7.16&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41B_20240101__20240331_z6Km33QRVof9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;March 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.96&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.51&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.17&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4.37&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9.19&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41D_20231001__20231231_zfymxGebu8Y1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;December 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.24&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.09&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(8.52&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(13.98&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41C_20230701__20230930_zYVuOdEuj0V2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;September 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.17&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.91&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7.13&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12.19&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_415_20230401__20230630_z482sluLYF29" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;June 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.39&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.65&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.42&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10.53&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14.25&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_414_20230101__20230331_z8oR9EjfSsIa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;March 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.62&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.67&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.55&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.44&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6.86&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14.23&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The NAV per Common Share, the market price and
percentage of premium/(discount) to NAV per Common Share on October 8, 2025,  was &lt;span id="xdx_90A_eus-gaap--NetAssetValuePerShare_iI_c20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zeD00yrjY0M"&gt;$14.05,
&lt;/span&gt; &lt;span id="xdx_909_eus-gaap--SharePrice_iI_c20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbF0DfEChS13"&gt;$13.62,
&lt;/span&gt;and &lt;span id="xdx_90B_ecef--LatestPremiumDiscountToNavPercent_dp_c20251008__20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zPwAZbEjvA1j"&gt;(3.06)&lt;/span&gt;%,
respectively. As of October 8, 2025, the Fund had&#160;&lt;span id="xdx_904_ecef--OutstandingSecurityNotHeldShares_c20251008__20251008__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zgwSi8IFiXDd"&gt;23,177,393&lt;/span&gt;&#160;Common
Shares outstanding, and net assets applicable to Common Shares of $325,657,313. See &#x201c;Repurchase of Fund Shares; Conversion to Open-End
Fund&#x201d; in the accompanying prospectus.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

</cef:SharePriceTableTextBlock>
    <cef:HighestPriceOrBid
      contextRef="From2025-07-012025-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000046"
      unitRef="USDPShares">13.64</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2025-07-012025-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000047"
      unitRef="USDPShares">12.92</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2025-07-012025-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000048"
      unitRef="USDPShares">14.02</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2025-07-012025-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000049"
      unitRef="USDPShares">13.73</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-07-012025-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000050"
      unitRef="Ratio">-0.0271</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-07-012025-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000051"
      unitRef="Ratio">-0.0590</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000052"
      unitRef="USDPShares">13.00</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000053"
      unitRef="USDPShares">11.48</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000054"
      unitRef="USDPShares">13.53</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000055"
      unitRef="USDPShares">12.89</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000056"
      unitRef="Ratio">-0.0392</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000057"
      unitRef="Ratio">-0.1094</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000058"
      unitRef="USDPShares">13.42</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000059"
      unitRef="USDPShares">12.80</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000060"
      unitRef="USDPShares">13.97</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000061"
      unitRef="USDPShares">13.57</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000062"
      unitRef="Ratio">-0.0394</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000063"
      unitRef="Ratio">-0.0567</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000064"
      unitRef="USDPShares">13.38</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000065"
      unitRef="USDPShares">12.72</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000066"
      unitRef="USDPShares">13.94</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000067"
      unitRef="USDPShares">13.82</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000068"
      unitRef="Ratio">-0.0402</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-10-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000069"
      unitRef="Ratio">-0.0796</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000070"
      unitRef="USDPShares">13.38</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000071"
      unitRef="USDPShares">12.42</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000072"
      unitRef="USDPShares">13.95</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000073"
      unitRef="USDPShares">13.33</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000074"
      unitRef="Ratio">-0.0409</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000075"
      unitRef="Ratio">-0.0683</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000076"
      unitRef="USDPShares">13.05</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000077"
      unitRef="USDPShares">12.18</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000078"
      unitRef="USDPShares">13.51</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000079"
      unitRef="USDPShares">13.12</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000080"
      unitRef="Ratio">-0.0340</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000081"
      unitRef="Ratio">-0.0716</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000082"
      unitRef="USDPShares">12.92</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000083"
      unitRef="USDPShares">11.96</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000084"
      unitRef="USDPShares">13.51</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000085"
      unitRef="USDPShares">13.17</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000086"
      unitRef="Ratio">-0.0437</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000087"
      unitRef="Ratio">-0.0919</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000088"
      unitRef="USDPShares">12.24</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000089"
      unitRef="USDPShares">10.40</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000090"
      unitRef="USDPShares">13.38</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000091"
      unitRef="USDPShares">12.09</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000092"
      unitRef="Ratio">-0.0852</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-10-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000093"
      unitRef="Ratio">-0.1398</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000094"
      unitRef="USDPShares">11.99</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000095"
      unitRef="USDPShares">11.17</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000096"
      unitRef="USDPShares">12.91</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000097"
      unitRef="USDPShares">12.72</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000098"
      unitRef="Ratio">-0.0713</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000099"
      unitRef="Ratio">-0.1219</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000100"
      unitRef="USDPShares">11.39</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000101"
      unitRef="USDPShares">10.65</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000102"
      unitRef="USDPShares">12.73</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000103"
      unitRef="USDPShares">12.42</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000104"
      unitRef="Ratio">-0.1053</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000105"
      unitRef="Ratio">-0.1425</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000106"
      unitRef="USDPShares">12.62</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000107"
      unitRef="USDPShares">10.67</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000108"
      unitRef="USDPShares">13.55</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000109"
      unitRef="USDPShares">12.44</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000110"
      unitRef="Ratio">-0.0686</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000111"
      unitRef="Ratio">-0.1423</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2025-10-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000112"
      unitRef="USDPShares">14.05</us-gaap:NetAssetValuePerShare>
    <us-gaap:SharePrice
      contextRef="AsOf2025-10-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000113"
      unitRef="USDPShares">13.62</us-gaap:SharePrice>
    <cef:LatestPremiumDiscountToNavPercent
      contextRef="From2025-10-082025-10-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000114"
      unitRef="Ratio">-0.0306</cef:LatestPremiumDiscountToNavPercent>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="From2025-10-082025-10-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000115"
      unitRef="Shares">23177393</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="From2025-10-082025-10-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000116"
      unitRef="Shares">23177393</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="From2025-10-082025-10-08_custom_CommonStockAdjustedForOfferingMember"
      decimals="INF"
      id="Fact000117"
      unitRef="Shares">29006741</cef:OutstandingSecurityNotHeldShares>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2025-10-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000118"
      unitRef="USDPShares">14.05</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2025-10-08_custom_CommonStockAdjustedForOfferingMember"
      decimals="INF"
      id="Fact000119"
      unitRef="USDPShares">13.81</us-gaap:NetAssetValuePerShare>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000020"
          xlink:label="Fact000020"
          xlink:type="locator"/>
        <link:footnote id="Footnote000023" xlink:label="Footnote000023" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Total offering costs, which will be borne by Nuveen Fund Advisors and not the Fund or Common Shareholders, are estimated to be $375,000, which assumes that the Rights offering is fully subscribed.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000020"
          xlink:to="Footnote000023"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000021"
          xlink:label="Fact000021"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000023"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000022"
          xlink:label="Fact000022"
          xlink:type="locator"/>
        <link:footnote id="Footnote000024" xlink:label="Footnote000024" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#x201c;Plan Agent&#x201d;), to sell your Common Shares held in a dividend reinvestment account.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000022"
          xlink:to="Footnote000024"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000028"
          xlink:label="Fact000028"
          xlink:type="locator"/>
        <link:footnote id="Footnote000033" xlink:label="Footnote000033" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Stated as percentages of average net assets
    attributable to Common Shares for the six-month period ended June 30, 2025 (unaudited).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000028"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnote id="Footnote000034" xlink:label="Footnote000034" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Interest and Other Related
    Expenses reflect actual expenses and fees for leverage incurred by the Fund for the six-month period ended June 30, 2025
    (annualized). The types of leverage used by the Fund for the six-month period ended June 30, 2025 (annualized) are described in the
    Fund Performance, Leverage and Holdings Summaries &#x2014; Leverage and Holdings section of the Fund&#x2019;s <xhtml:a href="https://www.sec.gov/Archives/edgar/data/1539337/000119312525196804/d64165dncsrs.htm">semi-annual report</xhtml:a>, Actual Interest and Other Related Expenses incurred in the future may be higher or lower. If short-term market interest
    rates rise in the future, and if the Fund continues to maintain leverage, the cost of which is tied to short-term interest rates,
    the Fund's interest expenses on its short-term borrowings can be expected to rise in tandem. The Fund's use of leverage will
    increase the amount of management fees paid to the Fund's adviser and sub-advisor(s).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000030"
          xlink:label="Fact000030"
          xlink:type="locator"/>
        <link:footnote id="Footnote000035" xlink:label="Footnote000035" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Other Expenses is based on estimated amounts for the current fiscal year. Expenses attributable to the Fund&#x2019;s investments, if any, in other investment companies are currently estimated not to exceed 0.01%. See &#x201c;The Fund&#x2019;s Investments&#x2014;Other Investment Companies&#x201d; in the SAI.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000031"
          xlink:label="Fact000031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000039"
          xlink:label="Fact000039"
          xlink:type="locator"/>
        <link:footnote id="Footnote000043" xlink:label="Footnote000043" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The example assumes that all dividends and distributions are reinvested at Common Shares NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#x2019;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000039"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000040"
          xlink:label="Fact000040"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000040"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000041"
          xlink:label="Fact000041"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000041"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000042"
          xlink:label="Fact000042"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000042"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
